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Summary
Gut-derived bacteria enter the liver via the portal vein where they induce
an innate immune response leading to inflammation. Lipopolysaccharide,
a part the baterial cell wall component endotoxin, functions as stimulus for
toll-like receptors in non-parenchymal liver cells leading to secretion of di-
verse cytokines. Among these cytokines tumor necrosis factor (TNF) is one
of the first to be produced. It binds to the TNF receptors of hepatocytes and
activates NF-κB signalling. The transcription factor NF-κB enhances gene
expressions of acute phase proteins. Its signalling primes hepatocytes for
cell proliferation.
In this work, I have studied NF-κB signalling in hepatocytes in various ways,
using computational models trained and validated with experimental data
from primary murine cells. First, I extended an ODE model of canonical NF-
κB signalling to include the experimentally validated influence of p38 MAPK
signalling on this signalling pathway. Additionally, by including the receptor
level to the model, I ensured an accurate description of dose response mea-
surements for the main pathway components. This was especially important
for the second part of this work, where I used the ODE intra-hepatocellular
model to investigate the influence of different non-parenchymal cells on
hepatocytes in the liver. By combining information on cell abundance and
cell size, and experimental TNF secretion profiles in response to LPS with
this ODE model, I was able to establish for the first time a computational
model combing all liver cell types relevant to LPS-induced TNF secretion
and intra-hepatocellular NF-κB signalling. I could show that liver resident
macrophages and liver sinusoidal endothelial cells produce the most TNF in
response to LPS. Furthermore, my simulations showed that not the final lev-
els of TNF regulate the in vivo response, rather the initial cytokine increase
defines how strongly NF-κB signalling is activated in hepatocytes. As a third
part I converted the ODE model into a PDE model, which describes possible
temporal and spatial aspects of single cell microscopy measurements. I was
able to show that the relevant reaction parameters of the ODE model could
be used for PDE simulations to describe experimental data on the localisa-
tion of fluorescently labeled NF-κB molecules after TNF stimulation. Further-
more, I could show that the dynamics observed on a population-based level
were comparable to those observable on a single cell level.
These new insights into NF-κB signalling in the liver may change experi-
mental procedures with respect to cytokine administration when analysing
inflammation. Furthermore, the new multi-cellular model can serve as a
basis for simulating the influence of non-parenchymal cells on hepatocytes
under various experimental conditions.
Zusammenfassung
Darmstämmige Bakterien gelangen über die Vena partae hepatis (Leber-
pfortader) in die Leber. Dort aktiverien sie die unspezifische Immunantwort,
welche zu Entzündungsprozessen führt. Lipopolysaccharide, Teile des Bak-
terienzellwandbestandteils Endotoxin, sind Stimuli für Toll-Like-Rezeptoren
von nicht-parenchymalen Zellen und führen zur Sekretion von diversen Zy-
tokinen. Unter diesen Zytokinen ist Tumornekrosefaktor (TNF) eines der ers-
ten, welches produziert wird. Es bindet an TNF-Rezepotren von Hepatozyten
und aktiviert die NF-κB-Signaltransduktion. Der Transkriptionsfaktor NF-κB
aktiviert die Genexpression von Akutphaseproteinen, seine Signaltransduk-
tion bereitet Hepatozyten auf die Zellproliferation vor.
In dieser Arbeit habe ich die NF-κB Signaltransduktion, unter Zuhilfenahme
von computergestützen Modellen, die mit experimentellen Daten trainiert
und validiert wurden, auf verschieden Arten studiert. Zuerst habe ich ein
differentialgleichungsbasiertes Modell des kanonischen NF-κB-Signalweges
erweitert, so dass es den experimentell validierten Einfluss der p38-MAPK-
Signaltransduktion beinhaltet. Zusätzlich habe ich eine exakte Beschreibung
von dosisabhängigen Messungen der Hauptbestandteile der NF-κB Signal-
transduktion gewährleistet, in dem ich die Rezeptorebene mit eingebaut
habe. Dies war besonders wichtig, da ich das ODE-Modell verwendet ha-
be, um den Einfluss der nicht-parenchymalen Zellen auf Hepatozyten in der
Leber zu analysieren. Indem ich Zellverteilungen und Zellgrößen mit TNF-
Sekretionsprofilen als Antwort auf LPS-Stimulierung der nicht-parenchymalen
Zellen und dieses ODE-Modell kombiniert habe, konnte ich zum ersten Mal
ein computergestütztes Modell aller Zelltypen der Leber, die für die LPS in-
duzierte TNF-Sekretion und die intrahepatozelluläre NF-κB-Signaltransduktion
relevant sind, erstellen. Ich konnte zeigen, dass leberspezifische Makropha-
gen und Lebersinusiodalendothelzellen am meisten TNF als Antwort auf LPS
produzieren. Darüber hinaus haben meine Simulationen gezeigt, dass nicht
die finalen TNF-Konzentrationen, sondern der initiale TNF-Ansteig bestimmt,
wie stark die Hepatozytenantwort ausfällt. Als dritten Teil dieser Arbeit ha-
be ich das ODE-Modell zu einem partiellen-Differentailgleichungs- (PDE) Mo-
dell erweitert, das zeitliche und räumliche Aspekte der Mikroskopieeinzel-
zellmessungen beschreibt. Ich konnte zeigen, dass die relevanten Reakti-
onsparameter des ODE-Modells auch in PDE–Simulationen experimentelle
Daten zur Lokalisation von fluoreszenzmarkiertem NF-κB gut beschreiben.
Desweiteren konnte ich zeigen, dass die Dynamiken, die auf Populations-
ebene beschrieben wurden, mit denen auf Einzellebene vergleichbar waren.
Diese neuen Einsichten zur NF-κB-Signaltransduktion in der Leber zeigen,
dass die experimentellen Protokolle zur Zytokinadmistration bei der Unter-
suchung von Entzündungsprozessen überdacht werden sollten. Außerdem
kann das neue multizelluläre Modell als Grundlage für Simulationen des Ein-
flusses der nicht-parenchymal Zellen auf Hepatozyten unter diversen epxe-
rimentellen Bedingungen genutzt werden.
Contents
Summary
Zusammenfassung
1 Introduction 1
1.1 The Liver . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1.1 Hepatocytes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.1.2 Stellate Cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.1.3 Liver Resident Macrophages . . . . . . . . . . . . . . . . . . . . 3
1.1.4 Sinusoidal Endothelial Cells . . . . . . . . . . . . . . . . . . . . 3
1.2 The Canonical NF-κB Signalling Pathway . . . . . . . . . . . . . . . . 4
1.2.1 The Signalosome . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.2.2 NF-κBs and IκBs . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
1.2.3 Inhibitors and Activators . . . . . . . . . . . . . . . . . . . . . . 5
1.2.4 Possible Crosstalk with IL-6-induced STAT3 Signalling . . . 7
1.2.5 Possible Crosstalk with Hippo/YAP Signalling . . . . . . . . . 7
1.3 Mathematical Models in Biology . . . . . . . . . . . . . . . . . . . . . 7
1.3.1 ODE Models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.3.2 PDE Models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
1.3.3 Model Parameters . . . . . . . . . . . . . . . . . . . . . . . . . . 9
1.3.4 NF-κB Models in Literature . . . . . . . . . . . . . . . . . . . . . 10
2 Material and Methods 12
2.1 Experimental Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
2.2 Data Processing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
2.3 ODE Simulations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
2.4 Automated Analysis of Protein-Protein-Interactions from STRING-
DB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
2.5 PDE Simulations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
2.6 Analysis of Single Cell Fluorescent Microscopy Images . . . . . . . 13
3 Results 15
3.1 Data Processing for Population Based Measurements . . . . . . . . 15
3.2 Using the FIM to Reduce the Dimensions of the Parameter Esti-
mation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
3.3 Analyzing and Enlarging the ODE-based NF-κB Model . . . . . . . 22
3.3.1 Hippo-YAP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
3.3.2 p38-MAPK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
3.3.3 NF-κB Dose Response in Hepatocytes . . . . . . . . . . . . . 23
3.3.4 Hepatocarcinoma Cell lines . . . . . . . . . . . . . . . . . . . . 29
3.4 Multi-Scale Model of NF-κB in the Liver . . . . . . . . . . . . . . . . . 29
3.4.1 Cell Type Specific Volumes . . . . . . . . . . . . . . . . . . . . . 29
3.4.2 Non-Parenchymal Cells’ Responses to LPS . . . . . . . . . . . 30
3.4.3 Hepatocellular Response to Non-Parenchymal Cells’ Se-
cretion Profiles . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
3.5 Spatial Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
3.5.1 Single Cell Analysis . . . . . . . . . . . . . . . . . . . . . . . . . 37
3.5.2 From ODEs to PDEs . . . . . . . . . . . . . . . . . . . . . . . . . 38
3.5.3 PDE Model Simulation . . . . . . . . . . . . . . . . . . . . . . . . 42
4 Discussion 48
4.1 Crosstalks in NF-κB Signalling in Hepatocytes . . . . . . . . . . . . 48
4.2 Extending the in vitro Model to Capture Dose Responsiveness . 49
4.2.1 Model Parameterization . . . . . . . . . . . . . . . . . . . . . . . 50
4.3 Modeling Liver Micro-Anatomy . . . . . . . . . . . . . . . . . . . . . . 51
4.3.1 TNF Amounts in the Liver Versus in vitro . . . . . . . . . . . . 52
4.4 NF-κB Signalling in the Liver . . . . . . . . . . . . . . . . . . . . . . . . 52
4.5 Linking NF-κB Signalling During Inflammation to Cancer . . . . . 54
4.6 Single Cell Investigations and PDE Modeling . . . . . . . . . . . . . 55
4.7 Concluding Remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
Acknowledgments 59
References 60
A Appendix 71
List of Figures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
List of Tables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
Abbreviations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
A.1 Experimental Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
A.2 TNF/NF-κB and Hippo/YAP Crosstalk Found by Martin Zauser . . . 92
A.3 ODE Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
A.4 Fisher Information Results . . . . . . . . . . . . . . . . . . . . . . . . . 118
A.5 Supplementary DVD contents . . . . . . . . . . . . . . . . . . . . . . . 135
1 Introduction
The liver is subject to many gut-derived bacteria and plays an important role
as a front-line immunological organ in the innate and adaptive immune re-
sponse [1]. On the microscopic scale, as one of the first events TNF-induced
NF-κB signalling orchestrates the early innate immune response during bac-
terial infection-induced inflammation [2]. During my PhD I have chosen dif-
ferent systems biology approaches to study this signalling pathway in hep-
atocytes, the main liver cells, and how other liver cell types induce it during
inflammation.
In the following introduction some biological and mathematical/computational
background knowledge will be given. I will present the histological setup of
the liver and the role of the different liver cells with emphasis on the in-
nate immune response, the canonical NF-κB pathway and its main players,
along with the JNK/p38/MAPK, IL-6/JAK/STAT and Hippo/YAP pathway. On the
mathematical/computational side I will present the basics of describing bio-
chemical reaction networks as compartmentalized, kinetic ODE models and
as biochemical reaction-diffusion PDE models.
1.1 The Liver
The main functions of the liver in mammalians are: regulation of blood
sugar, detoxification, and bile production. The hormones, insulin, adrenalin,
and glucagon regulate the hepatic sugar uptake and release. Insulin pro-
duced by α cells in pancreatic islets induces glucose uptake by hepatocytes.
There it is stored as glycogen and adrenalin or glucagon can trigger glycogen
breakdown and release. During detoxification hepatocytes take up many
drugs or metabolites which are insoluble in water. By bio-transformation
or conjugation with hydroxyl groups these molecules are then made water-
soluble [3].
Additionally, the liver is an important organ of the immune system. Its
special micro-architecture facilitates its significant role in clearance of gut-
derived bacteria delivered through the portal vein [1]. The main liver cells
making up 60% of liver mass are hepatocytes (Table 1). These parenchymal
cells form single cell thick plates with sinusoids on either side. The three
major non-parenchymal cells in the liver are: liver resident macrophages or
Kupffer cells (MCs) in the sinusoids, liver sinusoidal endothelial cells (LSECs)
separating the sinuoids and the hepatocytic plates, and hepatic stellate cells
(HSCs) in the space of Disse between the LSECs and hepatocytes (Figure
1.1). Each cell type produces cytokines and chemokines in response to cy-
tokines and chemokines produced by the other cells which form a unique
environment that at the same time ensures the correct differentiation of
liver cells. For example, MCs are retained in the liver by cytokines and
chemokines from LSECs. The cytokines and chemokines from MCs are nec-
essary for LSECs to correctly from their fenestrae clusters, so called sieves,
without a basal membrane, allowing most blood components except for
larger cells to diffuse into the space of Disse [4].
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Figure 1.1: Graphical depiction of the liver micro anatomy showing the loca-
tion of the different cell types in the liver.
Table 1: In 1977 Blouin et al. experimentally analysed the liver mico-
anatomy with electron microscopy and determined the relative distributions
of liver cells per liver volume and total liver cells [5]. (LSEC: liver sinusoidal
endothelial cells, MC: liver resident macrophages, HSC hepatic stellate cells)
Hepato- LSEC MC HSC Space of Sinusoidal
cytes Disse Lumen
% of total volume 77.8 2.8 2.1 1.4 4.9 10.6
% of total liver cells 60 19 15 5-8 – –
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1.1.1 Hepatocytes
Hepatocytes are the main liver cells with respect to both abundance and
mass (Table 1). They fulfill all the main tasks of the liver. They are vital to
regulating the blood sugar level, by taking up sugar from the blood, storing
it as glycogen, and releasing it when needed. Furthermore, they produce
bile fluid, and are vital to copper and iron metabolism, as well as detoxifi-
cation. During inflammation they may play a role in pathogen clearance via
endocytosis pathogen toxins [6, 7]. Hepatocytes express TLR4 receptors,
which can be bound by LPS, however, they do not directly response with
NF-κB signalling to LPS [8]. They produce many cytokines and chemokines
and are responsive towards cytokines from non-parenchymal cells [9, 1].
1.1.2 Stellate Cells
Hepatic stellate cells (Ito cells or fat-storing cells, HSCs) are astral cells
which reside outside of the sinusoidal lumen in the space of Disse. They
form long projections reaching around hepatocytes. In the absence of liver
damage or inflammation they are in a quiescent state, where their known
functions are vitamin A and lipid storage. During inflammation or liver dam-
age they proliferate and differentiate into myofibroblasts. They are the main
producers of collagen in the liver and thus are strongly involved in liver cir-
rhosis [10].
1.1.3 Liver Resident Macrophages
Liver Resident Macrophages (Kupffer cells, MCs) are bone marrow derived
macrophages which enter the liver via the portal vein. In contrast to other
macrophages, which are non-resident and circulate through the body, MCs
are trained to be resident by cytokines expressed by LSECs. They patrol
the sinusoid and together with HSCs they can slow its blood flow, by es-
sentially blocking the sinusoid. During inflammation their main function is
phagocytosis of gut derived pathogens and initiation of both innate an adap-
tive immune responses, via cytokines and as anti-body presenting cells [11].
1.1.4 Sinusoidal Endothelial Cells
Liver Sinusoidal Endothelial Cells (LSECs) form the endothelial border be-
tween the sinusoid and hepatocytes. They do not form a basal membrane
yet still contain large fenestrae clustered together in sieves which is a unique
endothelial form found no where else in the body. Thus there is a small
space between the LSECs and hepatocytes called space of Disse. The LSEC
control the molecules entering the space of Disse through their fenestrae.
Molecules of up to 120 nm can pass through the fenestrea and at the same
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time molecules as small as 12 nm can hindered of passing. LSEC are anti-
body presenting cells and can phagocyte diverse pathogens [12, 13, 14].
1.2 The Canonical NF-κB Signalling Pathway
Signal transduction via NF-κB is the integration point for various cues and
signals regarding cell fate. It plays an important role during infection, tissue
regeneration after injuries, autoimmune diseases, and cancer [9, 15]. In
these cases cellular decision making is a tremendously important event, as
coming back from necrosis or apoptosis is essentially impossible for a cell.
Similarly, proliferation requires resources and needs to be tightly controlled
to avoid cancer. NF-κB activation alone cannot trigger any of the processes
mentioned above. But its role in all of them is unique and usually it is one
of the first steps in a tightly regulated set of steps leading up to them [16].
1.2.1 The Signalosome
The name NF-κB signalling comprises many individual pathways [15]. They
can be activated by many different stimuli, such as viral RNA, DNA dam-
age, components of the bacterial cell wall, cytokines, or chemokines [17].
These stimuli each act through different molecules and lead to different cell
responses. The feature they have in common, is the activation of a NF-κB
dimer by repressing a NF-κB inhibitor (IκB). The canonical NF-κB signalling
can be activated by interleukin 1 alpha or beta (IL-1α or IL-1β) via IL-1R,
TNF via TNFR1, and lipopolysaccharide (LPS) via TLR4 [15]. All four stim-
uli act through IκB kinase (IKK)β phosphorylating IκBα, whose subsequent
ubiquination targets it for degradation. The NF-κB hetero dimer p50:p65 is
freed and can than act as transcription factors in the nucleus. This work
focuses on the TNF-induced canonical pathway, which has been studied in
some detail and the exact steps in the signalling cascade are described be-
low [].
TNF is a cytokine secreted by many cells. In its trimeric soluble form it
can bind to TNF receptor (TNFR) 1 and induce the recruitment of several
scaffolding proteins. First, TNFR-associated death domain protein (TRADD)
binds to the death domain of the TNFR1 [18]. TRADD then recruits receptor-
interacting serine/threonine-protein kinase (RIPK) 1 and together they re-
cruit the scaffolding protein TNF receptor associated factor (TRAF) 2 [19, 20].
TRAF2 can than bind cellular inhibitor of apoptosis protein (cIAP) 1 and cIAP2
(also know as BRIC1 and BRIC2) which can ubiquinate RIPK1. Together these
proteins form the so called complex I. (As apposed to the complex II consist-
ing of Fas-associated death domain protein (FADD) and caspase 8, which
induces cell death signalling.) RIPK1 is required for IKK activation, however,
most probably as a scaffolding protein, as NF-κB signalling is intact in kinase
deficient RIPK1 mutants [21]. RIPK1 facilitates TGFβ-activated kinase (TAK)
1 recruitment. TAK1 is bound to TAK1 associated binding protein (TAB) 2 and
TAB3 in the TAK1 complex. Most probably RIPK1 recruits the IKK complex
through NF-κB essential modifier (Nemo or IKKγ) together with TAK1 acting
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through TAB2. Thus the RIPK1-induced close proximatey of TAK1 and IKK
complexes leads to auto-trans-phosphorylation of TAK1 and IKK complexes
and thus activation of the IKK complex [22]. IKKβ can then phosphorylate
IκBα [23].
1.2.2 NF-κBs and IκBs
First discovered in 1986 [24], the nuclear factor κ light-chain-enhancer of B
cells (NF-κB) family consists of five members p65 (or RelA), RelB, C-Rel, p50
(or in its uncleaved form p105), and p52 (or in its uncleaved form p100). All
members contain the N-terminal Rel homology domain with which they can
bind κB-sites in DNA and form homo- and heterodimers. RelB is the only
NF-κB protein which cannot form homodimers. p65, RelB and C-Rel addi-
tionally contain a transcription activation domain with which they can bind
to p300, CBP, histone deacteylases (HDACs), and other transcription factors
to recruit the RNA-Polymerase II complex [25, 26].
Without stimulation a large property of the NF-κB is bound by inhibitors
(IκBs). Just as there are several NF-κBs, there are several IκB family mem-
bers: IκBα, IκBβ, IκBγ, IκBδ (IκBNS), IκBε, IκBζ, BCL-3, and the NF-κB pre-
cursor forms p100 (NF-κB1, precursor of p52) and p105 (NF-κB2, precursor
of p50). They all contain ankyrin repeat domains and bind NF-κB dimers
[22].
The canonical pathway describes mainly the NF-κB heterodimer p52:p65
bound to IκBα and how it is then freed. However, IκBε is among the genes
which are activated by p65 and can help turn-off NF-κB signalling [27].
1.2.3 Inhibitors and Activators
The NF-κB pathway has many regulators and crosstalks to other pathways.
Here, I would like to focus on A20 (or TNFAIP3) and phosphorylation of RelA.
A20 is a (de-)ubiquitinase. It’s role in NF-κB signalling is discussed vigor-
ously in literature [28]. It functions mainly upstream of the IKK complex
and inhibits its activation. In the TNF induced cannoncial pathway A20 most
likely by ubiquitinating RIP1, thus inhibiting the interactions of RIP1 with TAK
and IKK complexes. Furthermore, A20 is a target gene of NF-κB and its ex-
pression is induced by the canonical pathway, thus introducing an additional
negative feed-back to the NF-κB pathway [28].
During TNF induced signalling the activated TAK complex also leads to phos-
phorylation and thus activation of JNK and p38 (or MAPK14) [9]. These ki-
nases are involved in other pathways and allow crosstalk activated e.g. by
other cytokines [29]. Additionally, p38 can enter the nucleus and activate
the nuclear mitogen and stress activated kinase 1 (MSK1) [30]. MSK1 is a
kinase for Ser276 of p65 [31, 32]. Phosphorylation of p65 at this site en-
hances its ability to induce chromatin remodeling by increasing its ability
to recruit histone deacetylases (HDACs). p65 phosphorylation can in gen-
eral increase its effectiveness as transcription factor. Other kinases which
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Figure 1.2: Graphical depiction of the signalosome assembling at the TNFR1
upon TNF binding and activation of the canonical NF-κB signalling.
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can enhance p65’s transcriptinal potential upon TNF stimulation are protein
kinase C ζ (PKCζ) (Ser311) and casein kinase 2 (CK2) (Ser529) [33, 34, 35].
1.2.4 Possible Crosstalk with IL-6-induced STAT3 Signalling
NF-κB and STAT3 have been found to form protein complexes, if cells are
co-stimulated with IL-6 and IL-1 [36]. IL-6 acts through two glycoproteins
130 (gp130) and IL-6 receptors which form a complex upon IL-6 binding.
Janus kinases 1 (Jak1) associated to gp130 are thereby activated and phos-
phorylate gp130. Signal transducer and activator of transcription 1 and 3
(STAT1 and STAT3) can bind to the phosphorylated gp130 and are phospho-
rylated by Jak1. The phosphorylated STATs form homo- or heterodimers,
which enter the nucleus and act as transcription factors. Among the target
genes of STAT3 is suppresor of cytokine signalnig 3 (SOCS3), which inhibits
STAT3 binding to gp130 [37]. IL-1-activated NF-κB can form a complex with
STAT3 in the nucleus and may increase STAT3-induced gene expression [38].
1.2.5 Possible Crosstalk with Hippo/YAP Signalling
Hippo-YAP signalling is highly relevant to organ size control and thus may be
linked to cell proliferation by NF-κB signalling. Yes-associated protein (YAP)
over-expression in the liver leads to uncontrolled cell-division, which eventu-
ally leads to liver cancer. Mammalian STE20-like protein kinase 1/2 (MST1/2)
can form a complex with its regulatory protein salvador homolog 1 or 45 kDa
WW domain protein (Sav1) and phosphorylate. This activated complex can
then phosphorylate large tumor suppressor homolog 1/2 LATS1/2 and Mps
one binder kinase activator-like 1A/B (MOB1A/B). LATS1/2 then phosphory-
lates YAP and Transcriptional coactivator with PDZ-binding motif or Tafazzin
(TAZ). In their phosphorylated form YAP and TAZ can no longer enter the nu-
cleus and thus cannot bind to transcription factors such TEA domain family
members 1-4 (TEAD1-4) and smad family protein 1-4 (SMAD1-4). Addition-
ally, the phosphorylation of YAP/TAZ by LATS1/2 targets them for proteo-
somal degradation. The upstream receptors of the Hippo-YAP signalling in
mammalina remain unclear. It is known that Merlin or neurofibromatosis
type 2 (NF2) activates MST1/2 and thus YAP/TAZ phosphorylation, thereby
interrupting the YAP/TAY interaction with TEAD family members [39, 40].
1.3 Mathematical Models in Biology
To analyze biochemical reaction networks different mathematical modeling
techniques have been deployed. Here, I will present ODE based model and
PDE models in general. The I give an overview of models developed to
describe NF-κB signalling.
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1.3.1 ODE Models
Ordinary differential equations (ODEs) are often used to describe population
based dynamics in the field of biology such dynamics can be observed in ex-
periments such as western immuno-blots to detect concentrations changes.
Often the ODEs describe how species change over time. For modeling with
ODEs to be a valid approach two aspects need to be considered. ODE models
describe how species concentrations change with respect to one variable.
In biology this variable is mostly time. Other variables such as space are
not considered. Therefore, when applying ODEs in biology, we are assum-
ing that diffusion happens on a much faster time scale than the biochemi-
cal reactions described by the model system and that thus the species are
distributed homogeneously in the compartments modeled. Otherwise one
would need to consider several variables and chose a PDE model system.
The second aspect is that all biochemical reactions are ruled by Brown-
ian motion of molecules and as such are random or stochastic processes.
Thus the species concentrations should be relatively high and the population
should behave as the averaged behavior of a stochastic simulated model.
The experimental techniques applied to measure intra-cellular protein and
mRNA changes in hepatocytes applied in this work (western immuno-blot,
ELISA, LUMINEX, and RT-qPCR) all measure the average population-based
concentration changes. Thus, the ODE-model chosen is a valid representa-
tion.
The ODEs used to describe a species behavior depend on the biochemi-
cal reactions producing and degrading the species, and their rate laws. The
reaction rate laws (e.g. constant flux, mass action, Michaelis-Menten, or Hill-
kinetics) define the dynamics of reaction fluxes. If we consider the following
simple reaction system:
∅→ A (1)
A→ B (2)
B→ ∅ (3)
where reaction 1 follows the kinetics of a constant influx, reaction 2 is ezy-
matically catalyzed by a third species C, following Michaelis-Menten-kinetics
and reaction 3 follows mass action kinetics, we can then describe the differ-
ential equations or the overall reaction fluxes for A and B:
dA
dt
= +knƒ  − kct ∗ C∗ B
KM + B
dB
dt
= +
kct ∗ C∗ B
KM + B
− kdegB.
These ODEs together with given initial conditions for model systems can
be approximated and simulated by numerical integration with ODE solvers
such as the LSODA [41]. LSODA can solve stiff ODEs and is implemented
for the COPASI task time series. The sum of all degradation and production
reactions fluxes of a species is called a species reaction flux.
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1.3.2 PDE Models
As described above, in temporally dynamic ODE models of biochemical re-
actions used to describe the population-level experiments in this work the
reaction fluxes (v) defined by reaction rate laws and species concentrations
determine how the species concentration (c) changes over time (t): dcdt = .
To extend a temporally dynamic ODE model into a spatio-temporal PDE
model the diffusion flux (J) change with respect to space (x) needs to be
considered as well.
∂c
∂t =  +
∂J
∂ considering one space variable x.
With Fick’s 1st law of diffusion (J = −D ∂c∂) this can be transformed into the
reaction diffusion equation: ∂c∂t =  − D ∂
2c
∂2
.Similar as for the ODE simula-
tions a PDE solver needs initial conditions (i.e. the species concentration at
t=0). Additionally, boundary conditions need to be defined to solve PDEs.
These define what happens to the species at the boundaries of the space
we are looking at. Two popular types of boundary conditions are Neumann
and Dirichlet. Neumann conditions define the flux of a specie at a boundary,
whereas a Dirichlet condition defines the value of a species concentration at
a boundary [42]. For the models used in this work a Neumann condition was
applied, as the boundaries are cell membranes which the modeled species
should not be able to cross.
1.3.3 Model Parameters
In biological models most parameters cannot be measured and must there-
fore, be estimated from experimental data describing how model variable
or combinations of model variables so called observables change. However,
due to experimental limitations not all variables can be observed and thus
not all parameters can be estimated equally well from experimental data.
Some parameters may be structurally non-identifiable, with the given data
the parameters cannot be derived. In other cases the parameters may be
practically non-identifiable, e.g. due experimental errors the parameters
cannot be derived. In both cases the best solution would be acquire new
experimental data [43]. However, often this is not possible. In this case
there are two options: reduce the model until all parameters can be identi-
fied with the current experimental data or work with a model in which not all
parameters are identified. In both cases it can be helpful to figure out which
parameters are identifiable and which are not.
There are several methods to define parameter identifiability. For example
parameter sensitivity analysis describes how small parameter pertubations
influence model characteristics. It can employed to define which parame-
ters modify the target function of the parameter estimation. However, the
results apply only locally to the parameter space and describe the effect
of changing one parameter at a time. Sampling the parameter space and
defining parameter sensitivities for several parameter value combinations,
so called global sensitivity analysis gives a more complete picture [44]. An
other example is the profile-likelyhood method. Each parameter value is
scanned and while the other parameters are re-estimated, to describe the
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parameter landscape in dependence of this parameter [45]. However, both
methods are very cost intense with respect to computational time.
1.3.4 NF-κB Models in Literature
NF-κB signalling is a well studied system. The first mathematical description
in form of an ODE-model was published in 2000 [46]. This work described
NF-κ IκB complex association and dissociation and nuclear shutteling of NF-
κB, IκB and the complex. In 2002 a model including IKK and TNF as stimulus,
and differentiating between the different IκB forms IκBα, IκBβ, and IκBε ap-
peared [47], showing that NF-κB-induced IκBα transcription is necessary to
observe oscillatory dynamics of free NF-κB and the other two isoforms most
likely stablize damped oscillations. 2004 models describing the IKK regu-
lation with three types of IKK and A20 as its inhibitor followed [48, 49]. It
was also shown that on single cell levels not all cells show an oscillatory be-
haviour [50]. The amount of cells that do oscillate depends on the cell type,
and the oscillations dynamics define gene expression profiles [49]. Due to
these cell to cell variabilities on a single cell level stochastic models quickly
followed [51, 52] Later models focused on how stimulus administrations al-
ters gene expression, on the molecular details of certain regulations, and on
the roles of the diverse IκBs [53, 54, 55]. Many model analyses have been
used to determine key regulatory parameters, such as sensitivity analysis
and bifurcation analysis [56, 57, 58, 59].
During my master thesis I established a hepatocyte specific NF-κB model
that included protein turn-over of all major NF-κB pathway constituents. It
trained exclusively to experimental data obtained from primary murine hep-
aotcytes. Additionally, this model also included 2 forms of post-translational
modifications of NF-κB monomer p65 and experimental measurements of
these, as far as antibodies were available. Despite, its well-known influ-
ence on the ability of NF-κB to promote gene induction, phosphorylation
of p65 was not included in previous models [9]. The role of cross-talks on
these post-translational modifications was also not investigated so far. To
describe NF-κB signalling as accurate as possible, the model should also
be able to describe dose-response data, especially, as in vivo concentra-
tions may change and cover broader ranges. Furthermore, the role of the
TNF receptor in detecting TNF has been described in a mathematical model
for granulomas containing macrophages and lymphocytes [60]. However,
it has not been analysed in hepatocytes and it has never been combined
with detailed NF-κB intracellular signalling. Next, other pathways are known
or assumed to influence NF-κB signalling, such as p38-induced MAPK sig-
nalling, IL-6-induced STAT3 signalling, or Hippo-YAP signalling.
There are some models describing spatio-temporal NF-κB signalling. In 2012
a model describing a spherical three dimensional cell in was published. This
model was not based on PDEs but rather based on ODEs using approxi-
mately 62000 compartments between which species could "diffuse" to allow
spatial effects [61]. PDE-based models were published in 2011 and 2014
[62, 63]. These models use the same diffusion coefficients for all proteins
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or all mRNA, and the volumes used for cytoplasm and nucleus differ from
hepatocyte volumes. Both parameters have been shown to have strong in-
fluence on the outcome of spatial-temporal simulations [64, 62].
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2 Material and Methods
2.1 Experimental Data
Hepatocyte data was kindly provided by the group of Kai Breuhahn (Institute
of Pathology, University Hospital of Heidelberg, Germany). Federico Pinna
measured relative protein concentrations for total p65, phospho-p65, total
IκBα, phospho-IκBα, total p38, phospho-p38, total MSK1, phospho-MSK1,
total JNK1, and phospho-JNK1 via immuno-blotting, relative protein changes
for phospho-IKKβ with ELISA, relative mRNA concentrations for IκBα and A20
via reverse transcription quantitative PCR, and microarray data for primary
murine hepatocytes. Michaela Bissinger acquired images of florescently la-
beled RelA in single HLF cells. HLF cells are a hepato-cellular-carcinoma cell
line and measured relative protein changes as described above HCC Hep56
and Hepa1-6.
Dose response TNF secretion profiles were measured via LUMINEX: by Frank
Schildberg in Percy Knolle’s laboratory (Institute of Molecular Immunology
and Experimental Oncology, München Rechts der Isar, Technische Univer-
sität München, German) for liver resident endothelial cells, by Ute Albrecht
in Johannes Bode’s laboratory (Clinic for Gastroenterology, Heinrich-Heine-
University of Düsseldorf, Germany) for Kupffer cells, and by Roman Liebe in
Steven Dooeleys’ laboratory (Molecular Hepatology, Department of Medicine
II, Medical Faculty at Mannheim, Heidelberg University, Germany) for hep-
atic stellate cells.
All experimental data is listed in the Appendix Tables A.4 - A.17.
2.2 Data Processing
The experimental data was preprossed as described in the results section
with the help of the software R [65]. Optimization of parameters in R was
carried out using the R-built-in functions optimize and optim for single pa-
rameters and multiple parameters respectively. The default algorithm as
used in this work for the optim method is Nelder-Mead. The optimize method
uses a combination of golden section search and successive parabolic inter-
polation.
2.3 ODE Simulations
The software COPASI was used to modify and simulate the ODE-model, as
well as estimate its parameters. For time course simulations a specially
compiled version of COPASI was used, with the additional option of start-
ing the time-course simulations from the results of steady-state simulations.
For time-course simulations the implemented LSODA solver was used. For
parameter estimations the implemented particle swarm algorithm, genetic
algorithm SR and Levenberg-Marquardt algorithm were used. For steady
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state simulations a combination of damped Newton method and forward
and backward integration is used.[66]
All parameter simulations and parameter estimations were carried out with
model ensembles of models with 30 parameter sets. The modifications of
the models and scheduling of different tasks was carried out with Java lan-
guage bindings for COPASI.
2.4 Automated Analysis of Protein-Protein-Interactions
from STRING-DB
Protein-Protein Interactions for NF-κ and Hippo-YAP pathway components
were extracted from the STRING database. Together with experimental data
from microarrays, kindly provided by the group of Kai Breuhahn and sta-
tistically analyzed by the group of Fabian Theis (Institute of Computational
Biology, Helmholtz Zentrum München, Germany), this information was an-
alyzed with PHP-scripts written by Martin Zauser, a bachelor student in our
lab, under my guidance.
2.5 PDE Simulations
For PDE simulations software calling on the DUNE Package [67, 68, 69]
was used. The results were visualized and analyzed with the software PKV-
Viewer, the images were exported and combined to videos. Frank Bergmann
programmed an export of SBML files from COPASI to a graphical user inter-
face program (Edit Spatial). In this program I defined diffusion coefficients,
the size and shape of the compartments, the grid size on which the PDEs
were simulated, and the time intervals between simulation outputs. If files
describing the compartments spatial form were used, the grid size needed
to match the file size (e.g. 64 x 64 gridding, 64 x 64 image-file). These
files were in DMP-format. For later program versions an additional event file
could be created, this contained information on which species to modify at a
given time point, how to modify it, and whether to create output before the
time point of the event. This program then automatically extended the ODE
model into a PDE model. The time course simulations where then run with
DUNE. For modifying the reaction parameters and the diffusion coefficients
I later modified the file containing the model information itself (".conf-file").
2.6 Analysis of Single Cell Fluorescent Microscopy Im-
ages
The images provided by Michaela Bissinger were analysed with the help of
CellProfiler [70]. Nuclei were detected and defined as primary objects. Cells
were defined as secondary objects with then nuclei as the priming center
to find cells. Cytoplasm was defined as a ternary object by subtraction of
nuclei area from cell area. The red fluorescent intensity of all images was
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measured. The resulting CSV tables were read into R and analyzed. For
more details see the CellProfiler and R scripts on the supplementary DVD.
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3 Results
To study NF-κB signalling I chose three levels of investigation. First, I con-
centrated on the intracellular hepatocyte response on a population based
level. I investigated crosstalks with other pathways and extended an ODE-
based model established during my master thesis to describe TNF-induced
dose-response signalling in primary hepatocytes. As a second level, I looked
at hepatocytes within the context of other liver cell types. Based on se-
cretion data from non-parenchymal liver cells I simulated the different TNF
profiles hepatocytes would see during inflammation in vivo and simulated
the response in hepatocytes based on the intracellular NF-κB model. Third,
I investigated individual hepatocytes; I converted the ODE-model into a PDE
model and simulated the PDE model using the parameterisation for reac-
tion kinetics from of the ODE model trained on population based experi-
ments. The results were compared to microscopy images of single cells
from hepatocellular carcinoma cell lines stably transfected with red fluores-
cent protein-tagged p65 (p65-RFP).
In order to enlarge and investigate the ODE model I needed to run several
parameter estimations against a diverse set of experimental data. There-
fore, this chapter begins with two sections describing data preprocessing to
deal with experimental errors in semi-quantitative data and the reduction of
the parameters to estimate during parameter estimation based on parame-
ter identifiability information derived from the fisher information matrix.
3.1 Data Processing for Population Based Measurements
The data used for the ODE-based hepatocyte model was semi-quantitative
western blot, ELISA or quantitative real time PCR data from primary murine
hepatocytes. As no recombinant proteins were added to the western blot or
ELISA samples and absolute quantification with PCR is difficult, theses sam-
ples quantitatively display the changes in concentrations over time. How-
ever, no information on the absolute concentrations is given.
In biology many researchers normalize this kind of data to the first time
point (t0) or the control. Often they even combine both in a single sample.
This lays a strong emphasis on this first data point. If this first data point
was also known to have the least error, this would be a valid approach. How-
ever, in the described experimental setups the error is distributed over all
data points, therefore this may not be the best method.
In this work, the data error is assumed to be spread randomly and addi-
tive within one replicate or data series and to arise from pipetting and other
sample treatments. Between the replica the error is assumed to be multi-
plicative, originating from e.g. different protein expression profiles within
animals. Therefore, a multiplicative scaling factor is introduced for aligning
the data series to one another.
An arbitrary biological replicate is chosen as base for normalization (x0). All
other data series (x1−n) are multiplied with a scaling factor (k1−n) which are
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then optimized in such a way that the difference between all data series is
minimized. The resulting target function (T.F.) reads as follows:
T.F. = (0 − k1 ∗ 1) + (0 − k2 ∗ 2) + · · · + (0 ∗ kn ∗ n)
+ (k1 ∗ 1 − k2 ∗ 2) + · · · + (k1 ∗ 1 − kn ∗ n)
+ . . . (kn−1 ∗ n−1 − kn ∗ n). (4)
The resulting scaled data series still show the same relative changes be-
tween the values from a single time series as before, however, the differ-
ences between the different time series is minimal. In figure 3.1 the data
normalized to t0 and with optimized scaling factors is shown exemplary for
the Western immunoblot data measuring p-p65 concentration over time for
10 ng/ml TNF as stimulus.
The resulting data series still represent only the relative changes in concen-
tration and contain no information on the absolute values. In the model,
species are represented with absolute concentrations. Some absolute con-
centrations can be found in literature for some of the species in the model,
for others an additional scaling factor (kmode) in the model is needed to map
the scaled data series to species in the model:
Xobs = kmode ∗ Xsm. (5)
As the initial concentrations are assumed to be steady state values, which
mainly depend on the reaction parameters of the model, the initial values
can be calculated prior to time series simulations. Using the average initial
value of all data replicates the scaling factor (kmode) can then also be cal-
culated by adapting formula 5.
Therefore in the parameter estimations both the initial values of species and
the parameters are changed, as the initial values are directly depend on the
parameter values. The concentrations of TNF measured with LUMINEX from
the non-parenchymal cells are absolute protein measurements. Therefore,
they neither have a scaling factor in the model, nor are they normalized.
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Figure 3.1: Plotted time series of Western immunoblots measurements of
IκBα (A) normalized to the first time point, (B) normalized by minimizing the
differences between replicates with a multiplicative scaling factor.
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3.2 Using the FIM to Reduce the Dimensions of the Pa-
rameter Estimation
For enlarging the ODE-based NF-κB model many parameter estimations
were necessary. As the ODE-models contained many parameters and re-
actions taking place on diverse time scales, parameter estimation was time
intensive. Additionally, since I chose model ensembles to deal with param-
eter uncertainty, I needed several parameter sets, which required several
runs of parameter estimations. Model ensembles are several parameter
sets, for an identical model topology and reaction kinetics, which each de-
scribe the experimental data equally well [71, 72]l. If the model contains
uncertainties, these parameter sets included parameters which spread over
broad value ranges. Thus they should represent diverse possible parameter-
isations given the experimental data an the model topology. For validation,
all parameter sets of the model ensembles should describe the validation
data and for prediction, only observations which are true for all models are
considered. In order to make running parameter estimations for model en-
sembles feasible, I looked for ways tor reduce the amount of parameters I
needed to fit, without reducing the model itself, nor inhibiting the parame-
ters from distributing widely along the parameter space. Therefore, I em-
ployed the the Fisher Information Matrix (FIM) or Fisher Information. FIM is a
statistical method to measure the uncertainty of model parameters. In Com-
putational Biology or Systems Biology it has rarely been applied. However,
intermediate sized models such as those used and developed in this work
contain many parameters which are difficult to identify. Different strategies
have evolved to define these non-identifiabilities [45, 73, 74].
The method I developed in this work was aimed at reducing the computa-
tional cost of the parameter estimation for the ODE-based NF-κB hepatocyte
model. The calculation of the FIM was already implemented in COPASI as
part of the parameter estimation results. Therefore, no further computing
was required to receive the FIM. The general idea of the approach was to
reduce the parameter estimation problem by eliminating parameters which
are practically non-identifiable, but using model ensembles allowing differ-
ent parameter values for the other estimated parameters. Thus the compu-
tational cost of the parameter estimation was reduced, without losing the
flexibility of an intermediate sized model containing parameters which are
derived from typical biological specifications such as Km or kct values for
enzymatic reactions following Michaelis-Menten kinetics.
After an initial parameter estimation starting from random start values within
biologically reasonable ranges for the model parameters and using a global
optimization algorithm such as the Particle Swarm algorithm followed by a
local optimization for example with the Levenberg-Marquardt algorithm to
find parameter values, I employed the FIM to define parameters that have
little to no influence on the models behavior and are thus ill defined or non-
identifiable. The FIM describes the sensitivities of two parameters on the
objective function. However, it is important to note that the FIM is depen-
dent on the parameterization and a different parameter set for the model
may have a different FIM. The FIM is an approximation of the Hessian of the
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parameter estimation target function. Thus, it is an intrinsic characteristic
of the model and its parameterization.
Eigenvalues of the FIM describe dimensions of the model with respect to the
parameter estimation target function. Large eigenvalues describe well de-
fined dimensions, small eigenvalues describe ill defined dimensions [73, 74].
The eigenvectors describe how the parameters contribute to the dimensions
described by the corresponding eigenvalues. If a parameter is exclusively
involved in ill defined dimensions, it is practically non-identifiable. If a pa-
rameter is involved in ill and well defined dimensions, it may be structurally
non-identifiable, or taking part in a combination of structural and practical
non-identifiablity. In the case of practical non-identifiability the parameter
can be omitted from the parameter estimation, without further analysis. If
there are structural non-identifiabilities in the model, it is necessary to have
a closer look at the eigenvectors and the model structure. Parameters which
are structurally non-identifiable, can compensate each other changes. The
question is, how is this observable in the FIM? Unfortunately, it is not neces-
sarily observable. However, in most cases by clustering the absolute values
of the eigenvector entries, eigenvectors or parameters with similar partici-
pation in dimensions of the parameter landscape can be found. This is not
a proof, but rather an indication for ill defined parameters and when com-
bining it with knowledge about the model topology, these ill defined model
parameters can be determined.
As a simple example, the TNF-induced JNK phosphorylation (as depicted in
the NF-κB model in Figure 3.4) can be analyzed. Here, I fitted all parameters
of the TNF degradation, the JNK phosphorylation, and dephosphorylation
reactions (k(TNF degradation), k(JNK basal phosphorylation), kkt(JNK phos-
phorylation), KM(JNK phosphorylation), k(JNK dephosphorylation)). The total
amount of JNK is assumed to be 1 μM. The data is normalized as described in
section 3.1. The scaling factor for the initial state is determined by the abso-
lute value of the mean of all data points at 0 min and the steady-state value
of phospho-JNK. The experimental data shows, that phospho-JNK exists to a
certain extent before the induction with TNF. It is assumed that this initial
state corresponds to the steady state of the system. This initial state is thus
defined by the ratio of basal phosphorylation and the de-phosphorylation of
JNK. The initial increase in phospho-JNK after TNF administration depends
mainly on the parameters of the active phosphorylation reaction. However,
as the KM value depends on the JNK concentration, this value is also some-
what correlated to the basal phosphorylation and degradation. The decrease
in phospho-JNK then depends on JNK dephosphorylation and on the vm of
JNK phosphorylation, which is defined as the product of TNF and the kct
value of the JNK phsophorylation. Thus all parameters are interlaced.
When looking at the FIM for various parameterizations of this model it be-
comes clear, that there are at least two very small and one small eigen-
values. Figure 3.2 shows the FIM eigenvalues and clustered eigenvectors.
For the parameterization chosen here the KM value of JNK phosphorylation
is mainly involved in the very small eigenvalues, thus is practically non-
identifiable and it can immediately be omitted from the parameter estima-
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Figure 3.2: Matrix showing all eigenvalues and absolute values of the eigen-
vector entries after clustering. Entries with values higher than 0.001, 0.01,
or 0.1 are colored in light, medium, and dark blue, respectively.
tion. The kkct(JNK phosphorylation) and the k(JNK basal phosphorylation)
cluster together, as do the k(TNF degradation) and k(JNK dephosphoryla-
tion). The latter two are mainly involved in the larger eigenvalues, there-
fore these are left in the parameter estimation. The others are involved
in all eigenvalues and are most likely combined in a form of practical and
structural ill-identifiability. Here, it makes sense to chose one parameter to
omit from further parameter estimations. To compare if the omitting the
two parameters (KM JNK phosphorylation, kkct JNK phosphorylation) simpli-
fies the parameter estimation task, parameter estimations with Levenberg-
Marqaurdt algorithm from random start values (parameter boarders indi-
cated in Appendix) were repeated 200 times with all parameters and with
only three parameters, after reducing the parameters estimated. When all
parameters were tried to be estimated the global minimum was found only
148 times and the parameter estimations ran on average for 7457 s CPU
time, whereas for the second case it was found for all 200 estimates and the
parameter estimations ran on average for 290 s CPU time (Appendix Tables
A.22, A.23).
The parameters estimated for the final intra-hepatocellular model were cho-
sen with this approach. As described in the scheme 3.3 an initial guess of
the parameters was obtained for all unknown parameters with the particle
swarm algorithm starting from randomized values, followed by an optimiza-
tion with the Levenberg-Marquardt algorithm to ensure a local minimum.
Then for each parameter set of the model ensemble parameters were omit-
ted based on their FIM entries, the FIM eigenvalues and eigenvectors. Sub-
sequently parameter estimation was repeated, again first using the particle
swarm algorithm then the Levenberg-Marquardt algorithm. The resulting
parameters are listed in the Appendix Table A.20.
In summary, I was able to drastically reduce the cost of parameter estima-
tion for the NF-κB model in hepatocytes by eliminating ill defined parame-
ters from the parameter estimation I identified with the help of the FIM. At
the same time I employed model ensembles that covered broad ranges of
parameter space and only features all parameter sets of the model ensem-
ble had in common were considered as model predictions.
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Figure 3.3: Scheme for employing the FIM to reduce fit parameters. In stead
of Particle Swarm or Levenberg-Marquardt algorithms other global and local
parameter estimation algorithms could be employed.
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3.3 Analyzing and Enlarging the ODE-based NF-κB Model
In previous work during my master thesis I established an ODE-based NF-κB
model, which described protein turnover for all model species in detail [59].
In the following sections the extension of that work is described and further
analysed. Most of these results will be submitted to Hepatology.
3.3.1 Hippo-YAP
NF-κB signalling controls cell proliferation and apoptosis [23]. The Hippo-
YAP pathway is import for organ size control and regulates the organ growth
in dependence of cell-cell contacts [75]. The assumption that the two path-
ways are somehow correlated and share some sort of crosstalk is thus obvi-
ous. Trying to find a connection between TNF-induced NFκB signalling and
Hippo-YAP signalling lead to a bioinformatics based approach.
Under my guidance Martin Zauser a Bachelor student created PHP scripts ac-
cessing STRING [76]. STRING is a database on protein-protein-interactions
describing seven different categories of interactions (neighborhood, fusion,
occurence, coexpression, experiments, database, and textminig). The re-
sults used in this work, were interactions found with experiments or in databases,
as the other categories are not reliable indicators for protein interactions in
eukaryotes. For the analysis I created two lists of genes encoding proteins
involved in the signalling cascades (TNF/NF-κB pathway and Hippo/YAP path-
way) derived from literature research. Martin then extracted the identifiers
for these proteins from the PDB database [77], STRING database and Kegg
database [78]. Next he searched for each of these genes in all entries for
mus musculus and homo sapiens in STRING and within these entries he
then searched for connections to the other pathway (e.g. for all entries for
p65/RelA he searched for connections to genes of the Hippo/YAP pathway).
If connections were found, they were verified with literature research. Addi-
tionally, the search was repeated for second level connections, connections
where a protein from the NF-κB pathway interacted with a protein that also
interacted with protein from the Hippo/YAP pathway. With this method CK2
was found as a possible link. CK2 can phosphorylate p65 and E-cadherin.
E-cadherin in turn can lead to modulations of the subcellular localisation of
YAP [79]. Additionally, it was found that Smad1 and YAP may form a com-
plex and that TAK1 may phosphorylate Smad1.
Furthermore, microarray results from hepatocytes stimulated with TNF and
from hepatocytes in which YAP was over-expressed where analyzed. First,
Martin analyzed, if members of the according other pathway showed al-
tered expression patterns in the microarrays. Next he analyzed, if among
the genes up- or down-regulated in response to TNF any interacted with
members of the Hippo-YAP pathway according to the STRING entries found
and vice versa for genes induced by YAP over-expression and members of
the TNF/NF-κB pathway.
The results from this study showed an up-regulation of IκBα, A20 and cIAP1/2
by Hippo/YAP signalling in the microarray. However this could not be vali-
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dated experimentally. mRNA measurements with RT qPCR in the same cells
showed no significant changes in the IκBα mRNA or A20 mRNA concentra-
tions.
Modified expression of cIAP1/2 and interactions between YAP, Smad1 and
TAK1 were not investigated further experimentally. Together with our col-
laborations, we decided that it was not very likely these connections would
have an effect on canonical NF-κB signalling or Hippo/YAP signalling. As
there were no further direct crosstalks found, I did not extend the NF-κB
model with Hippo/YAP signalling. (Appendix Figure A.1 show the connec-
tions found.)
3.3.2 p38-MAPK
In my previous work on this project the hypothesis of p38 (MAPK14) sig-
nalling being induced by TNF and leading to further activation of a nuclear
kinase which additionally phosphorylated p65 at serine 276 was formulated
[59]. This hypothesis was verified with experimental data by Federico Pinna.
There are several steps between TNF-induction and the phosphorylation of
p38 and JNK1. For extending the model topology the simplest solution well
describing the data was chosen, which was a direct activation of p38 and
JNK phosphorylation by TNF or in later model version TNF bound to TNFR1.
To describe the phosphorylation of p38 in the model an enzyme driven phos-
phorylation activated by TNF, a basal phosphorylation and a dephosphoryla-
tion reaction were added to topology published in 2012 [59], together with
a phosphorylation of MSK1 catalyzed by p-p38 and dephosphorylation. A
parameter estimation for the parameters of this new model part was exe-
cuted without altering any of the other parameters in the 30 parameter sets.
The parameter estimation for the p38/JNK/MSK1 branch resulted in a model
ensemble which described the data published equally well as the original
model and also described the new MAPK data well. See figure 3.4 for the
new model topology and the new plots, the ODEs and parameters for the
final model topology are summarized in the Appendix Tables ?? - A.18. All
parameters of the p38/JNK/MSK1 module were identifiable except for the KM
values of the active phosphorylation reactions. The parameter algorithms
tried to minimize these, which indicates that the active phosphorylation re-
actions were running at vm. Subsequently the KM were set to small values.
3.3.3 NF-κB Dose Response in Hepatocytes
Previous work was carried out for TNF concentrations of 10 ng/ml. However,
the predictive power of the model is much higher, if it can also describe
dose response data. In vivo hepatocytes are exposed to TNF over a broad
range of concentrations and the systems fine tuned response to these dif-
ferent concentrations are important for an appropriate cellular response to
different scenarios. Western Immunoblots of total IκBα, p-IκBα, total p65
and p-p65 for TNF doses of 0.1, 1.0, 10, 20, and 50 ng/ml were measured by
Federico Pinna.
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Figure 3.4: (A) Model topology including the new p38/JNK/MSK1 module. (B)
Plots of model simulations (solid lines, n=30) and experimental data from
the publication, as well as new measured p-p38, p-JNK, p-MSK1 experimen-
tal data (symbols, n=3) after estimating parameters for the p38/JNK/MSK1
model branch. Experimental data was measured by Federico Pinna, Ap-
pendix Table A.4.
As a first approach the model was not fitted to the data, but simply used
to predict the time courses for the indicated TNF concentrations (see figure
3.5). The parameter sets do capture many features of the dose-response
data. They show a saturation effect for high doses and that for low doses
the amplitude height and width are changed.
However, the saturation is observed for lower concentrations in the experi-
mental data than most model ensemble simulations predict and the exper-
imental data show a stronger response to low data then the simulations of
the model ensembles.
To improve the models description of the protein dose response data and
the mRNA data for 10 ng/ml TNF several model versions were tested. First,
a simple re-parameterization of the model was applied. Second, the active
IKKβ phosphorylation reactions kinetic currently described as a simple en-
zyme catalyzed reaction was changed to a Hill-Kinetic. Third, an inhibition
of the active IKKβ phosphorylation by an arbitrary molecule induced by TNF
was included. Fourth, a combination of the Hill-kinetic and the inhibition of
the active IKKβ were included. None of the above improved the results satis-
factorily (data not shown). Finally, the TNF receptor 1 (TNFR1) was added to
the model topology (see figure 3.6). TNFR1 synthesis and degradation were
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Figure 3.5: Plots of model simulations (solid lines, n=30) and experimen-
tal data (symbols, n=2) for dose response data with c(TNF)={0.1 ng/ml,
1 ng/m, 10 ng/ml, 20 ng/ml, 50 ng/ml} and the previously measured mRNA
trajectory for c(TNF)=10 ng/ml predictions of the model without further pa-
rameter or model topology modifications. Experimental data was measured
by Federico Pinna, Appendix Talbe A.5.
assumed to be negligble for the time span investigated. Receptor numbers
measured for hepatocytes are between 1500 - 2900 [80], therefore the con-
centration of total TNFR1 was set to be 0.0068 μM. By including the receptor
with a specific receptor number the extracellular volume and particle num-
ber of TNF in this volume became relevant. Before, the TNF concentration
multiplied with an additional parameter freely chosen was used in the re-
actions, making the relative concentration changes, not absolute numbers
relevant for the kinetics. Therefore, the extracellular volume was adjusted
to account for the experimental conditions of 800 000 cells in 3 ml medium
and the TNF concentration was simulated in molar concentrations instead
of mass concentrations. Literature values were taken from a computational
model on the TNF TNFR1 signalling in granulocytes [81], the estimated pa-
rameters were re-estimated using the original values as starting points and
for setting the parameter estimation boundaries. After parameterization of
the new model the simulations of the time courses of the protein concen-
tration changes for the dose response data were drastically improved (see
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Figure 3.7).
Figure 3.6: Model topology including the receptor TNFR1.
Describing the mRNA remained a challenge. By increasing the weight of the
mRNA data in the target function, the model could be forced to describe
the mRNA data. However, this led to a strong deviation in simulations from
experimental measurements of the protein time courses. mRNA transcrip-
tion and translation are both complex processes and mathematical model
have been published, which describe them in much more detail [82, 83].
However, I aimed to find a mathematical description that could describe the
mRNA levels without including much details. Again here two approaches
were applied, to resolve this problem. First, the equation describing the
transcription initiation of the IκBα mRNA was described with a Michaelis-
Menten kinetic. Previously, this mechanism had been suggested to be im-
portant in the NF-κB system [84]. However, in my work the system became
very unstable and a steady-state was no longer found (data not shown).
Second, the mass action kinetics for the IκBα translation were replaced by
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a Michaelis-Menten kinetic. After re-parameterization a good description of
the protein and mRNA data was found. Figure 3.7 shows the new plots of the
model with both TNFR1 and the changed kinetics for the mRNA translation.
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Figure 3.7: Plots of model simulations (solid lines, n=30) and experimen-
tal data (symbols, n=2) for dose response data with c(TNF)={0.1 ng/ml,
1 ng/m, 10 ng/ml, 20 ng/ml, 50 ng/ml} and the previously measured mRNA
trajectory for c(TNF)=10 ng/ml simulations of the model after model topol-
ogy modifications and parameter estimation. Experimental data was mea-
sured by Federico Pinna.
This model could also be validated with dose response measurements of the
IκBα mRNA. The model accurately described the mRNA time course dynam-
ics for all concentrations, without any further modifications (Figure 3.8).
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IκBα mRNA
Figure 3.8: Plots of model simulations (solid lines, n=30) and experimental
data (symbols, n=1) for dose response mRNA data with c(TNF)={0.1 ng/ml,
1 ng/m, 10 ng/ml, 20 ng/ml, 50 ng/ml}. The model describes all data without
further adjustments. Experimental data was measured by Federico Pinna.
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3.3.4 Hepatocarcinoma Cell lines
Under my supervision Nicolas Huber wrote his bachelor thesis on "Model-
based comparison of TNFα/NF-κB signalling between primary hepatocytes
and hepatocellular carcinoma cell lines Hep56 and Hepa1-6". In this thesis
he used the model presented here, which I generated for and trained on
experimental data from primary murine cells, to describe experimental data
from murine heptocellular carcinoma cell lines.
The aim of these investigations was to establish which changes were needed
to describe the carcinoma cell lines. If the NF-κB pathway signalling had
been found to be altered beyond different protein expressions, for example
if the binding affinity between IKKβ and the IκBα:NFκB complex was altered,
which have been reflected in the KM of the phosphorylation reaction, then
this would have indicated a possible mutation in the carcinoma cell lines.
However, only changes in the protein levels were needed, indicating that
the protein transcription or translation profile varied. This was most likely
not due to a mutation, but simply due to a different state of the carcinoma
cells compared to the primary cells.
3.4 Multi-Scale Model of NF-κB in the Liver
In order to analyze the hepatocytes response to LPS-induced TNF secretion
I integrated the input-output descriptions of the non-parenchymal cells TNF
secretion profiles into the ODE model by using the average cell sizes, as-
suming that these cells are distributed rather homogeneously in the liver.
Thus the final integrative model describes all cell types relative to a sin-
gle hepatocyte. This approach gives an estimate of the upper limit of TNF
concentrations that can arise locally in vivo.
3.4.1 Cell Type Specific Volumes
The cell populations’ abundance in the liver have been determined by Blouin
et al. in 1977[5]. Table 1 summarizes these numbers. Using the volume of
a single hepatocyte the average size and adjacent extra cellular volume for
all liver cell types can be determined. Below this is done exemplarily for the
upper volume limit of LSECs.
Vsnge LSEC = Vsnge Heps ∗
V LSEC
n LSEC
∗
n Heps
V Heps
= 13 p∗
77.8%
2.8%
∗
19%
60%
= 1.5 p
In Table 2 the volumes of all cell types and their adjacent extra cellular
volumes are summarized. It is important to note that the average extra
cellular volume adjacent to cell varies for the different cell types. Figure 3.9
shows this difference for hepatocytes and LSECs. Since there are less LSECs
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than hepatocytes, (there are 3.16 hepatocytes per 1 LSEC, see Table 3) the
average extra cellular volume per LSEC is 3.16 times larger than the extra
cellular volume per hepatocyte.
Table 2: Average volumes per liver cell type.
Heps LSEC Kupffer Cells Stellate Cells
cell volume 3 - 13 pl[85, 86] 0.3 - 1.5 pl 0.3 - 1.4 pl 0.4 - 2.8 pl
Space of Disse per
cell
0.19 - 0.82 pl 0.60 - 2.61 pl (0.7 - 3.27 pl) 1.4 - 9.8 pl
Sinusoid Lumen per
cell
0.41 - 1.77 pl 1.13 - 5.68 pl 1.51 - 7.0 pl (3.03 - 21.2 pl)
total extracellular
volume per cell
0.60 - 2.59 pl 1.73 - 8.29 pl 2.21 - 10.27 pl 4.43 - 31.0 pl
Figure 3.9: Simplified scheme of the liver anatomy. Cubical hepatocytes (or-
ange) are in contact with Space of Disse which is lined by long stretched en-
dothelial cells (yellow), separating the hepatocytes from the sinusoid. Right
side: Space of Disse a hepatocyte is in contact with. Left side: Space of
Disse an endothelial cell is in contact with.
Table 3: Comparison of cell abundance and size for non-parenchymal cells
with hepatocytes as reference.
LSEC Kupffer Cells Stellate Cells
hepatocytes per cell 3.16 4 12 - 7.5
times smaller than hepatocytes 8.7 9.26 4.6 - 7.41
3.4.2 Non-Parenchymal Cells’ Responses to LPS
Primary bone marrow derived macrophages, liver sinusoidal endothelial cells,
and hepatic stellate cells were isolated from mice and cultured in vitro by
Ute Albrecht, Frank Alexander Schildberg, and Roman Liebe, respectively.
For each of these cell types LPS-induced TNF secretion profiles were mea-
sured for a defined number of cells in vitro. Using the ratios in numbers and
in volume of non-parenchymal and parenchymal cells (Table 2, 3), and the
moleculare weight of the soluble TNF trimer 52 kDa [87] these profiles could
be translated into in vivo concentration profiles (Figure 3.10).
All non-parenchymal cells secrete TNF. However, the LPS induction of TNF se-
cretion by macrophages (MCs) and liver sinusoidal endothelial cells (LSECs)
is clearly observable. The stellate cells (HSCs) show a mostly constant level
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Figure 3.10: Secretion profiles of LPS-induced TNF secretion from non-
parenchymal cells. (B) Recalculated profiles accounting for cell abundance
in the liver to estimate in vivo TNF concentration profiles. Experimental
data was measured by Ute Albrecht (MCs), Frank A. Schildberg (LSECs), and
Robert Liebe (HSCs).
of TNF secretion and due to their low abundance in the liver, the estimated
in vivo concentration is comparable to the basal level of the TNF secreted by
MCs or LSECs. The non-parenchymal cells were subject to stress, from cell
isolation and experimental treatment. Thus, these basal TNF levels are likely
to be caused form these experimental procedures. Therefore, I set the TNF
concentration to be zero in the absence of LPS, to mimic the in vivo situation
and the stellate cell profiles were not included into the further investigations.
3.4.3 Hepatocellular Response to Non-Parenchymal Cells’ Secre-
tion Profiles
Additionally to the compartmentalisation further assumptions were neces-
sary to calculate the LPS-induced TNF/NF-κB signalling:
1. The diffusion of TNF happens on a faster time scale than the modelled
biochemical processes. (Proteins diffuse within seconds through LSECs
[12], the measured and simulated protein and mRNA concentration
changes take place within minutes to hours.)
2. TNF can diffuse freely between the sinusoidal lumen and the Space of
Disse through LSEC fenestrae, as was illustrated for albumin (diameter
34 nm) [12]. (Assuming that TNF is of globular shape and by using the
formula from Erickson, the cytokine diameter was estimated to be 5
nm [88].)
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3. TNF is approximately homogeneously distributed. (This follows directly
from 1. and 2.).
The secretion profiles of the calculated molar TNF concentrations from MCs
and LSECs were described by a small ODE-system which was added as an
input to the in vitro hepatocellular model. The extracellular volume was ad-
justed to match the in vivo volumes described in this integrative liver model
(Figure 3.11).
The model ensemble with its 30 parameter sets was used to simulate the
intra-hepatocellular response to TNF secreted by MCs and LSECs individually
and combined after LPS induction for 0.1, 1, 5, and 10 ng/ml (Figure 3.12).
These simulation results revealed that TNF concentrations are dependent on
the LPS concentration the non-parenchymal cells are stimulated with. Fur-
thermore, TNF concentrations reached locally in vivo are much higher than
the concentrations used for training the in vitro hepatocellular model. How-
ever, the intra-hepatocelluar response in the simulations of the integrative
model is not as strong as the in vitro response (i.e. the amplitude height
of phospho-p65 and phospho-IκBα is lower, the decrease of IκBα less pro-
nounced). At first this seems paradox. However, when taking into account
the small extra-cellular volumes in vivo and the large medium volume in
vitro, as well as the dynamics of the TNF secretion in the integrative liver
model and the intra-hepatocellular response this can be perfectly explained.
The TNFR1 particle number and the dynamics of its shuttling to and from
the extra-cellular membrane to intracellular vesicles define, how much TNF
can be detected by the hepatocytes. In the in vitro experiments a single
dose of TNF is administered to the hepatocytes. Due to the large medium
volume the TNF particle number is much higher in the medium than in
the extra-cellular volume in the simulations of the integrative model (in
vitro experiments: 10 ng/ml TNF = 0.000193 μM TNF = 440800 TNF parti-
cles / hepatocyte, integrative model simulations: MCs and LSECs combined
TNF secretion: 5 ng/ml LPS, 0.049 μM TNF = 7640 TNF particles / hepato-
cyte). Additionally these TNF particles can immediately bind to all available
TNFR1 particles. In the integrative model TNF is secreted gradually, thus
the TNFR1:TNF complexes form gradually. When looking at the amount of
time it takes for the intra-heptaocellular response to be triggered, it be-
comes clear that this response takes place long before the maximal TNF
levels are reached (Figure 3.13, for 5 ng/ml LPS stimulations phospho-p65
peaks after 30 minutes, maximal TNF concentrations are reached after 10
hours). Thus the final TNF levels cannot be decisive for the strength of the
intra-hepatocellular response. Rather it is the initial increase in TNF levels
that defines this response. MCs showed a weaker initial TNF secretion than
LSECs, when both secreted TNF, its levels increased the fasted. However,
secretion velocity is limited for cells. Therefore, once the non-parenchymal
cells have reached the maximal speed at which they can secrete TNF higher
LPS dosages cannot increase the TNF increase and thus cannot increase the
intra-hepatocellular response. Therefore, LPS doses higher than 5 pg/ml do
not invoke a stronger intra-hepatocellular response.
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Figure 3.11: Model Topology of the integrative NF-κB liver model. LPS in-
duces non-parenchymal TNF synthesis, TNF induces parenchymal NF-κB sig-
nalling.
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In general the dynamics of the intra-hepatocellular response depend on the
LPS stimulus and resulting initial TNF increase. For very low stimulus concen-
trations (0.1, 1 ng/ml LPS) the intra-hepatocellular response shows broader
and lower phospho-p65 and phospho-IκBα peaks. The IκBα expression is
less strongly induced than for high LPS concentrations (>5 ng/ml). How-
ever, as described above, for these higher LPS concentrations the steep-
ness of the initial TNF increase cannot be increased further and thus the
intra-hepatocellular response can also not be increased further.
In summary, TNF secreted by LSECs or MCs individually in response to low
dosages of LPS (0.1 and 1 ng/ml) was sufficient to induce a partial intra-
hepatocellular response. However, the highest intra-hepatocellular response
was invoked when LSECs and MCs secreted TNF simultaneously in response
to doses higher than 5 ng/ml LPS. These high LPS concentrations induced
concentrations of more than 240 ng/ml TNF secreted by LSECs or MCs indi-
vidually.
Although the maximal intra-hepatocellular response simulated for the in-
tegrative model was not as strong as the response provoked by in vitro
experiments, this response could not be increased by stimulating the non-
parenchymal cells with more LPS. This can explained by the cytokine secre-
tion dynamics of cells which differs strongly from stimulating cells with a
single high dose, as done according to current in vitro experimental proce-
dures.
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Figure 3.12: Integrative liver model predictions. Upon LPS-induction with
various LPS concentrations the simulated response of the non-parenchymal
cells individually and combined in form secreted TNF is shown in A. Subse-
quently NF-κB signalling in hepatocytes is induced, B - E show concentration
changes of phospho-p65, phopho-IκBα, IκBα, and IκBα mRNA.
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Figure 3.13: Characteristics of the integrative liver model predictions. Panel
A shows the strength of characteristics in the simulations, panel B shows the
time points of these events for different LPS dosages.
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3.5 Spatial Model
On the single cell level, I wanted to look at spatial and temporal effects of
TNF on the NF-κB pathway. For this our collaborators established human
hepatocarcinoma cell lines with first transiently and later stably transfected
red fluorescent protein (RFP) tagged p65. Images of these cells after TNF
stimulation were recorded with a fluorescence microscope and I quantita-
tively analyzed the RelA localization based on the red fluorescence intensity
in these images. At the same time I converted a reduced NF-κB ODE model
into a PDE model taking into account both time and x and y positions of
species concentrations. Finally, I extended for the final intra-hepatocellular
ODE model of NF-κB signalling into a PDE model and redid the simulations.
3.5.1 Single Cell Analysis
The experimental data, the spatial model should describe, were fluorescent
images of hepatocyte carcinoma cell lines expressing p65/RelA tagged with
RFP (p65-RFP, RelAdsRed). For the establishment of the experimental set-
up our collaborators (Michaela Bissinger) provided us with different image
types and we analyzed these. Based on the feedback we could give on these
results, the experiments were adopted.
The first sets of experiments were performed in HLF cells, later HLE cells
were used. HLF is a human hepatic carcinoma cell line which shows fibrob-
last like behavior, HLE is a human hepatic carcinoma cell line which shows
eptihelial like behaviour [89].
First, p65-RFP was transfected transiently in the cells before each experi-
ment. Thus the amount of red-fluorescent RelA varied between individual
cells. Some cells had a very strong red-fluorescent signal, here, the trans-
fection was successful. The cells took up the vector with the gene encoding
for p65-RFP and expressed it at high levels. Some cells didn’t show any
red-fluorescent signal, these cells most likely did not take up any vector. A
third group of cells only showed a weak red-fluorescent signal, these cells
most likely took up the vector but for some reason did not express p65-RFP
in a strong manner. The very first images of cells were additionally col-
ored with a plasma membrane specific fluorescent protein: CellMask. This
dye specifically integrates into the plasma membrane. However, it was not
possible to analyze these pictures in an automated way. The background
signal was equally strong as the signal from some of the cells, making au-
tomated cell detection not feasible. Therefore, I decided to analyze these
images manually based on the bright field recordings. Thus, I established a
semi-automated script using CellProfiler. Cells borders were outlined manu-
ally, Hoechst stained nuclei were detected automatically. The program then
measured the area and RelA intensity in the cells and nuclei. A student as-
sistant completed these analyses under my guidance. The manual analysis
of a single time series following up to 10 cells took six hours.
Later, the experimental set-up was changed. The cells were stained with
37
Figure 3.14: Time course showing how the distribution of p65-RFP between
the nucleus and the cytoplasm changes over time in HLE cells. A p65-RFP
nuclear intensity, B p65-RFP cytoplasm intensity, C ratio of p65-RFP nuclear
intensity normalized per area and p65-RFP cytoplasm intensity normalized
per area.
CellTracker a cytoplasm specific stain fluorescing green. This than allowed
a fully automated CellProfiler analysis of the images. The green fluores-
cent signal from CellTracker was used to identify the cells. A threshold was
set automatically. In some cases this was not successful, then manually
a threshold was set for each image set. Pixels with intensity of above the
threshold, and grouped together to form objects with a radius larger than 10
pixels and smaller than 50 pixels were defined as cells. In a second channel
the blue light emitted from Hoechst stained nuclei was recorded. An au-
tomatic threshold for pixel intensity was calculated from within CellProfiler,
and objects with a radius between 5 and 30 pixels were defined as nuclei.
The cell area without the nuclei was defined as cytoplasm. For cells, nu-
clei, and cytoplasm the p65-RFP fluorescence intensity was detected and
the area was calculated. An exemplary CellProfiler Script can be found in
the Appendix.
CellProfiler writes the analysis results into large tables which than need fur-
ther processing. For this I loaded the tables into R and resorted the data.
For each cell I then created time-course profiles depicting the changes in
RFP intensity. Figure 3.14 shows an exemplary cell profile.
3.5.2 From ODEs to PDEs
As described in the introduction PDEs describe biochemical reaction and
diffusion processes. Essentially, they can be divided into the biochemical
reaction flux vector which is similar to the ODEs in a biochemical reaction
model and the diffusion fluxes. As simulating the final PDE model took up
to several days, it would not have been feasible to try to do parameter es-
timation for the parameters of the PDE model. Therefore, the paramteres
of the reaction flux vector were taken from the parameters estimated from
population based data with the ODE system. For the diffusion flux the diffu-
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sion coefficients for each species are needed. A literature research did not
yield any measured values for the species of the NF-κB system. Therefore,
the Young-Carroad-Bell method was used to calculate estimates of the dif-
fusion coefficients based on the molecular weights of the species [90]. The
formula was derived for spherical molecules in aqueous solutions. It yields
rough estimates for proteins moving within in the cytoplasm. Table 4 lists
the molecular weights and the estimated diffusion coefficients. mRNA diffu-
sion was measured to be between 108 μm2/h and 2160 μm2/h [91], I set
the diffusion coefficient to 140 μm2/h in the PDE model.
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Table 4: Diffusion coefficients for the NF-κB pathway. The diffusion coefficients were calculated with Young-Carroad-
Bell Method.[90]
Molecule Moleculare Weigth Diff. Coef. Diff. Coef.
in Da (= g/mol) in cm2/s in μm2/h
p65 / RelA 60212 4.05235E-10 146
p50 47508 5.13598E-10 185
IκBα 35071 6.95732E-10 251
P_ (PO_3) 79 3.08861E-07 111190
NFκB 107720 2.26513E-10 82
P-IκBα 35239 6.92415E-10 249
NFκB:IκBα complex 142801 1.70867E-10 82
P-p65 60291 4.04704E-10 145
PP-p65 60370 4.04174E-10 145
P-(p65)NFκB 127799 1.90925E-10 82
PP-(p65)NFκB 127878 1.90807E-10 82
IKKβ 86564 2.81872E-10 101
P-IKKβ 96643 2.52476E-10 91
IKKα 84640 2.8828E-10 104
IKKgmm 48198 5.06245E-10 182
IKK-complex 219402 1.11211E-10 40
MSK1 89865 2.71518E-10 98
P-MSK1 89944 2.7128E-10 98
p38 41293 5.90899E-10 213
P-p38 41384 5.896E-10 212
JNK1 48296 5.05218E-10 182
P-JNK1 48357 5.04581E-10 182
TNFR1 50495 1.611E-10 58
TNF 25644 4.685E-10 170
TNF:TNFR1 complex 76139 1.199E-10 43
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Furthermore, in spatial models the geometry of the cell plays an important
role. As the Diffusion coefficients were calculated in μm2/h, the dimensions
of the cells should be in μm, as well. Hepatocytes have an almost cubic form
with a side length 20 − 30μm [92]. Therefore, I chose a 20 x 30 rectangle
with rounded corners as the shape for the cytoplasm. Primary hepatocytes
often have two nuclei, however the cell lines we used mainly showed one nu-
cleus, therefore I only included one nucleus. I used the formula of a sphere
and the volume of the nuclei (0.8 pl) used in the ODE model to calculate the
radius of the nucleus (5.7 μm). For the nuclear geometry I then included a
circle with this radius.
As currently, the exact simulation of species crossing into different com-
partments for the dune package is not available, we chose to estimate the
crossing of molecules from one compartment into the next by having over-
lapping regions of the nucleus and the cytoplasm. Only in these regions the
transport processes, transforming e.g. cytoplasmic p65 into nuclear p65,
could take place 3.15.
The exact PDE solutions for the species concentrations are calculated on a
grid, in between the grid knots the concentrations are interpolated from the
grid positions. This plays an important role in defining the geometry. Espe-
cially the circular overlap region should have the a continuous thickness, or
to be more precise a continuous amount of knots. Otherwise artificial spatial
effects may occur.
Figure 3.15: Spatial distribution of the compartments in the PDE simulations
on a 64 x 64 grid. The green area is defined as cytoplasm, the white area
is defined as nucleus and the blue area is defined as both cytoplasm and
nucleus.
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3.5.3 PDE Model Simulation
As solving PDEs is a much complexer problem than solving ODEs, initially
a reduced version of the ODE model was used to reduce the computational
costs of the PDE simulations (see figure 3.16). After the reduced model could
roughly reproduce the experimental single cell images, the final intrahepa-
tocellular NF-κB ODE model was also extended to a PDE model. The insights
gained from extending the reduced version could then be transferred to the
extended model. The aim of this study was to reproduce the experimental
data qualitatively in the simulations.
Figure 3.16: Model topology of the reduced NF-κB model for PDE-
simulations. The boxes mark the p65 species observed in experimental
single cell microscopy images.
To ensure the reduced ODE model was transferred correctly into a PDE
model, I ran a simulation of the model using very high (1 000 μm2/s) dif-
fusion coefficients and I defined the area of the nucleus and cytoplasm to
be identical. In this simulation the diffusion took place on a much faster
time scale than the biochemical reactions. Therefore, the total species con-
centration changes in a compartment should behave as in the ODE model.
Figure3.17 shows the simulation results. The PDE simulations match the
ODE simulations.
Next the diffusion coefficients calculated from the formulas as described
above were used. These simulations indicated a different problem. As
shown in Figure ?? the simulations did not show the expected behavior.
42
Figure 3.17: Simulations of the reduced reduced PDE model with very high
diffusion coefficients to show the ODE model and PDE model show the same
general dynamics. p65 local concentrations in PDE simulations are shown
at time points 0, 20, 40, and 120 min.
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We were observing two things happening at the same time, in the over-
lap region between nucleus and cytoplasm the concentrations of all species
shuttling between nucleus and cytoplasm was increasing strongly, addition-
ally, the TNF induced concentrations changes were taking place. The initial
concentrations of species from the ODE model are average concentrations
for all areas of cytoplasm or nucleus. In the PDE model the species are
not distributed equally, because there is an on going exchange between the
nucleus and cytoplasm. Thus the model was not in a steady-state when
simulating TNF addition in the beginning of the simulations. Therefore, I de-
cided to simulate the addition of TNF after 48 h. This allowed the model to
find a steady-state given the geometrical conditions.
Additionally, the aggregation of the species in the overlap region was very
high. Most species did not leave the overlap region again. The initial trans-
port rates from the ODE model, describe diffusion and the transport pro-
cess. In the PDE model, this needs to be separated further. The diffusion
processes are described by the diffusion vectors. The reaction processes
of the transport only should be described in the reaction flux vector. As all
species modeled can cross the nuclear membrane rather quickly, I increased
the transport rates from the ODE model by a factor of 100 for the PDE sim-
ulations. The translocation of p65 from the cytoplasm into the nucleus is
much slower in the PDE simulations than in the ODE simulations. Most likely
the diffusion coefficients are too slow. Therefore, I simulated how increasing
the diffusion coefficients by factor 2, 5, 10, 40 and 100 altered the results.
(Figure 3.18 shows the simulation results for diffustion factors increased by
factor 40.)
The simulations show that increasing the diffusion coefficients by factor
100 leads to dynamics that are similar to the observed dynamics in the sin-
gle cell microscopy images for 65-RFP localisation. After XXX minutes the
concentration in the nucleus peaks followed by a shift of p65 concentration
back to the cytoplasm. It does not re-enter the nucleus. Similarly the mi-
croscopy images show that in most cells p65-RFP is in the nucleus after 20
minutes and after approximately 4 hours it is back in the cytoplasm .
Next the complete NF-κB intra-hepatocellular model was extended to a PDE
model. However, in PDE models only species in the same compartment
can react. There I needed to add import and export reactions of p38 and
phospho-p38 to this model. As the dephosphorylation reaction is indepen-
dent of the TNF-TNFR1-complex it also can take in the nucleus, however,
phosphorylation reaction cannot (Figure 3.19).
For this extended model only simulations were run with adjusted trans-
port rates and increased diffusion coefficients (factor 40). Figure 3.20 shows
the results form the final simulations together with images from the single
cell microscopy experiment. When comparing these to the p65-RFP single
cell microscopy images, it can be seen, that the model nicely reproduces
the dynamics of these experiments.
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Figure 3.18: Simulations of the reduced PDE model with adjusted transport
rates and TNF stimulation after the steady state is reached. p65 local con-
centrations in PDE simulaitons with diffusion coefficients increased by factor
40 are shown at time points 0, 20, 40, and 120 min. Inner circle is the nu-
cleus, outer area is the cytoplasm.
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Figure 3.19: Model topology of the complete NF-κB model for PDE-
simulations. The boxes mark the p65 species observed in experimental
single cell microscopy images.
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Figure 3.20: Simulations of the complete PDE model (left column) and im-
ages form the single cell microscopy experiments (right column). In the PDE
model transport rates and diffusion coefficients were adjusted. TNF addition
was simulated after the steady state is reached. p65 local concentrations
for 0, 20, 40, 120 min are shown. A complete simulation video can be found
on the supplementary DVD.
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4 Discussion
NF-κB signalling is involved in cancer development and in inflammation,
making it an important system to understand [93]. The details of its crosstalks,
which become even more important during these complex processes with
several cytokines and other stimuli activating cells, are far from being well
understood [94]. With the population-based ODE-model the crosstalk to
p38-MAPK signalling could be established as a feature of primary NF-κB sig-
nalling in primary hepatocytes.
Furthermore, the local cytokine concentrations that arise during inflamma-
tion were formerly unknown, as experimental procedures hinder their deter-
mination. By simulating, this situation with a model trained to describe
quantitative time resolved data from diverse primary liver cell types we
now have an estimate of the upper limit of concentrations occurring locally,
which are surprisingly high (240 ng/ml TNF).
Third, the single cell analysis of HCCs has revealed that in these cells NF-κB
does not oscillate without a stimulus addition, providing an important dif-
ference in hepatocyte specific NF-κB signalling and that of other cell types
such as SK-N-AS. I have established a PDE model describing these dynamics
and the NF-κB signalling pathway in detail in spatio-temporal resolution.
4.1 Crosstalks in NF-κB Signalling in Hepatocytes
Inflammation in the liver and the innate immune response are complex pro-
cesses involving many cell types and cell-cell-communications via cytokines
and chemokines [1]. During early LPS-induced inflammation TNF and inter-
leukins, such as IL-1α, IL-1β, IL-6 are among the first cytokines produced
by non-parenchymal liver cells [36]. TNF, IL-1, and IL-6-induced signalling
results in acute phase protein production in hepaotcytes. TNF, IL-1α and
IL-1β can act as stimuli to the cannonical NF-kppB pathway by binding to
TNFR and IL-1 receptor (IL-1R) [95, 15]. IL-6 induces the JAK/STAT pathway
[96, 97]. There are several cross links between these pathways e.g. via
MAPK p38 [36].
Adiitionally, it has been suggested that NF-κB enhances STAT3 signalling
transduciton, by complex formation of p65 and STAT3 [98, 38]. Many of the
NF-κB and STAT3 target genes overlap, supporting this hypothesis [99]. To
further investigate this cross-talk experiments with co-stimulation and stim-
ulation with the individual cytokines could be done followed by cross-link
chromatin immuno precipitaion (XChIP) assays [100]. Then one could inves-
tigate, if p65 and STAT3 are bound to genes simultaneously. Additionally,
a comparison of micro-arrays of co-stimulated and cells stimulated with the
individual cytokines could be compared. Micro-array results could then be
further confirmed by RT-qPCR analysis.
In the conserved NF-κB pathway as described in the introduction the stim-
ulus leads to an activation of IKKβ, which phosphorylates IκBα, thus tar-
geting it for degradation and freeing NF-κB which can act as transcription
factor in the nucleus for diverse genes. The modifications described by the
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crosstalk to p38/MSK1 signalling do not alter this pathway, but the additional
phosphorylation of p65 at serine 276 increases the NF-κB affinity for certain
genes [101]. Here, I was able to validate the prediction made in my mas-
ter thesis, that a second form of phosphorylated NF-κB is necessary to de-
scribe TNF-induced NF-κB signalling. Our experimental collaborators mea-
sured the concentration changes in phosphorylated p38 and MSK1. When
substituting the unspecified placeholder reactions in the original model with
p38 phosphorylation and MSK1 phosphorylation reactions that lead to NF-
κB signalling and fitting only the parameters of these steps to the newly
measured data, the model was able to capture all the prior data proving
this a valid replacement for the original placeholder reactions. In summary
the model predictions lead to new experimental measurements and brought
new understanding of the systems regulation.
As it remains unclear how hepatocytes keep their ability to proliferate even
as mature cells. It be would interesting to find out, if this phosphorylation
of p65 and the according gene transcription profiles are relevant to this
process. Future experiments could involve blocking this post-translational
modification or analyzing, if other stimuli activating hepatocellular NF-κB
signalling induce it as well.
Furthermore, p38 is involved in cancer development in some cases, most
likely its activation has an inhibitory effect on cancer formation[102]. Thus
including it in the model in this early stage allows further investigations to
take the role of this crosstalk into account.
For a furhter analysis of crosstalks the role of IL-1 in hepatocyte NF-κB sign-
laing should be investigated. Hepatocytes express IL-1R [103], therefore a
next step could be to extend the model, so that it describes IL-1-induced
NF-κB signalling as well as TNF-induction and to compare the effects of the
different stimuli on the NF-κB pathway. An ODE-based model describing
IL-1R-induced signalling has been published [104]. The receptor and IL-1 in-
teractions could easily be included in my model and used to analyze exper-
imental data. This would especially be interesting, when combined with the
integrative model and cytokine expression profiles form non-parenchymal
cells for IL-1α and IL-1β secretion. Most likely the NF-κB-induction will in-
duced stronger during inflammation when both cytokines are expressed.
4.2 Extending the in vitro Model to Capture Dose Re-
sponsiveness
The in vivo concentration of TNF varies, therefore, it is important to describe
and understand TNF-induced NF-κB signalling not just for a single concen-
tration but for a concentration range. The original in vitro hepatocyte model
was trained with experimental data from primary hepatocytes stimulated
with 10 ng/ml TNF only. However, varying the dose (0.1, 1, 10, 20, 50 ng/ml
TNF) showed that the system has a strong saturation for higher stimuli (20,
50 ng/ml) and remains responsive even for the lowest dosage (0.1 ng/ml).
The model as it was originally set up was not able to describe this data in
full detail (even after re-parameterization), thus its topology and reaction
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kinetics needed to be changed. Choosing the levels of detail to include in a
model is an important decisions. My goal was to keep the model as accu-
rate as possible with respect to knowledge from literature research and our
collaborators experiments on biochemical reactions taking place and at the
same time keep the model simple enough to understand and learn about
the systems characteristics from the model.
Other models publised include three states of IKKβ, an activated, an inacti-
vated, and an unactivated state [48]. Thus, I decided to try different model
versions to see which described the data best. A model including IKKβ and
an arbitrary TNF-induced post-translational modification inhibiting IKKβ ac-
tivation did not describe the data sufficiently. This was not a proof that this
does not take place in hepatocytes, it may very well take place, but includ-
ing it in the model did not help with analyzing the dose responsive dynamics
the system shows. However, including TNF receptor 1 (TNFR1) and model-
ing TNF uptake in the cell did work to describe the dose responsiveness of
the protein measurements. Therefore, this model version was chosen for
further simulations.
This is the first NF-κB model to include details on the signalling itself and the
receptor level. Previous models included either the receptors level [81], or
the details on the intra-cellular signalling [55]. The receptor number in this
case turned out to be a crucial parameter in the model, as the number of
receptors at the cell surface defines how much TNF can be detected by a cell
at a specific point in time and how much TNF is needed to provoke NF-κB sig-
nalling in hepatocytes. It directly relates TNF concentrations in the medium
or extracellular volume to the intracellular hepatocyte species concentra-
tions. Especially, when simulating the TNF secretion from non-parenchymal
cells this became of particular importance. Including the receptors as a part
of the model additionally makes it feasible to use this model without further
adaptations in pharmaco-kinetic/pharmaco-dynamic modeling [105].
4.2.1 Model Parameterization
The ODE-models of NF-κB signalling presented here have many parameters
which cannot all be estimated accurately from the available experimental
data. Therefore, I have used model ensembles. These are ensembles of
several parameterizations of the same model topology that describe the ex-
perimental data equally well. As the parameter sets cover large ranges of
the parameter space for the ill defined parameters it is likely that behaviour
exhibited by all parameter sets in a model ensemble will be inherent to the
true (unknown) parameterization, as it is independent of these ill-defined
parameters. Therefore, the model ensembles allow predictions despite pa-
rameter non-identifiability.
Nevertheless, the parameter estimation can be rendered difficult, as pa-
rameter dependencies can lead to flat planes in target functions. In this
particular work, it took up to a week to estimate all parameters of the in
vitro hepatocyte model. Therefore, I reduced the complexity of the parame-
ter estimation problem by excluding parameters based on their identifiabil-
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ity. Using the Fisher Information Matrix to identify parameter identifiability
is efficient with respect to computational cost, as it is already calculated
in COPASI for each parameter estimation. Whereas, computing parameter
sensitivities or the target function landscape with respect to every parame-
ter on the other hand is rather computational cost intensive [45, 106, 107].
However, it is possible that the FIM does not reveal all parameter depen-
dencies. Here the correlation matrix, the inverse of the FIM could be used
instead [74]. However, in this work it proved sufficient to reduce only some
of the parameters in the parameter estimation to reduce time for running
the parameter estimation by more than factor two. Therefore, employing
the FIM was a timely efficient and in the resulting model ensembles all pa-
rameter sets described the experimental data very well.
Experimental data used for parameter estimation contains unknown errors.
To deal with these errors, some groups work with sophisticated error models,
they calculate before running a parameter estimation on the experimental
data [108], others include the error models as model parameters into the
parameter estimation and estimate them together with the model parame-
ters [59], others ignore it. For this work originally a multiplicative error as
parameter was included to the model. As the model grew bigger over time,
the parameter estimation problem grew bigger as well. At some point, it be-
came too time consuming trying to estimate parameters and errors simulta-
neously for the model. Therefore, I have tried to combine data normalization
and thus indirect error estimation, by using other parameters to describe the
error. The solution I have found works for this specific type of model with
the data available very well: a signal transduction model, which is assumed
to be in a steady-state before stimulus addition, optimized against semi-
quantitative data, describing relative concentration changes.
Calculating the scaling factor from the average initial experimental value
and the steady state value may introduce an error, as the averaged initial
experimental value may not represent the best initial value for the time-
series simulation. Using the median instead of mean initial experimental
values or estimating the scaling factor in the model together with the other
parameters could overcome this potential problem. However, in this work
the parameter estimation resulted in good fits without any of further modifi-
cation and the reduced computational time made the chosen approach the
best solution for this particular problem.
4.3 Modeling Liver Micro-Anatomy
The liver is a complex organ, with several cell types and different levels of
anatomical structures. As described in the introduction in details, the lobules
form larger lobes that than form the liver. It would not have been feasible
to try to describe these anatomical structures in detail in this work. Luckily,
on a micro-anatomical level liver lobules have a homologue distribution of
cells and extra cellular structures. Hepatocytes form one to two cells thick
layers around a sinusoid. The sinusoid is lined by liver resident endothe-
lial cells (LSEC) which form so called fenestrae through which most blood
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components can enter the Space of Disse between the LSEC and the hepa-
tocytes. Within the sinusoids of one liver zone liver resident macrophages
so called Kupffer Cells are distributed homogeneously. They can control the
blood flow through the sinusoid, which is slow (270-410 μm/s [109]) com-
pared to flow through other vessels (1500 μm/s [110]).
All these attributes of the liver make it feasible to assume that by compart-
mentalising the liver into small sections until looking at the immediate sur-
roundings of a single hepatocyte, we can still describe the average behavior
of all hepatocytes in the liver would show, if they were at an inflammatory
core. Thus the average volumes of sinusoidal lumen and Space of Disse ad-
jacent to a single liver cell were used to calculate the secretion profiles of
TNF in response to LPS and the hepatocyte response to these estimated in
vivo concentrations of TNF.
4.3.1 TNF Amounts in the Liver Versus in vitro
The TNF secretion levels from the non-parenchymal cells were measured per
single cell. Yet in the liver these cells are not equally abundant. Thus the
influence of the HSCs was weak compared to the influence of MCs or LSECs.
Furthermore, the HSCs cytokine secretion was not increased by LPS addition,
but remained constant. Thus, the HSCs were not included in the integrative
liver model. If they had been included, the hepatocytes would have had to
remain responsive to TNF despite a constitutive TNF level. With the model
as it was trained, this would not have been explicable. It is unlikely that
constitutive TNF levels are secreted by all non-parenchymal cells in vivo.
Rather the constitutive TNF levels measured for all non-parenchymal cells
in vitro are due to experimental procedures such as cell isolation and cul-
tivation, which exert stress to the cells. Otherwise in vivo the hepatocytes
would have to shut off the signalling response to low TNF levels until a cer-
tain threshold was reached, which could not be observed in vitro. This would
require a more complex system then is currently known and would be more
costly with respect to biosynthesis of cytokines and signalling molecules
than simply not producing TNF under non-inflammatory or non-cancerous
conditions. Therefore, it is biologically feasible to assume that no TNF is
secreted from non-parenchymal cells in vivo in the absence of stimuli such
as LPS. However, for the further analysis of my simulation results, it should
be considered that HSCs might additionally increase the TNF levels during
inflammation, despite that no induction was observed in the experiments
presented here.
4.4 NF-κB Signalling in the Liver
MCs and LSECs secreting TNF simultaneously invoke the greatest hepato-
cyte response, although the in vitro experiments and model show a greater
hepatocellular response in NF-κB signalling would be possible. The TNF val-
ues simulated can arise in the center of inflammation. 5 pg/ml LPS stimu-
lation lead to more than 240 ng/ml TNF. Thus, they would only occur locally
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and the average values measured for the entire liver as an organ would be
much lower. Therefore it is not surprising that these values are above the
measured TNF serum concentrations in vivo (5-43 ng/ml TNF [111, 112]).
In the in vitro experiments TNF was added in a fixed concentration to the
medium. This set-up differs strongly from the in vivo processes. Here, TNF
is secreted gradually from non-parenchymal cells, this secretion takes some
time and does not result in a sudden exposure of hepatocytes to a very
high dose of TNF, furthermore, the extracellular volume into which the non-
parenchymal cells secrete TNF is several orders of magnitudes smaller than
the in vitro volume of the medium into which the TNF is added in the in vitro
experiments. Therefore, the in vitro concentration of TNF is much smaller
than the in vivo concentrations, yet the in vitro particle numbers of TNF
are much higher than the 440800 in vivo particle numbers (TNF in vivo:
240 ng/ml = 7640 particles, TNF in vitro: 10 ng/ml = 440800 particles).
There are 2300 TNFR1 particles per hepatocyte, thus the amount of recep-
tors which can bind free TNF is limited. In the in vitro experiments TNF can
immediately bind to all available TNFR1s as there is immediately enough
TNF available. In the in vivo simulations TNF becomes available gradually
and thus only some of the TNFR1 receptors are bound at first. These are
then internalized and TNF is internally degraded until the receptors are free
again and can be recycled to the outer cell membrane. However, for the
NF-κB signalling response the intact TNF:TNFR1 complex on the membrane
is decisive and not the internalized, partly degraded forms. Thus, the NF-κB
response in the in vitro experiments is much stronger than in the in vivo
simulations, because secretion velocity of the non-parenchymal cells is lim-
ited and lead to limited TNF particles available in the first few hours.
This is an important result and new insight, as it shows that the mode of cy-
tokine administration has a strong influence on the NF-κB response. There-
fore, it may be worth wile to reconsider the way cytokines are administered
in in vitro experiments, when investigating inflammation. It would make
sense to use a pump to slowly increase the TNF levels, mimicking the TNF
secretion profiles of non-parenchymal cells. Furthermore, the volumes of
the medium could be reduced strongly to mimic the smaller extracellular in
vivo volumes. Alternatively co-culture experiments with non-parenchymal
cells and parenchymal cells would also help validate these results. How-
ever, these would most likely not be feasible with primary cells and thus it
would be necessary to ensure that the TNF secretion in the non-parenchymal
cell line and the NF-κB signalling in the hepatocyte cell line are not al-
tered. Furthermore additional cytokines or chemokines produced by the
non-parenchymal cells such as IL-1 may alter the NF-κB signalling. There-
fore the model could be extended in a way that it includes responses to
these cytokines as well.
Our results show that MCs and LSECs combined can invoke the largest re-
sponse. However, TNF secreted by either cell type individually is more
than sufficient to invoke a intra-hepatocellular response, even for very low
dosages of LPS. As described above, the secretion velocity is the decisive
parameter for the hepatocellular reaction strength. MCs secrete TNF slower
than LSECs thus they invoke a less strong response. The secretion veloc-
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ity can only be altered within certain ranges. Adding very high LPS con-
centrations thus cannot increase the TNF secretion velocity of the non-
parenchymal cells beyond a certain speed and therefore, cannot lead to
a stronger a hepatocyte response. However, by increasing the number or
abundance of non-parenchymal cells in the liver, more cells could secrete
TNF, TNF levels could increase faster, and this would lead to a stronger hep-
atocellular response.
4.5 Linking NF-κB Signalling During Inflammation to Can-
cer
Unresolved chronic inflammation in the liver leads to liver fibrosis which
in turn leads to hepatocellular carcinomas [113]. The role of NF-κB sig-
nalling in hepatocytes can vary. Depending on the surrounding conditions
permanently active NF-κB signalling can enhance or inhibit hepatocellular
carcinoma formation [16]. Therefore, it is especially important to investi-
gate NF-κB signalling in hepatocytes in a setting as close as possible to
in vivo conditions. For the work presented here, I had the opportunity to
work with experimental results from primary murine cells. Therefore, this
model has the is different from many models of NF-κB signalling that exist
[54, 47]. As these were all dervied from experimental data from carcinoma
cell lines, where a potential modification of NF-κB signalling cannot be ruled
out [114, 115].
However, under my guidance, Nicolas Huber was able to show that the dif-
ferences in NF-κB signalling of investigated hepatocellular carcinoma cell
lines (Hep56 and Hepa1-6) and hepatocytes can be explained by differential
protein expression levels. This was an important step as not all experiments
for this work could be carried out in primary cells. For the final single cell
analysis protocol stably transfected cell lines were used. However, as pa-
rameter estimation for the PDE model is not feasible a pre-requisite to model
this data was that the human hepatocellular carcinoma line on a population
level follows the same dynamics as the primary murine hepatocytes the ODE
model was trained against.
Additionally, under my guidance, Martin Zauser tried to link NF-κB sigan-
ling with the Hippo-YAP signalling. The Hippo-YAP pathway is known to be
cruical to organ size control [39] and NF-κB signalling is a mayor player in
cell fate decisions [116]. Although organ size control and cell fate should
be linked, we were not able to find a connection between the NF-κB and
the Hippo-YAP pathway. Our results indicate that most likely these pathways
are co-regulated. To further understand how priming cells for proliferation
by NF-κB signalling and organ size control are interlinked a more complete
picture of other signaltransduction processes is necessary.
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4.6 Single Cell Investigations and PDE Modeling
Single cell dynamics may not be identical to population-based dynamics.
This is especially interesting as these effects may affect the way cells re-
sponse to different stimuli administrations [54]. Other groups have observed
that on the single cell level there are stochastic effects in the NF-κB pathway
[117]. Some cells oscillate without stimulus and the amount of cells that os-
cillate depends on the cell types investigated. For example 30 % of HeLa
cells and 70% of SK-N-AS cell oscilllate [49]. The cells are oscillating asyn-
chronously in the absence of a stimulus and synchronous temporarily after
stimulus addition. Thus, the average behavior measured in population-level
experiments shows no oscillations without a stimulus.
In our experiments we found that HLE and HLF cells do not oscillate in the
absence of TNF. Rather all p65 is in the cytoplasm and enters the nucleus
only once in some cells twice upon TNF stimulation. This is a difference
of NF-κB signalling in hepatocytes compared to other cell types. Thus the
population-level experiments and the single cell experiments should have
similar dynamics. However, in the single cell experiments we see that NF-
κB remains longer in the nucleus (p65 has returned back to the cytoplasm
after 180 min) than in the population experiments (p65 has returned back
to the cytoplasm after 60 min). For the population-level experiments I had
only one replicate of the experiment from hepatocytes. Therefore, I cannot
completely rule out an experimental error in the data or a difference be-
tween dynamics in primary hepatocytes and HLE cells. On the other hand,
the ODE model predictions are in good agreement with this experiment.
Therefore, the difference may arise from the experimental set-up for mea-
suring the nuclear fraction of p65. It may be that over-expression of p65
in the stably transfected HLE cells is the reason for the delayed return of
p65 to the cytoplasm. If there is more NF-κB the IκBα concentration could
also be up regulated and thus it may simply take longer until enough IκBα
is reproduced and the system can return to its steady-state. An alternative
explanation may be that the red fluorescent protein tagged to p65 may slow
the nuclear export of the complex. Or the red fluorescent tag could reduce
the transcription activator strength of p65.
In the PDE model changes were also necessary to describe the experiments
qualitatively. It would not have been feasible to re-estimate the parame-
ters for the biochemical-reactions, therefore, I was lucky that the single cell
dynamics showed the same qualitative behaviour as the population-based
dynamics. Otherwise, I would have needed to reparameterize the model so
that it would be able to describe oscillations. Here, I used the parameters
of biochemical-reactions estimated for the ODE-model [118]. However, the
transcription rates of the ODE-model could not be used in the PDE model.
In the PDE model as it is currently implemented the nuclear transport of
molecules poses as problem. Currently there is no mathematically exact so-
lution to this problem available in DUNE. Therefore, I decided to work with an
overlap region.This region is defined as both nucleus and cytoplasm at the
same time. This is not an accurate solution, however, it does approximate
a membrane. In this region a nuclear species can become a cytoplasmic
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species for example nuclear p65 can turned into cytoplasmic p65. The as-
pect of diffusion is already included in the PDE model, as a species needs to
cross the overlap region to have crossed the membrane. Therefore, I con-
sidered only molecules in the cytoplasm out side of the overlap region as
true cytoplasmic molecules. Essentially I need to ignore the species in the
overlap region, as these are species in the membrane.
In the currently published spatio-temperal models of NF-κB signalling the
diffusion factor for all proteins is assumed to be the same, although there
are differences in the protein sizes (IκBα weighs approximately six times
less than the IKK complex) and these will affect the diffusion coefficients
[62, 63, 61, 64, 119]. My PDE model is the first to consider different diffu-
sion coefficients for each species based on their molecular weight.
Further investigations in the PDE model could involve changing the ratio of
nucleus to cytoplasm and changing the cell shape. In oscillating regimes
of the model this has an influence on the oscillations[62]. However, these
results were based on a 2D PDE where it was assumed that active IKK only
appears at the outer edge of the cytoplasm. In in vitro experiments TNF is
added the medium which has contact to the upper side of the cell and would
thus be available to all parts of the cytoplasm of a 2D PDE model. Therefore
the effect of the nuclear and cytoplasm size and shape should be reconsid-
ered in a 3D PDE model describing the TNF addition and IKK activation more
accurately. Furthermore, it would be worthwhile to simulate the cell in 3D
and include the medium as an additional compartment on upper side of the
cell and at same time limiting the area in which receptor complexes with
TNFR1 and IKK can form to be close to the upper membrane. Furthermore
it would be good to measure the diffusion coefficients of the main species
in the NF-κB pathway with fluorescent recovery after photobleaching (FRAP)
[120].
Additionally, the amount of cells which are responsive to TNF vary depend-
ing on the TNF dose, thus the average population level peak height is not
the result of cells showing a less pronounced change in NF-κ localisation but
rather the result of less cells being activated by TNF [117]. The PDE model
to describe the single cell data was created based on the ODE model. The
parameters for the biochemical reactions remained the same, a part from
the transport reactions. If the population-based dynamics were the result
of single cells acting differently, however canceling out each others effects
in the population-based measurements this would have posed a great prob-
lem. However, in our data this was not the case, therefore and as parameter
estimation for the PDE model was not feasible due to its large computational
costs, it was valid to keep the parameters from the ODE model.
The diffusion coefficients of the individual species were unknown. They were
calculated with a formula derived for spherical molecules in water was taken
as an approximations. Cytoplasm and nucleoplasm are aqueous solutions,
however, as the concept of molecular crowding illustrates there are more
than just water molecules in cells. Additionally there are motor proteins
moving cells a long cytoskeletal molecules such as myosines moving a long
actin filaments. Some signalling molecules are mobile, such as NF-κB or
its inhibitor, however, the signalsome or the recruited IKK-complex are less
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mobile and rather rest in one place as soon as they are recruited. Therefore
assuming spherical molecules moving in water is a very rough approxima-
tion. Our results showed that to describe the single cell measurements these
estimated diffusion coefficients needed to be increase by a factor of 100.
The single cell data showed no spatial effects. All effects observed could
be easily described with the compartmentalized ODE model. However, they
did show that the hepatocellular carcinoma cell lines did not oscillate as
apposed to other cell lines such as SK-N-AS, were the cells oscillated asyn-
chronously in the absence of a stimulus and were synchronized when treated
with e.g. TNF. These synchronized oscillations were then observable on a
population-based level. The absence of these asynchronous oscillations still
remains unclear. It may be that these cells are simply in a different state
that the other so far investigated cells. An alternative explanation could be
that most cells secrete TNF as a result of NF-κB signalling, however, hepato-
cytes do not. Maybe the secreted TNF acts autocrinely in other cell lines and
this is the reason for the asynchronous oscillations.The current model would
suggest that the cells are indifferent states. It is capable of oscillating in the
absence of TNF, if the steady-state ratio of IκBα to p65 is changed. However
a prolonged exposure to TNF would not lead to continuous oscillations. This
could be validated by inhibiting TNF secretion in cell lines oscillating in the
absence of a stimulus. If these cells continued to oscillate they would be in
a different state than the hepatocellular cell lines analyzed here.
4.7 Concluding Remarks
In this work NF-κB signalling in hepatocytes was first investigated with popu-
lation based measurements, describing its dose responsiveness and crosstalks
to other pathways, such as MAPK and Hippo/YAP. It was found that the
MAP-kinase p38 can induce NF-κB post-translational modification via MSK1,
which is essential to accurately describe all kinetic data available for hepa-
tocyte NF-κB signalling. Furthermore, NF-κB and Hippo/YAP signalling most
likely share upstream co-regulation. The established hepatocyte ODE model
was further used to validate, if NF-κB signalling is altered beyond varied
protein expression in the hepato-caricinoma cell lines Hep56 and Hepa1-
6. It could be shown, that altering the concentrations of proteins is suffi-
cient for the ODE model to describe all kinetic data for both cell lines. The
hepatocyte ODE model was used to described the effects of different non-
parenchymal cells on hepatocytes in an integrative model of parenchymal
and non-parenchymal cells. This model is the first to describe these different
cell types of the liver. The results from these investigations show that TNF
administration is decisive for the hepatocytes dynamic response and that
the current experimental procedures, with a single high dose TNF adminis-
tration are not in good correlation to the in vivo gradual TNF secretion from
non-parenchymal secretion, thus the current in vitro measurements may
not be good models of in vivo reactions. As a last step the ODE model was
converted into a PDE model. Using microscopy images from newly estab-
lished cell lines expression p65-RFP as reference it can be concluded that
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the PDE simulations of the NF-κB model compare well to the TNF-induced
p65 translocation.
Taking together these findings give new insight on regulation of NF-κB sig-
nalling in hepatocytes, the role of different non-parenchymal cells during
inflammation, the high impact of cytokine administration on signalling and
lead to the question if NF-κB oscillations in other cells arises from intrinsic
factors or from autocrine or paracrine cytokine secretion.
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A.1 Experimental Data
Table A.1: Western immunoblot measurements of the principal NF-κB path-
way components from primary murine hepatocytes treated with 10 ng/ml
TNF.
Time p65 p-p65 IκBα p-IκBα
in min in arb. units in arb. units in arb. units in arb. units
0 100.00 131.82 152.31
5 79.79 100.72 161.04
10 104.71 74.64 380.29
20 73.22 25.18 168.16
40 90.88 48.31 250.30
60 104.29 107.49 358.91
120 75.37 128.37 248.22
180 105.54 109.63 226.91
240 57.61 94.96 231.43
0 56.59 42.73 99.89
5 68.08 41.16 82.33
10 73.95 610.54 36.25
20 68.48 358.93 7.90
40 60.17 168.82 23.24
60 66.30 168.77 74.87
120 44.80 113.59 126.00
180 62.95 112.37 114.83
240 72.53 68.30 49.02
0 47.70 43.26 85.05
5 42.96 77.20 95.68
10 48.96 312.89 61.58
20 80.43 358.04 19.32
40 90.17 134.25 32.02
60 63.04 88.02 78.59
120 9.90 82.71 134.50
180 32.76 73.94 94.50
240
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Table A.2: Western immunoblot measurements of the principal NF-κB path-
way components from primary murine hepatocytes treated with 10 ng/ml
TNF, continued .
Time p65 p-p65 IκBα p-IκBα
in min in arb. units in arb. units in arb. units in arb. units
0 43.36 83.66 71.16
5 50.55 73.39 83.16
10 74.67 291.99 66.77
20 75.40 346.71 27.00
40 72.77 162.77 25.11
60 59.92 130.88 73.82
120 37.20 94.11 129.08
180 40.87 78.02 119.93
240 37.19 155.95 106.49
0 69.77 126.09 88.21 144.03
5 53.25 186.27 87.98 612.71
10 64.92 390.01 29.38 414.96
20 65.38 190.80 10.28 137.18
40 59.78 141.20 42.82 144.88
60 72.09 113.99 83.95 248.78
120 59.57 110.63 130.66 174.51
180 53.84 126.70 103.05 158.31
240 72.43 134.63 101.54 114.72
0 46.20 57.19 89.03 134.97
5 34.35 132.62 113.05 159.32
10 36.25 355.01 61.91 444.46
20 49.17 282.06 18.78 133.19
40 73.02 171.70 28.46 168.13
60 65.21 150.84 75.69 312.44
120 94.86 225.75 124.12 302.59
180 59.96 203.48 82.36 235.67
240 95.65 76.39 97.75 121.57
0 41.35 157.94 98.36 138.27
5 55.48 169.08 118.55 174.55
10 52.80 390.78 64.37 513.58
20 48.67 207.71 18.39 117.02
40 73.33 58.61 22.18 56.91
60 68.70 67.33 77.80 152.29
120 44.90 90.46 114.07 223.40
180 49.33 17.62 72.28 140.01
240
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Table A.3: Western immunoblot measurements of the principal NF-κB path-
way components from primary murine hepatocytes treated with 10 ng/ml
TNF, continued .
Time p65 p-p65 IκBα p-IκBα
in min in arb. units in arb. units in arb. units in arb. units
0 105.51 77.80 55.65
5 204.26 75.30 275.05
10 316.43 59.00 532.52
20 213.33 23.28 98.43
40 187.12 28.23 120.58
60 173.17 76.62 150.10
120 127.26 201.91
180 121.89 210.13
240 132.68 140.86
0 65.15 123.40 81.63 187.13
5 68.33 138.77 93.50 368.36
10 60.34 411.77 47.89 411.55
20 61.64 177.53 30.95 241.55
40 54.28 82.59 40.04 167.06
60 84.89 154.34 118.85 400.54
120 61.18 116.12 107.66 165.40
180 42.83 60.60 84.13 168.28
240 46.03 22.53 70.09 329.27
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Table A.4: Western immunoblot measurements of phospho-p38, phospho-
JNK, and phospho-MSK1 from primary murine hepatocytes treated with 10
ng/ml TNF.
Time p-MSK1 p-p38 p-JNK
in min in arb. units in arb. units in arb. units
0 0.567531736
5 1.00863806
10 1.715031255
20 1.603915653
40 0.814274814
60 0.908020218
120 0.889970256
180 0.833002587
240 1.045993857
0 0.57593767 0.850443549 0.643737004
5 1.150723464 1.289479964 1.046253984
10 1.881588367 1.419104346 1.74080456
20 1.387433846 1.300109093 1.438627616
40 1.139204711 0.96957664 1.036920318
60 0.794793984 0.847606624 0.59758753
120 0.687669578 0.842222958 0.659065857
180 0.637563 0.599861535 0.716991354
240 0.793642109 0.954413725 0.740610256
0 0.726754954 0.795615538 0.834281982
5 0.906263428 1.361767847 0.902137282
10 1.492754676 1.57041044 1.551975182
20 0.901902898 1.077660313 0.853243123
40 0.702772041 0.880048592 0.830677533
60 1.219494813 0.822416451 0.911495542
120 0.872105945 0.708597005 0.936355724
180 0.930973096 0.874938637 1.027428104
240 1.198418919 0.835722361 1.14542291
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Table A.5: Western immunoblot measurements from primary murine hepa-
tocytes treated with 0.1, 1, 10, 20, 50 ng/ml TNF, Experiment 1.
Time TNF p-p65 IκBα p65 p-IκBα
in min in ng/ml in arb. units in arb. units in arb. units in arb. units
0 0.1 0.57 1.31 1.58 0.43
5 0.1 1.17 1.39 1.64 0.72
10 0.1 0.83 1.12 1.44 0.43
20 0.1 1.00 0.92 1.10 0.41
40 0.1 1.09 0.84 1.41 0.43
60 0.1 0.76 0.95 0.91 0.30
120 0.1 0.74 0.97 0.75 0.36
0 1 0.57 1.31 1.58 0.43
5 1 1.02 0.76 1.09 1.13
10 1 1.14 0.90 1.45 2.03
20 1 0.97 0.39 1.12 0.55
40 1 0.62 0.43 1.06 0.45
60 1 0.51 0.87 1.08 0.48
120 1 0.56 1.44 1.19 0.66
0 10 0.57 1.31 1.58 0.43
5 10 1.63 0.63 1.11 2.44
10 10 1.87 0.53 0.86 1.37
20 10 1.38 0.25 0.97 0.42
40 10 1.39 0.76 1.04 0.74
60 10 1.04 1.67 0.86 0.63
120 10 1.03 2.11 0.84 0.70
0 20 0.57 1.31 1.58 0.43
5 20 2.12 0.80 1.43 3.46
10 20 1.60 0.48 1.23 2.07
20 20 0.93 0.15 1.10 0.33
40 20 0.73 0.37 1.17 0.57
60 20 0.61 0.97 1.03 0.51
120 20 0.54 1.21 1.35 0.81
0 50 0.57 1.31 1.58 0.43
5 50 3.19 1.03 0.93 2.76
10 50 3.33 0.43 0.96 1.30
20 50 2.23 0.20 0.72 0.16
40 50 1.83 0.77 0.64 0.49
60 50 1.64 2.45 1.09 0.79
120 50 1.36 2.57 0.38 0.88
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Table A.6: Western immunoblot measurements from primary murine hepa-
tocytes treated with 0.1, 1, 10, 20, 50 ng/ml TNF, Experiment 2.
Time TNF p-p65 IκBα p65 p-IκBα
in min in ng/ml in arb. units in arb. units in arb. units in arb. units
0 0.1 0.60 1.43 1.16 0.44
5 0.1 1.03 1.46 1.28 1.00
10 0.1 0.67 1.50 1.28 0.45
20 0.1 0.94 1.23 1.52 0.73
40 0.1 0.50 1.12 1.34 0.54
60 0.1 0.73 1.30 1.39
120 0.1 0.46 0.95 0.78
0 1 0.60 1.43 1.16 0.44
5 1 1.14 0.76 0.86 1.20
10 1 1.40 0.81 0.89 1.26
20 1 1.48 0.40 1.40 0.61
40 1 0.94 0.56 1.38 0.65
60 1 0.76 0.86 0.94
120 1 0.59 1.97 1.01
0 10 0.60 1.43 1.16 0.44
5 10 2.99 0.62 1.10 2.93
10 10 2.43 0.33 0.82 1.43
20 10 0.94 0.13 1.15 0.46
40 10 0.62 0.60 1.18 0.97
60 10 0.53 1.37 1.09
120 10 0.55 1.65 0.90
0 20 0.60 1.43 1.16 0.44
5 20 1.92 0.85 1.27 2.85
10 20 2.66 0.40 1.02 1.99
20 20 0.96 0.16 1.18 0.42
40 20 0.70 0.44 0.98 0.86
60 20 0.53 1.10 0.91
120 20 0.64 1.54 0.89
0 50 0.60 1.43 1.16 0.44
5 50 2.38 0.65 1.06 2.74
10 50 1.99 0.22 0.81 0.99
20 50 0.74 0.10 1.13 0.30
40 50 1.06 0.48 1.22 0.83
60 50 0.56 1.47 1.01
120 50 0.84 1.98 1.37
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Table A.7: Reverse transcription, quantitative PCR measurements of IκBα
mRNA from primary murine hepatocytes treated with 10 ng/ml TNF.
Time IκBα mRNA in arb. Units
in min Exp. 1 Exp. 2 Exp. 3
0 1 1.25 0.95
5 1.24 1.15 1.15
10 1.10 1.14 1.34
20 1.14 1.43 1.99
40 4.76 5.53 5.61
60 6.489 6.22 6.63
120 3.88 3.68 2.87
180 4.56 3.41 2.82
240 3.342
Table A.8: Reverse transcription, quantitative PCR measurements from pri-
mary murine hepatocytes treated with 0.1, 1, 10, 20, 50 ng/ml TNF.
Time TNF IκBα mRNA TNFa IκBα mRNA TNFa IκBα mRNA
in min in ng/ml in arb. units in ng/ml in arb. units in ng/ml in arb. units
0 0.1 0.25 1 0.25 10 0.25
5 0.1 0.14 1 0.20 10 0.29
10 0.1 0.14 1 0.26 10 0.26
20 0.1 0.20 1 0.29 10 0.41
40 0.1 0.39 1 0.65 10 1.66
60 0.1 0.74 1 1.30 10 2.60
120 0.1 0.52 1 3.57 10 1.12
180 0.1 0.48 1 0.69 10 1.07
240 0.1 0.37 1 0.54 10 0.80
0 20 0.25 50 0.25
5 20 0.26 50 0.26
10 20 0.20 50 0.19
20 20 0.41 50 0.46
40 20 1.66 50 2.15
60 20 2.21 50 2.25
120 20 1.32 50 1.39
180 20 1.15 50 1.07
240 20 1.21 50 0.87
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Table A.9: TNF LUMINEX measurements from primary murine liver sinusoidal
endothelial cells treated with diverse LPS concentrations.
Time LPS TNF
in min in ng/ml in ng/cell in ng/cell in ng/cell
Exp. 1 Exp. 2 Exp. 3
180 0 3.29E-07 3.29E-07 1.17E-06
360 0 3.43E-07 7.43E-07 1.17E-06
720 0 7.43E-07 1.17E-06 7.43E-07
1080 0 0.00E+00 3.29E-07 2.03E-06
1440 0 3.29E-07 3.29E-07 0.00E+00
180 1 3.29E-07 3.29E-07 2.03E-06
360 1 3.29E-07 0.00E+00 1.17E-06
720 1 2.46E-06 8.67E-07 1.89E-06
1080 1 1.17E-06 1.17E-06 2.90E-06
1440 1 0.00E+00 3.29E-07 0.00E+00
180 10 3.29E-07 3.79E-06 2.46E-06
360 10 2.46E-06 3.54E-07 2.90E-06
720 10 4.08E-06 2.90E-06 5.59E-06
1080 10 4.69E-06 6.05E-06 5.59E-06
1440 10 6.05E-06 4.69E-06 4.69E-06
180 50 2.90E-06 5.59E-06 3.79E-06
360 50 5.59E-06 5.59E-06 6.03E-06
720 50 4.69E-06 6.94E-06 9.23E-06
1080 50 1.02E-05 6.98E-06 9.48E-06
1440 50 7.97E-06 7.40E-06 5.59E-06
180 100 2.90E-06 2.18E-06 2.90E-06
360 100 5.59E-06 5.05E-06 6.49E-06
720 100 5.80E-06 8.31E-06 9.23E-06
1080 100 6.49E-06 7.40E-06 6.49E-06
1440 100 8.61E-06 9.42E-06 1.11E-05
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Table A.10: TNF LUMINEX measurements from primary murine hepatic stel-
late cells treated with diverse LPS concentrations.
Time LPS TNF
in min in ng/ml in ng/cell in ng/cell in ng/cell
Exp. 1 Exp. 2 Exp. 3
0 0 6.09E-06 5.69E-06 7.69E-06
120 0 5.84E-06 4.08E-06 8.76E-06
360 0 3.32E-06 3.02E-06 1.12E-05
1440 0 3.44E-06 3.44E-06 6.81E-06
0 10 2.22E-05 2.22E-05 2.22E-05
120 10 5.48E-06 5.12E-06 6.92E-06
360 10 3.93E-06 4.87E-06 8.12E-06
1440 10 5.94E-06 5.10E-06 1.50E-05
0 50 6.09E-06 5.69E-06 7.69E-06
120 50 4.42E-06 5.48E-06 8.02E-06
360 50 6.15E-06 8.12E-06 1.09E-05
1440 50 5.66E-06 6.53E-06 7.61E-05
0 100 6.09E-06 5.69E-06 7.69E-06
120 100 6.56E-06 5.12E-06 4.42E-06
360 100 4.55E-06 5.83E-06 3.18E-05
1440 100 1.20E-05 6.53E-06 3.64E-05
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Table A.11: TNF LUMINEX measurements from primary murine bone marrow-
derived macrophages treated with diverse LPS concentrations.
Time LPS TNF
in min in ng/ml in ng/cell in ng/cell
Exp. 1 Exp. 2
0 10 3.41E-08 3.10E-08
120 10 1.06E-06 8.75E-07
180 10 2.05E-06 1.47E-06
240 10 3.26E-06 2.06E-06
360 10 3.95E-06 2.89E-06
420 10 3.80E-06 2.98E-06
480 10 3.74E-06 2.99E-06
960 10 7.77E-06 5.91E-06
1440 10 7.73E-06 8.09E-06
0 50 3.41E-08 3.10E-08
120 50 1.07E-06 8.54E-07
180 50 2.24E-06 1.98E-06
240 50 3.23E-06 2.62E-06
360 50 6.00E-06 4.18E-06
420 50 5.82E-06 4.31E-06
480 50 6.36E-06 4.90E-06
960 50 1.03E-05 1.09E-05
1440 50 1.21E-05 9.20E-06
0 100 3.41E-08 3.10E-08
120 100 1.12E-06 9.68E-07
180 100 2.05E-06 2.04E-06
240 100 2.98E-06 3.17E-06
360 100 7.04E-06 5.10E-06
420 100 8.09E-06 5.46E-06
480 100 7.81E-06 4.90E-06
960 100 1.07E-05 1.12E-05
1440 100 1.20E-05 1.03E-05
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Table A.12: Western immunoblot measurements from Hep56 treated with 10 ng/ml TNF.
time p65 p-p65 IkBa p-IkBa p38 p-p38 MSK JNK p-JNK
in min in arb. u. in arb. u. in arb. u. in arb. u. in arb. u. in arb. u. in arb. u. in arb. u. in arb. u.
0 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
5 0.50 2.48 0.70 2.79 0.59 1.98 0.66 0.79 1.82
10 0.50 3.11 0.38 2.98 0.70 2.03 0.98 0.98 2.57
20 1.14 0.96 0.32 1.74 0.83 2.07 0.75 0.93 2.34
40 0.66 1.61 0.76 3.56 0.84 1.71 0.69 0.82 2.19
60 0.21 1.48 0.85 4.16 0.85 1.68 0.51 0.93 2.12
120 0.45 1.02 0.60 3.75 0.67 1.41 0.65 0.92 1.88
180 1.43 1.70 0.93 3.21 0.81 1.69 0.72 1.08 2.36
240 1.94 2.23 0.83 3.74 1.04 1.53 1.49 1.50 2.67
300 1.08 2.99 0.76 3.75 1.01 1.53 1.11 1.38 2.65
360 1.45 2.78 0.65 2.66 0.88 1.46 1.48 1.45 2.52
420 1.36 2.54 0.56 1.69 1.07 1.43 1.73 1.53 2.42
480 0.74 4.85 0.50 2.12 0.92 1.00 1.11 1.25 1.92
0 0.88 2.32 0.79 1.02 0.46 1.93 1.09 1.10 2.07
5 0.66 1.79 0.77 3.09 0.50 2.19 0.46 0.49 2.15
10 0.60 3.36 0.88 3.64 0.55 1.92 0.71 0.79 2.38
20 0.79 1.62 0.42 1.66 0.58 0.98 0.37 0.46 1.54
40 0.36 1.64 0.28 3.27 0.69 0.82 0.80 1.12 1.23
60 0.57 1.39 0.53 2.72 0.75 0.97 0.48 0.60 1.86
120 0.55 1.43 0.56 3.02 0.86 0.99 0.78 1.07 1.86
180 0.61 1.35 0.68 2.38 0.87 0.78 0.50 0.73 2.35
240 1.26 2.14 0.59 2.45 1.06 1.17 0.96 1.04 2.07
300 1.27 2.21 0.61 2.17 0.97 1.19 0.96 0.97 2.05
360 1.50 1.57 0.47 2.49 0.88 1.02 1.38 1.53 2.27
420 1.24 2.33 0.49 1.58 0.76 1.26 1.35 1.49 2.34
480 1.24 2.80 0.40 2.21 1.28 1.51 1.11 1.33 1.09
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Table A.13: Western immunoblot measurements from Hep56 treated with 10 ng/ml TNF.
time p65 p-p65 IkBa p-IkBa p38 p-p38 MSK JNK p-JNK
in min in arb. u. in arb. u. in arb. u. in arb. u. in arb. u. in arb. u. in arb. u. in arb. u. in arb. u.
0 0.65 1.11 0.62 2.28 0.76 0.91 0.66 1.10 0.71
5 0.75 2.57 0.65 2.00 0.75 1.53 0.64 1.17 0.94
10 0.56 3.70 0.39 2.03 0.71 2.20 0.53 0.96 2.42
20 0.66 1.26 0.19 2.51 0.68 1.97 0.54 0.97 2.27
40 0.90 2.35 0.51 3.23 0.83 1.56 0.37 0.89 1.88
60 0.75 1.56 0.88 2.60 0.78 1.26 0.73 1.14 2.08
120 0.80 1.37 0.85 1.88 0.77 1.53 0.38 0.89 1.39
180 0.87 2.00 0.58 1.54 0.76 1.32 0.32 0.88 2.10
240 0.93 1.42 0.66 1.71 0.95 0.90 0.58 0.92 2.42
300 1.05 2.15 0.51 2.63 0.83 0.86 1.51 1.20 2.06
360 1.09 1.51 0.57 0.54 0.87 0.93 1.42 1.16 2.29
420 1.49 2.46 0.43 4.02 1.03 1.16 1.03 1.08 2.80
480 1.32 1.72 0.64 2.83 0.91 0.62 1.40 1.13 1.36
0 0.95 0.44 0.60 1.74 0.64 0.93 1.63
5 0.98 0.56 0.65 1.69 0.69 0.86 1.60
10 2.76 0.48 0.75 1.93 0.67 0.97 2.49
20 1.77 0.38 0.64 1.04 0.61 0.94 2.02
40 1.83 0.37 0.71 1.17 0.72 0.97 1.16
60 1.68 0.60 0.64 1.38 0.68 1.09 1.35
120 1.24 0.81 0.74 1.00 0.67 1.03 1.59
180 2.26 0.99 0.82 1.15 1.11 1.25 1.51
240 1.91 0.58 0.80 1.11 0.79 1.01 1.47
300 2.19 0.62 0.84 1.38 0.98 1.10 2.18
360 2.08 0.59 1.21 1.35 0.97 1.14 2.26
420 3.40 0.67 0.89 1.18 1.54 1.21 3.13
480 2.36 0.43 1.11 1.49 1.05 1.10 2.38
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Table A.14: Reverse transcription, quantitative PCR measurements from
Hep56 treated with 10 ng/ml TNF.
time p65 mRNA IkBa mRNA
in min in arb. units in arb. units
0 1 1
5 0.75 0.79
10 0.83 1.11
20 0.81 5.59
40 1.39 17.14
60 1.22 13.48
120 1.19 6.35
180 0.85 4.49
240 1.56 5.71
300 1.31 4.89
360 1.2 4.49
420 1.32 4.57
480 1.19 3.89
0 1.05 1.02
5 0.80 0.76
10 0.84 1.02
20 0.82 1.14
40 0.92 8.33
60 1.00 14.48
120 1.17 5.40
180 1.37 7.52
240 1.28 6.46
300 1.16 4.31
360 1.37 5.74
420 1.23 5.22
480 1.34 5.58
0 0.84 0.85
5 0.80 0.78
10 0.80 0.84
20 0.74 3.02
40 1.05 13.98
60 1.13 10.17
120 1.17 8.45
180 1.35 5.92
240 1.31 6.08
300 1.34 5.61
360 1.23 3.41
420 1.40 5.15
480 1.18 4.80
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Table A.15: Western immunoblot measurements from Hepa1-6 treated with 10 ng/ml TNF.
time p65 p-p65 IkBa p-IkBa p38 p-p38 MSK JNK p-JNK
min arb. u. arb. u. arb. u. arb. u. arb. u. arb. u. arb. u. arb. u. arb. u.
0 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
5 0.30 2.88 0.53 3.16 0.75 11.66 0.65 0.87 1.93
10 0.64 4.54 0.24 1.45 1.05 18.92 1.13 1.07 6.21
20 0.49 1.29 0.23 0.25 1.24 9.97 1.16 1.11 7.62
40 0.50 1.54 0.86 2.53 1.14 6.06 0.91 1.02 3.20
60 0.33 1.17 3.21 1.63 2.08 3.70 1.06 1.03 2.08
120 0.59 1.36 1.62 1.55 1.35 2.51 1.27 1.11 2.09
180 0.67 1.79 1.55 1.12 1.40 2.65 1.97 1.25 2.08
240 0.78 1.53 1.33 1.56 1.21 2.24 1.75 1.18 2.18
300 1.12 2.02 1.18 1.24 1.48 2.66 2.54 1.23 1.99
360 1.20 1.90 1.10 0.96 1.80 2.02 2.09 1.31 2.14
420 0.93 1.87 0.82 1.01 1.44 1.71 2.81 1.24 1.89
480 0.96 2.37 0.81 0.85 1.98 1.13 2.31 1.27 1.98
0 0.49 0.75 0.83 0.45 1.03 1.33 0.20 0.19 4.36
5 0.28 3.27 0.24 3.34 0.86 14.52 0.43 0.42 3.52
10 0.45 3.03 0.09 0.30 0.96 15.96 0.76 0.82 3.34
20 0.42 1.01 0.17 0.32 1.09 6.75 0.78 0.63 2.94
40 0.45 1.51 1.74 1.29 1.16 2.94 0.56 0.55 0.94
60 0.32 1.00 1.91 1.02 1.16 2.81 0.90 0.87 0.56
120 0.37 1.32 1.18 0.95 1.18 3.03 0.80 0.64 0.87
180 0.42 1.33 0.95 0.71 1.18 2.24 0.86 0.67 0.30
240 0.63 1.43 0.95 0.54 1.36 2.49 0.82 0.66 1.28
300 0.87 1.88 0.94 0.56 1.44 1.76 1.63 1.08 0.43
360 1.04 1.86 0.88 0.77 1.56 2.35 1.13 0.86 1.10
420 0.81 1.61 0.80 0.77 1.35 1.66 0.83 0.76 0.45
480 1.18 1.71 0.81 0.71 1.75 1.78 1.60 0.91 0.33
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Table A.16: Western immunoblot measurements from Hepa1-6 treated with 10 ng/ml TNF.
time p65 p-p65 IkBa p-IkBa p38 p-p38 MSK JNK p-JNK
min arb. u. arb. u. arb. u. arb. u. arb. u. arb. u. arb. u. arb. u. arb. u.
0 0.55 1.12 1.33 0.96 1.43 0.96 1.35 0.84 1.09
5 0.52 4.19 0.27 1.65 1.35 16.51 0.92 0.72 2.93
10 0.44 2.74 0.06 0.47 1.39 14.08 1.14 0.72 5.50
20 0.44 0.83 0.17 0.51 1.36 5.18 0.76 0.66 4.06
40 0.37 1.32 1.79 2.43 1.28 3.17 1.15 0.72 1.61
60 0.31 0.76 1.86 1.73 1.15 2.66 0.78 0.58 0.98
120 0.47 1.02 1.25 0.98 1.38 2.93 1.04 0.69 1.16
180 0.61 1.25 1.05 1.06 1.41 2.38 0.89 0.67 1.05
240 0.60 1.14 0.82 0.76 1.16 2.27 0.95 0.82 1.62
300 0.68 0.90 0.64 1.02 0.99 1.91 0.96 0.79 0.98
360 0.82 1.32 0.76 0.64 0.70 2.02 0.74 0.81 1.19
420 0.96 1.95 0.78 0.96 0.60 1.66 1.04 0.93 2.03
480 1.21 1.57 0.65 1.20 1.23 1.76 0.72 0.89 1.29
0 0.34 2.06 2.33 0.93 1.18 0.88 2.24 1.76 0.97
5 0.34 3.66 0.14 1.60 0.93 12.58 0.27 0.25 1.74
10 0.42 1.28 0.06 0.42 1.25 18.73 0.93 0.63 6.13
20 0.60 0.97 0.10 0.96 1.09 5.41 0.18 0.22 3.05
40 0.29 0.92 0.92 1.89 0.98 1.78 0.41 0.43 1.11
60 0.55 1.20 1.99 1.76 1.10 1.39 0.17 0.22 1.45
120 0.99 0.69 0.62 1.28 0.95 1.35 0.18 0.21 1.98
180 0.49 1.31 0.58 1.16 1.24 0.88 0.57 0.35 1.53
240 0.31 1.04 0.44 0.72 0.92 0.77 0.25 0.19 1.06
300 0.38 1.56 0.48 0.66 1.32 0.61 0.60 0.44 0.80
360 0.62 1.40 0.42 0.78 1.62 0.60 0.22 0.24 0.55
420 0.67 2.19 0.48 0.97 1.68 0.50 0.56 0.74 2.39
480 1.30 2.15 0.48 1.55 1.64 0.45 0.17 0.25 0.42
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Table A.17: Reverse transcription, quantitative PCR measurements from
Hepa1-6 treated with 10 ng/ml TNF.
time p65 mRNA IkBa mRNA
min arb. u. arb. u.
0 1.00 1.00
5 0.69 0.71
10 0.78 1.30
20 0.92 6.61
40 1.37 36.86
60 1.57 34.40
120 1.78 11.27
180 2.39 11.79
240 2.05 9.07
300 2.02 7.60
360 2.82 9.53
420 1.95 6.66
480 2.56 9.13
0 0.99 1.69
5 0.80 1.56
10 0.91 3.67
20 1.16 15.48
40 1.14 35.15
60 1.99 16.16
120 2.31 17.94
180 1.91 11.36
240 1.45 7.21
300 2.94 13.56
360 1.48 6.08
420 1.57 6.88
480 1.63 6.49
0 1.13 1.76
5 1.12 2.18
10 1.32 6.70
20 1.09 19.06
40 1.47 35.37
60 1.78 13.30
120 2.61 16.71
180 1.89 11.44
240 1.48 8.42
300 1.78 7.68
360 1.98 7.39
420 1.43 5.80
480 2.06 6.71
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A.2 TNF/NF-κB and Hippo/YAP Crosstalk Found by Mar-
tin Zauser
Figure A.1: NF-κB signalling pathway from the KEGG-pathway database.
Species marked in green were found to be up regulated micro-array of YAP
overexpression. When measuring the mRNA induction with RT-qPCR these
findings could not be verified. Image and bioinformatic analysis by Martin
Zauser, experimental experiments by Federico Pinna, micro-array analysis
by the group of Fabian Theis.
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A.3 ODE Model
Table A.18: Initial concentrations values of all species of the integrative liver
model for LPS induced signalling. These values were used to calculate and
the steady state values of the species, time course simulations were started
from the steady state.
Species Compartment Inital Concentration in μM
p65_P cytoplasm 0.004142097
IkBa_p cytoplasm 0.058069182
IKKb cytoplasm 0.3
IKKb_p cytoplasm 0
p65-IkBa cytoplasm 0.046678665
IkBa_mRNA cytoplasm 0.158128991
IkBa cytoplasm 0.447641581
p65_mRNA cytoplasm 1
p65 cytoplasm 0.001541889
p38 cytoplasm 1
p38_P cytoplasm 0
JNK cytoplasm 1
JNK_P cytoplasm 0
TNFR1 cytoplasm 3.00E-04
TNF:TNFR1 cytoplasm 0
p65_P nucleus 0.207101584
IkBa nucleus 0.895282942
p65-IkBa nucleus 8.69E-01
IkBa_mRNA nucleus 2.85E-07
IkBa_pre_mRNA_1 nucleus 2.357263853
p65 nucleus 0.077093694
p65_2P nucleus 0.050685507
IkBa_pre_RNA_2 nucleus 2.357263853
MSK1_P nucleus 0
MSK1 nucleus 15
TNF EL 0
TNFR1 EL 0
TNF:TNFR1 EL 0
LPS EL 0
TNF_mRNA LSEC 0
TNF_pre_mRNA LSEC 0
TNF_mRNA MC 0
TNF_pre_mRNA MC 0
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[ODE Model, Reactions I]Reactions of the integrative liver model for LPS induced signalling.
Reaction Name Chemical Equation Rate Law
LPS degradation LSCEs LPS -> mass action
LPS degradation MCs LPS -> mass action
TNF transcription initiation LSECs ->TNF_mRNA see model file for details
TNF transcription termination LSECs TNF_pre_mRNA ->TNF_mRNA mass action
TNF translation LSECs TNF_mRNA ->TNF_mRNA + TNF mass action
TNF transcription initiation MCs ->TNF_pre_mRNA see model file for details
TNF transcription termination MCs TNF_pre_mRNA ->TNF_mRNA mass action
TNF translation MCs TNF_mRNA ->TNF_mRNA + TNF mass action
TNF degradation TNF -> mass action
TNFR1 vesicle to outer membrane shuttle TNFR1_cyt ->TNFR1_EL mass action
TNFR1 outer membrane shuttle to vesicle shuttle TNFR1_EL ->TNFR1_cyt mass action
TNF TNFR1 association TNF + TNFR1_EL ->TNF:TNFR1_EL mass action
TNF TNFR1 dissociation TNF:TNFR1_EL ->TNF + TNFR1_EL mass action
TNF:TNFR1 complex internalisation TNF:TNFR1_EL ->TNF:TNFR1_cyt mass action
TNF internal degradation TNF:TNFR1_cyt ->TNFR1_cyt mass action
IKKbeta basal phosphorylation IKKb ->IKKb_P mass action
IKKbeta active phosphorylation IKKb ->IKKb_P michaelis menten
IKKbeta dephosphorylation IKKb_P ->IKKb mass action
IkBa:p65 complex phosphorylation IkBa:p65_cyt ->IkBa_P + p65_P_cyt michaelis menten
IkBa phosphorylation IkBa_cyt ->IkBa_P michaelis menten
IkBa_P degradation IkBa_P -> mass action
p65 dephosphorylation (cyt) p65_P_cyt ->p65_cyt mass action
p65_dephosphorylation (nuc) p65_P_nuc ->p65_nuc mass action
p65 nuclear import p65_cyt ->p65_nuc mass action
p65 nuclear export p65_nuc ->p65_cyt mass action
p65_P nuclear import p65_P_cyt ->p65_P_nuc mass action
p65_P nuclear export p65_P_nuc ->p65_P_cyt mass action
IkBa nuclear import IkBa_cyt ->Ikba_nuc mass action
IkBa nuclear export IkBa_nuc ->IkBa_cyt mass action
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Reactions of the integrative liver model for LPS induced signalling, continued.
Reaction Name Chemical Equation Rate Law
complex nuclear import IkBa:p65_cyt ->IkBa:p65_nuc mass action
complex nuclear export IkBa:p65_nuc ->IkBa:p65_cyt mass action
complex association (cyt) IkBa_cyt + p65_cyt ->IkBa:p65_cyt mass action
complex dissociation (cyt) IkBa:p65_cyt ->IkBa_cyt + p65_cyt mass action
complex association (nuc) IkBa_nuc + p65_nuc ->IkBa:p65_nuc mass action
complex dissociation (nuc) IkBa:p65_nuc ->IkBa_nuc + p65_nuc mass action
p65 MSK1 phosphorylation 1 p65_nuc ->p65_P2 michaelis menten
p65 MSK1 phosphorylation 2 p65_P_nuc ->p65_P2 michaelis menten
p65 P2 dephosphorylation p65_P2 ->p65_nuc mass action
p38 basal phosphorylation p38 ->p38_P mass action
p38 active phosphorylation p38 ->p38_P michaelis menten
p38 dephosphorylation p38_P ->p38 mass action
MSK1 phosphorylation MSK1 ->MSK1_P michaelis menten
MSK1 dephosphorylation MSK1_P ->MSK1 mass action
JNK basal phosphorylation JNK ->JNK_P mass action
JNK active phosphorylation JNK ->JNK_P michaelis menten
JNK dephosphorylation JNK_P ->JNK mass action
IkBa transcription initiation ->IkBa_pre_mRNA1 see model file for details
IkBa transcription elongation IkBa_pre_mRNA1 ->IkBa_pre_mRNA2 mass action
IkBa transcription termination IkBa_pre_mRNA2 ->IkBa_mRNA_nuc mass action
IkBa nuclear export IkBa_mRNA_nuc ->IkBa_mRNA_cyt mass action
IkBa translation IkBa_mRNA_cyt ->IkBa_mRNA_cyt + IkBa_cyt michaelis menten
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Table A.19: Origins of the parameters of the integrative liver model for LPS induced signalling.
Parameters fitted or assigned References
k_LPS_LSEC_degradation fitted
kA_TNF_mRNA_LSEC_ transcription_initiation fitted
vA_TNF_mRNA_LSEC_ transcription_initiation fitted
k_TNF_mRNA_LSEC_ transcription_elongations fitted
k_TNF_mRNA_LSEC_degradation fitted
k_TNF_LSEC_translation fitted
k_LPS_KC_degradation fitted
kA_TNF_mRNA_KC_ transcription_initiation fitted
vA_TNF_mRNA_KC_ transcription_initiation fitted
k_TNF_mRNA_KC_ transcription_elongations fitted
k_TNF_mRNA_KC_degradation fitted
k_TNF_KC_translation fitted
k_TNF_degradation fitted
k_TNF:TNFR1_aassociation set to lit. value (16.833μM−1 ∗ s−1) [121]
k_TNF:TNFR1_dissociation set to k_TNF:TNFR1_association * Kd,
Kd = 1.9∗ 10−5μM [121]
k_TNFR1_vesicle2outer_membrane _shuttle fitted
k_TNFR1_outer_membrane2vesicle _shuttle set to lit value (1.8∗ 10−5s−1) [60]
k_TNF:TNFR1_EL_internalisation set to lit. value (7.7∗ 10−4s−1 [60]
k_TNF_internal_degradation fitted
k_IKKb_dephosphorylation fitted
k_basal_IKKb_phosphorylation fitted
vmax_IKKb_phosphorlyation fitted
Km_IKKb_phosphorylation fitted
Ka_IKKb_phosphorylation fitted
k_IkBa:p65_association set to lit. value (0.31μM−1s−1) [46]
k_IkBa:p65_dissociation set to k_IkBa:p65_association*Kd, Kd=3 nM [46]
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Origins of the parameters of the integrative liver model for LPS induced signalling, continued.
Parameters fitted or assigned References
k_IkBa:p65_nuclear_export fitted
k_IkBa:p65_nuclear_import fited
kcat_IkBa:p65_phosphorylation fitted
Km_IkBa:p65_phosphorylation fited
k_IkBa_complex_cyt_degradation mesured [59]
k_p65_degradation measured [59]
k_IkBa_nuclear_export set to k_IkBa_nuclear_import/2 [46]
k_IkBa_nuclear_import fitted
kcat_IkBa_phosphorylation set to kcat_IkBa: p65_phosphorylation
Km_IkBa_phosphorlyation fitted
k_IkBa_cyt_degradation measured [59]
Km_IkBa_translation fitted
vmax_IkBa_translation fitted
k_p65_nuclear_export set to k_p65_nuclear_import/50 [46]
k_p65_nuclear_import fitted
k_p65_translation set to 1.68∗ 10−06s−1
calculated from concentration p65 per cell / k_p65_degradation
(60000 Molecules per Cell, V =13 pl) [46]
k_p65_dephosphorylation fitted
k_IkBa_P_degradation fitted
k_IkBa_mRNA_cyt_degradation fitted
k_IkBa_mRNA_nuc_degradation fitted
k_IkBa_mRNA_nuclear_export fitted
k_basal_p38_phosphorlyation set to 1∗ 10−05s−1
kcat_p38_phosphorylation fitted
Km_p38_phosphorylation fitted
k_p38_dephosphorylation fitted
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Origins of the parameters of the integrative liver model for LPS induced signalling, continued.
Parameters fitted or assigned References
k_basal_JNK_phosphorlyation set to 1∗ 10−05s−1
kcat_JNK_phosphorylation fitted
Km_JNK_phosphorylation fitted
k_JNK_dephosphorylation fitted
k_IkBa_complex_nuc_degradation measured [59]
k_IkBa_nuc_degradation measured [59]
kcat_p65_phosphorylation_MSK1 fitted
Km_p65_phosphorylation_MSK1 fitted
kcat_MSK1_phosphorylaiton fitted
Km_MSK1_phosphorylation fitted
k_MSK1_dephosphorylation fitted
Ka_p65_IkBa_transcription_initiation fitted
Ka_p65_P_IkBa_transcription_initiation fitted
Ka_p65_P2_IkBa_transcription_initiation fitted
kbasal_IkBa_transcription_initiation set to 1.25∗ 10−06s−1
k_IkBa_transcription_elongation fitted
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Table A.20: Parameter values of the integrative liver model for LPS induced signalling for all 30 parameter sets of the
model ensemble.
kcat_IkBa_phos. k_IkBa:p65_ass. Km_IkBa_phos. k_IkBa_nuc._import k_IkBa_nuc._export k_IkBa:p65_diss.
1 467.2027177 0.017946353 0.1 0.005 2.50E-03 5.38E-05
2 45.935676 0.00727705 0.1 0.005 2.50E-03 2.18E-05
3 40.38409802 0.024732262 0.1 0.005 2.50E-03 7.42E-05
4 12.18097498 0.1 0.5 0.005 2.50E-03 3.00E-04
5 86.52935483 0.012988275 0.1 0.005 2.50E-03 3.90E-05
6 428.7578213 0.007146764 0.1 0.005 2.50E-03 2.14E-05
7 12.29483239 0.1 0.5 0.005 2.50E-03 3.00E-04
8 76.40962068 0.018324346 0.1 0.005 2.50E-03 5.50E-05
9 55.02060641 0.018125004 0.1 0.005 2.50E-03 5.44E-05
10 1000 0.1 0.5 0.005 2.50E-03 3.00E-04
11 36.82269751 0.01773735 0.1 0.005 2.50E-03 5.32E-05
12 73.645074 0.018316983 0.1 0.005 2.50E-03 5.50E-05
13 736.2082262 0.023783952 0.1 0.005 2.50E-03 7.14E-05
14 34.87895202 0.006636416 0.195181213 0.005 2.50E-03 1.99E-05
15 999.9414605 0.069326274 0.1 0.005 2.50E-03 2.08E-04
16 60.36335637 0.007150419 0.1 0.005 2.50E-03 2.15E-05
17 69.39246781 0.007246717 0.1 0.005 2.50E-03 2.17E-05
18 307.3139827 0.023907962 0.1 0.005 2.50E-03 7.17E-05
19 13.59748752 0.1 0.5 0.005 2.50E-03 3.00E-04
20 16.53505852 0.018126017 0.1 0.005 2.50E-03 5.44E-05
21 9.353319035 0.018277378 0.1 0.005 2.50E-03 5.48E-05
22 65.1998415 0.017896688 0.1 0.005 2.50E-03 5.37E-05
23 119.4523092 0.017958188 0.1 0.005 2.50E-03 5.39E-05
24 49.4377608 0.007173585 0.1 0.005 2.50E-03 2.15E-05
25 71.77868887 0.024457449 0.1 0.005 2.50E-03 7.34E-05
26 392.9065615 0.013157803 0.1 0.005 2.50E-03 3.95E-05
27 12.08697202 0.1 0.5 0.005 2.50E-03 3.00E-04
28 35.46332988 0.032316731 0.109722104 0.005 2.50E-03 9.70E-05
29 23.78424907 0.033429659 0.141052341 0.005 2.50E-03 1.00E-04
30 66.17364879 0.021404127 0.1 0.005 2.50E-03 6.42E-05
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Parameter values of the integrative liver model for LPS induced signalling for all 30 parameter sets of the model
ensemble, continued.
k_IkBa_transc._e. k_p65_degr. k_IkBa_com._cyt_degr. vmax_IkBa_transl. k_p65_transl. Ka_p65_P_IkBa_transc._i.
1 0.002052611 1.33E-05 1.00E-05 8.42E-04 1.68E-06 1.00E-04
2 0.002476155 1.33E-05 1.00E-05 7.57E-04 1.68E-06 1.00E-04
3 0.00203816 1.33E-05 1.00E-05 3.74E-04 1.68E-06 1.00E-04
4 0.002542963 1.33E-05 1.00E-05 3.87E-04 1.68E-06 1.00E-04
5 0.002230905 1.33E-05 1.00E-05 5.27E-04 1.68E-06 1.00E-04
6 0.002481247 1.33E-05 1.00E-05 7.66E-04 1.68E-06 1.00E-04
7 0.002530753 1.33E-05 1.00E-05 3.90E-04 1.68E-06 1.00E-04
8 0.002041545 1.33E-05 1.00E-05 8.57E-04 1.68E-06 1.00E-04
9 0.002034178 1.33E-05 1.00E-05 8.71E-04 1.68E-06 1.00E-04
10 0.002378198 1.33E-05 1.00E-05 1.99E-04 1.68E-06 1.00E-04
11 0.002056322 1.33E-05 1.00E-05 8.45E-04 1.68E-06 1.00E-04
12 0.002035278 1.33E-05 1.00E-05 8.55E-04 1.68E-06 1.00E-04
13 0.002077978 1.33E-05 1.00E-05 3.76E-04 1.68E-06 1.00E-04
14 0.001009944 1.33E-05 1.00E-05 7.79E-04 1.68E-06 3.44E-04
15 0.002076947 1.33E-05 1.00E-05 3.40E-04 1.68E-06 1.00E-04
16 0.002485372 1.33E-05 1.00E-05 7.65E-04 1.68E-06 1.00E-04
17 0.002458427 1.33E-05 1.00E-05 7.67E-04 1.68E-06 1.00E-04
18 0.002071373 1.33E-05 1.00E-05 3.75E-04 1.68E-06 1.00E-04
19 8.20E-04 1.33E-05 1.00E-05 4.71E-04 1.68E-06 5.35E-02
20 0.002048133 1.33E-05 1.00E-05 8.49E-04 1.68E-06 1.00E-04
21 0.002032457 1.33E-05 1.00E-05 8.70E-04 1.68E-06 1.00E-04
22 0.002056966 1.33E-05 1.00E-05 8.41E-04 1.68E-06 1.00E-04
23 0.002040525 1.33E-05 1.00E-05 8.76E-04 1.68E-06 1.00E-04
24 0.002473728 1.33E-05 1.00E-05 7.65E-04 1.68E-06 1.00E-04
25 0.002049251 1.33E-05 1.00E-05 3.74E-04 1.68E-06 1.00E-04
26 0.002224471 1.33E-05 1.00E-05 5.26E-04 1.68E-06 1.00E-04
27 0.002553547 1.33E-05 1.00E-05 3.85E-04 1.68E-06 1.00E-04
28 0.002163517 1.33E-05 1.00E-05 8.30E-04 1.68E-06 1.00E-04
29 0.002297852 1.33E-05 1.00E-05 8.31E-04 1.68E-06 1.00E-04
30 9.42E-04 1.33E-05 1.00E-05 8.50E-04 1.68E-06 1.00E-04
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Parameter values of the integrative liver model for LPS induced signalling for all 30 parameter sets of the model
ensemble, continued.
k_IkBa_mRNA_nuc._exp. k_IkBa_mRNA_cyt._degr. k_IkBa_mRNA_nuc._degr. k_IkBa_cyt_degr. vmax_IKKb_phos.
1 1.00E-04 2.39E-04 5.00E-05 1.00E-05 6.31E+01
2 1.00E-04 2.23E-04 5.00E-05 5.00E-05 9.94E+02
3 1.00E-04 2.18E-04 5.00E-05 3.97E-05 3.86E+02
4 1.00E-04 2.10E-04 5.00E-05 2.52E-05 4.28E+01
5 1.00E-04 2.18E-04 5.00E-05 5.00E-05 6.74E+02
6 1.00E-04 2.24E-04 5.00E-05 5.00E-05 1.20E+02
7 1.00E-04 2.10E-04 5.00E-05 2.63E-05 1.00E+03
8 1.00E-04 2.37E-04 5.00E-05 1.00E-05 7.53E+02
9 1.00E-04 2.39E-04 5.00E-05 1.00E-05 4.69E+01
10 1.00E-04 2.27E-04 5.00E-05 5.00E-05 8.89E+02
11 1.00E-04 2.39E-04 5.00E-05 1.00E-05 1.00E+03
12 1.00E-04 2.39E-04 5.00E-05 1.00E-05 1.00E+03
13 1.00E-04 2.19E-04 5.00E-05 3.16E-05 8.43E+02
14 1.00E-04 9.41E-04 5.00E-05 5.00E-05 2.01E+02
15 1.00E-04 2.56E-04 5.00E-05 5.00E-05 7.84E+02
16 1.00E-04 2.24E-04 5.00E-05 5.00E-05 1.00E+03
17 1.00E-04 2.25E-04 5.00E-05 5.00E-05 4.28E+02
18 1.00E-04 2.19E-04 5.00E-05 3.31E-05 6.48E+01
19 1.00E-04 1.00E-03 5.00E-05 5.00E-05 2.13E+02
20 1.00E-04 2.38E-04 5.00E-05 1.00E-05 4.21E+02
21 1.00E-04 2.38E-04 5.00E-05 1.00E-05 1.00E+03
22 1.00E-04 2.38E-04 5.00E-05 1.00E-05 1.00E+03
23 1.00E-04 2.39E-04 5.00E-05 1.00E-05 6.45E+02
24 1.00E-04 2.25E-04 5.00E-05 5.00E-05 1.00E+03
25 1.00E-04 2.18E-04 5.00E-05 3.72E-05 5.76E+02
26 1.00E-04 2.18E-04 5.00E-05 5.00E-05 6.43E+01
27 1.00E-04 2.10E-04 5.00E-05 2.42E-05 4.31E+02
28 1.00E-04 2.04E-04 5.00E-05 1.53E-05 9.92E+02
29 1.00E-04 2.04E-04 5.00E-05 4.52E-05 6.34E+01
30 1.00E-04 1.00E-03 5.00E-05 1.00E-05 1.00E+03
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Parameter values of the integrative liver model for LPS induced signalling for all 30 parameter sets of the model
ensemble, continued.
k_IkBa_nuc._degr. k_IkBa_com._nuc._degr. k_IkBa:p65_nuc._exp. Ka_IKKb_phos. Km_IKKb_phos.
1 1.00E-05 1.00E-05 1.00E-04 0.001 5
2 1.00E-05 1.00E-05 1.00E-04 0.001 5
3 1.00E-05 1.00E-05 0.002 0.001 5
4 1.00E-05 1.00E-05 0.002 0.048 5
5 1.00E-05 1.00E-05 1.00E-04 0.004 5
6 1.00E-05 1.00E-05 1.00E-04 0.002 5
7 1.00E-05 1.01E-05 0.002 1.120 5
8 1.00E-05 1.00E-05 1.00E-04 0.001 5
9 1.00E-05 1.00E-05 1.00E-04 0.001 5
10 1.00E-05 1.00E-05 0.001910774 1.797 5
11 1.00E-05 1.00E-05 1.00E-04 0.001 5
12 1.00E-05 1.00E-05 1.00E-04 0.001 5
13 1.00E-05 1.00E-05 0.002 0.058 5
14 1.00E-05 1.00E-05 1.00E-04 0.164 5
15 1.00E-05 1.01E-05 0.002 1.763 5
16 1.00E-05 1.00E-05 1.00E-04 0.001 5
17 1.00E-05 1.00E-05 1.00E-04 0.002 5
18 1.00E-05 1.00E-05 0.001968836 0.001 5
19 1.00E-05 1.00E-05 7.23E-04 0.233 5
20 1.00E-05 1.00E-05 1.00E-04 0.001 5
21 1.00E-05 1.00E-05 1.00E-04 0.001 5
22 1.00E-05 1.00E-05 1.00E-04 0.005 5
23 1.00E-05 1.00E-05 1.00E-04 0.003 5
24 1.00E-05 1.00E-05 1.00E-04 0.001 5
25 1.00E-05 1.00E-05 0.002 0.001 5
26 1.00E-05 1.00E-05 1.00E-04 0.008 5
27 1.00E-05 1.00E-05 0.001999842 0.480 5
28 1.00E-05 1.00E-05 1.00E-04 0.720 5
29 1.00E-05 1.00E-05 1.00E-04 0.046 5
30 1.00E-05 1.00E-05 1.00E-04 0.002 5
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Parameter values of the integrative liver model for LPS induced signalling for all 30 parameter sets of the model
ensemble, continued.
k_basal_IKKb_phos. k_IKKb_dephos. k_p65_nuc._exp. k_TNF_degr. Km_IkBa:p65_phos. kcat_IkBa:p65_phos.
1 4.71E-06 3.047 5.00E-04 1.56E-04 0.500 467.20
2 8.44E-05 4.856 5.00E-04 1.22E-04 0.500 45.94
3 3.14E-05 2.885 5.00E-04 1.45E-04 0.500 40.38
4 1.00E-07 0.002 5.00E-04 1.08E-04 0.100 12.18
5 1.37E-05 1.988 5.00E-04 1.33E-04 0.347 86.53
6 6.27E-06 3.350 5.00E-04 1.23E-04 0.500 428.76
7 1.00E-07 0.002 5.00E-04 1.08E-04 0.100 12.29
8 5.61E-05 5.867 5.00E-04 1.55E-04 0.500 76.41
9 3.51E-06 0.259 5.00E-04 1.56E-04 0.500 55.02
10 1.27E-07 0.335 5.00E-04 1.00E-03 0.100 1000.00
11 7.53E-05 3.815 5.00E-04 1.55E-04 0.500 36.82
12 7.49E-05 7.570 5.00E-04 1.56E-04 0.500 73.65
13 1.17E-06 1.976 5.00E-04 1.44E-04 0.500 736.21
14 1.10E-07 0.004 5.00E-04 1.11E-04 0.499 34.88
15 1.25E-07 0.302 5.00E-04 1.00E-03 0.100 999.94
16 8.47E-05 6.371 5.00E-04 1.23E-04 0.500 60.36
17 1.50E-05 1.295 5.00E-04 1.23E-04 0.500 69.39
18 5.26E-06 3.690 5.00E-04 1.44E-04 0.500 307.31
19 1.11E-07 0.002 5.00E-04 1.10E-04 0.100 13.60
20 3.15E-05 0.716 5.00E-04 1.56E-04 0.500 16.54
21 7.51E-05 0.950 5.00E-04 1.55E-04 0.500 9.35
22 1.36E-05 1.230 5.00E-04 1.56E-04 0.500 65.20
23 1.62E-05 2.608 5.00E-04 1.55E-04 0.500 119.45
24 8.50E-05 5.240 5.00E-04 1.23E-04 0.500 49.44
25 4.69E-05 7.669 5.00E-04 1.44E-04 0.500 71.78
26 6.74E-07 0.444 5.00E-04 1.33E-04 0.347 392.91
27 1.00E-07 0.002 5.00E-04 1.08E-04 0.100 12.09
28 1.00E-07 0.004 5.00E-04 1.62E-04 0.500 35.46
29 1.00E-07 0.002 5.00E-04 1.65E-04 0.500 23.78
30 3.37E-05 3.417 5.00E-04 2.00E-04 0.500 66.17
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Parameter values of the integrative liver model for LPS induced signalling for all 30 parameter sets of the model
ensemble, continued.
Ka_p65_IkBa_transc._i. k_IkBa_P_degr. k_p65_dephos. Ka_p65_P2_IkBa_transc._i. Km_p65_phos._MSK1
1 0.36 0.0028 5.61E-04 0.00010 1.073
2 0.22 0.0029 0.001100125 0.04555 9.999
3 0.61 0.0028 1.18E-03 0.00010 0.001
4 0.43 0.0100 0.004676856 1.00000 10.000
5 0.40 0.0028 1.12E-03 0.00010 10.000
6 0.29 0.0029 0.001101231 0.39917 10.000
7 0.61 0.0100 4.69E-03 0.00013 0.002
8 0.74 0.0028 5.52E-04 0.00010 1.005
9 0.19 0.0028 5.60E-04 0.00010 0.927
10 0.79 0.0064 1.00E-01 0.00010 0.001
11 0.27 0.0028 5.67E-04 0.00010 1.066
12 0.59 0.0028 5.52E-04 0.00010 1.002
13 0.42 0.0028 1.17E-03 0.00010 0.001
14 0.99 0.0037 1.67E-03 0.00010 0.001
15 0.69 0.0061 0.1 0.00023 0.001
16 0.23 0.0029 1.10E-03 0.03329 0.052
17 0.05 0.0029 0.00110344 0.00011 0.002
18 0.57 0.0028 1.17E-03 0.00010 0.001
19 1.00 0.0100 4.96E-03 0.01762 0.001
20 0.70 0.0028 5.58E-04 0.00010 1.013
21 0.64 0.0028 5.52E-04 0.00010 0.945
22 0.73 0.0028 5.61E-04 0.00010 1.070
23 0.63 0.0028 5.53E-04 0.00010 0.907
24 0.11 0.0029 1.10E-03 0.00035 0.002
25 0.59 0.0028 0.00117611 0.00771 0.001
26 0.20 0.0028 1.12E-03 0.00046 0.421
27 0.58 0.0100 4.66E-03 0.66931 9.738
28 0.89 0.0033 7.47E-04 0.00010 0.972
29 0.07 0.0039 9.96E-04 0.00010 0.723
30 0.08 0.0028 5.77E-04 0.00683 6.561
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Parameter values of the integrative liver model for LPS induced signalling for all 30 parameter sets of the model
ensemble, continued.
kcat_p65_phos._MSK1 k_MSK1_dephos. Km_MSK1_phos. kcat_MSK1_phos. k_IkBa:p65_nuc._imp.
1 6.93E+00 0.010 0.332 9.05E-04 2.00E-03
2 3.74E-04 0.010 0.332 1.00E-05 1.99E-03
3 1.00E-06 0.010 0.332 1.00E-05 1.00E-05
4 2.25E-05 0.010 0.332 1.00E-05 1.00E-05
5 1.87E-04 0.010 0.332 1.09E-05 2.00E-03
6 2.95E-05 0.010 0.332 2.38E-04 2.00E-03
7 5.72E-06 0.010 0.332 1.01E-05 1.06E-05
8 2.53E-02 0.009 0.332 1.00E-03 2.00E-03
9 2.08E-02 0.009 0.332 1.00E-03 2.00E-03
10 1.00E-06 0.010 0.332 1.00E-05 1.00E-05
11 1.50E-01 0.010 0.332 1.28E-04 2.00E-03
12 2.83E-02 0.009 0.332 9.35E-04 2.00E-03
13 1.00E-06 0.010 0.332 1.00E-05 1.00E-05
14 1.01E-06 0.010 0.332 1.03E-05 2.00E-03
15 1.00E-06 0.010 0.332 1.00E-05 1.00E-05
16 1.07E-06 0.010 0.332 1.00E-05 2.00E-03
17 1.51E-06 0.010 0.332 1.23E-05 2.00E-03
18 1.00E-06 0.010 0.332 1.00E-05 1.00E-05
19 1.00E-06 0.010 0.332 1.02E-05 1.00E-05
20 5.10E-02 0.010 0.332 1.00E-03 2.00E-03
21 1.36E-02 0.009 0.332 1.00E-03 2.00E-03
22 1.08E-01 0.010 0.332 1.00E-03 2.00E-03
23 2.57E-02 0.009 0.332 5.25E-04 2.00E-03
24 3.09E-06 0.010 0.332 1.21E-05 2.00E-03
25 1.00E-06 0.010 0.332 9.21E-04 1.00E-05
26 2.20E-05 0.010 0.332 1.77E-05 2.00E-03
27 1.38E-06 0.010 0.332 1.00E-05 1.00E-05
28 2.74E+00 0.010 0.332 1.07E-05 2.00E-03
29 8.53E-02 0.010 0.332 1.00E-03 2.00E-03
30 1.57E+01 0.010 0.332 1.90E-05 2.00E-03
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Parameter values of the integrative liver model for LPS induced signalling for all 30 parameter sets of the model
ensemble, continued.
6 k_p65_nuc._exp. k_basal_IkBa_transc._i. kcat_p38_phos. Km_p38_phos. k_basal_p38_phos.
1 1.00E-05 1.00E-06 776.9485942 1.46E+00 9.56E-07
2 1.00E-05 1.00E-06 563785.5531 1.00E+01 1.44E-04
3 1.00E-05 1.00E-06 96118.13064 7.16E-01 1.68E-04
4 1.00E-05 1.00E-06 22962.77872 1.94E+00 2.65E-05
5 1.00E-05 1.00E-06 158456.2339 1.00E+01 4.64E-05
6 1.00E-05 1.00E-06 76703.93034 8.50E+00 2.72E-05
7 1.00E-05 1.00E-06 139948.7048 1.09E+00 1.93E-04
8 1.00E-05 1.00E-06 836139.6067 6.80E+00 2.10E-04
9 1.00E-05 1.00E-06 903645.1961 6.32E+00 2.31E-04
10 1.00E-05 1.00E-06 90404.29738 5.29E+00 6.64E-05
11 1.00E-05 1.00E-06 138790.2018 1.59E-01 3.05E-04
12 1.00E-05 1.00E-06 147328.5571 7.22E-01 2.07E-04
13 1.00E-05 1.00E-06 89220.46791 1.00E-02 3.00E-04
14 1.00E-05 1.00E-06 124043.6716 3.33E+00 9.47E-05
15 1.00E-05 1.00E-06 69204.73592 1.00E-02 3.32E-04
16 1.00E-05 1.00E-06 549742.8212 9.99E+00 1.42E-04
17 1.00E-05 1.00E-06 61662.87246 1.00E-02 2.12E-04
18 1.00E-05 1.00E-06 371488.5643 8.38E+00 1.15E-04
19 1.00E-05 1.00E-06 16277.63331 1.00E+01 5.26E-06
20 1.00E-05 1.00E-06 38215.45207 1.00E-02 1.15E-04
21 1.00E-05 1.00E-06 166798.1435 1.06E-01 3.70E-04
22 1.00E-05 1.00E-06 18434.53528 1.00E-02 5.54E-05
23 1.00E-05 1.00E-06 163666.7303 1.03E-01 3.68E-04
24 1.00E-05 1.00E-06 142404.4151 7.65E-01 2.31E-04
25 1.00E-05 1.00E-06 35903.29318 1.00E-02 1.21E-04
26 1.00E-05 1.00E-06 71762.6859 7.42E+00 2.82E-05
27 1.00E-05 1.00E-06 87400.24468 1.00E-02 2.98E-04
28 1.00E-05 1.00E-06 1000000 5.64E+00 2.55E-04
29 1.00E-05 1.00E-06 71235.27778 1.17E+00 8.54E-05
30 1.00E-05 1.00E-06 264913.8708 7.53E+00 7.25E-05
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Parameter values of the integrative liver model for LPS induced signalling for all 30 parameter sets of the model
ensemble, continued.
k_p38_dephos. kcat_JNK_phos. Km_JNK_phos. k_basal_JNK_phos. k_JNK_dephos.
1 8.87E-04 40247.89728 1.00E-03 9.33E-05 6.68E-04
2 9.91E-04 415043.0373 1.00E+01 7.09E-05 6.40E-04
3 9.43E-04 20925.99385 1.78E+00 1.61E-05 6.90E-04
4 0.001121089 36990.90401 3.94E+00 1.61E-05 6.97E-04
5 0.001079286 119342.2196 1.00E-03 2.62E-04 4.51E-04
6 0.001127981 45535.77481 1.00E-03 1.02E-04 6.23E-04
7 9.36E-04 14242.27727 1.40E+00 1.29E-05 7.04E-04
8 6.63E-04 32031.63929 3.44E+00 1.63E-05 7.42E-04
9 6.47E-04 15458.14016 1.00E-03 3.59E-05 7.27E-04
10 0.001874858 37216.12152 1.00E+01 1.14E-05 0.001232786
11 5.61E-04 129582.4385 1.00E-03 3.00E-04 4.62E-04
12 6.72E-04 15412.23183 1.29E+00 1.53E-05 7.41E-04
13 8.29E-04 26162.29254 9.96E+00 5.18E-06 7.05E-04
14 0.001136963 153969.9816 2.87E+00 8.07E-05 6.80E-04
15 0.001627902 136953.445 1.00E-03 4.67E-04 7.80E-04
16 9.99E-04 81755.17568 3.65E+00 3.65E-05 6.81E-04
17 9.45E-04 47395.71057 1.00E+01 9.42E-06 7.13E-04
18 9.99E-04 46111.60543 8.48E+00 1.04E-05 6.98E-04
19 0.001191885 124825.9771 1.00E-03 2.85E-04 4.62E-04
20 7.78E-04 94631.91071 1.00E-03 2.19E-04 5.42E-04
21 4.99E-04 128223.2817 1.00E-03 2.97E-04 4.66E-04
22 8.35E-04 32930.61271 1.25E-03 7.63E-05 6.84E-04
23 5.00E-04 19378.06683 9.54E+00 4.24E-06 7.59E-04
24 9.07E-04 66609.2981 4.89E-01 9.15E-05 6.26E-04
25 0.001006143 38060.52567 1.00E-03 8.32E-05 6.26E-04
26 0.001099618 30433.81989 1.00E-03 6.69E-05 6.46E-04
27 8.47E-04 87809.24084 1.00E-03 1.94E-04 5.24E-04
28 5.99E-04 791828.5149 1.00E-03 1.00E-03 9.72E-04
29 7.30E-04 129397.2517 1.00E-03 2.88E-04 4.40E-04
30 6.78E-04 61012.89357 1.00E-03 1.43E-04 6.31E-04
1
0
7
Parameter values of the integrative liver model for LPS induced signalling for all 30 parameter sets of the model
ensemble, continued.
k_TNF:TNFR1_ass. k_TNF:TNFR1_diss. k_TNFR1_v.2o._m. _sh. k_TNFR1_o._m.2v. _sh. k_TNF:TNFR1_EL_int.
1 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
2 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
3 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
4 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
5 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
6 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
7 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
8 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
9 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
10 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
11 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
12 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
13 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
14 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
15 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
16 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
17 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
18 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
19 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
20 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
21 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
22 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
23 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
24 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
25 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
26 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
27 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
28 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
29 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
30 1.68E+01 3.20E-04 4.00E-04 1.80E-05 7.70E-04
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Parameter values of the integrative liver model for LPS induced signalling for all 30 parameter sets of the model
ensemble, continued.
k_TNF_int._degr. Km_IkBa_transl. k_LPS_LSEC_degr. kA_TNF_mR_LSEC_ transc._i. vA_TNF_mR_LSEC_ transc._i.
1 8.88E-05 4.90 2.36E-04 1.07E+00 1.22E-05
2 7.04E-05 4.80 2.88E-04 1.02E+00 1.19E-05
3 6.25E-05 10.00 2.51E-04 1.05E+00 1.20E-05
4 6.78E-05 7.05 3.34E-04 9.78E-01 1.20E-05
5 6.50E-05 7.23 2.68E-04 1.03E+00 1.20E-05
6 7.09E-05 6.35 2.87E-04 1.02E+00 1.19E-05
7 6.79E-05 9.86 3.34E-04 9.78E-01 1.20E-05
8 8.92E-05 10.00 2.38E-04 1.07E+00 1.22E-05
9 8.94E-05 2.54 2.37E-04 1.07E+00 1.22E-05
10 1.00E-03 6.05 1.42E-04 1.23E+00 1.92E-05
11 8.90E-05 3.67 2.38E-04 1.07E+00 1.22E-05
12 8.96E-05 7.95 2.36E-04 1.07E+00 1.22E-05
13 6.38E-05 7.45 2.52E-04 1.05E+00 1.20E-05
14 9.26E-05 9.05 3.20E-04 9.89E-01 1.20E-05
15 1.00E-03 3.00 1.41E-04 1.23E+00 1.92E-05
16 7.08E-05 5.12 2.86E-04 1.02E+00 1.19E-05
17 7.10E-05 1.05 2.87E-04 1.02E+00 1.20E-05
18 6.35E-05 10.00 2.52E-04 1.05E+00 1.20E-05
19 8.19E-05 4.47 3.24E-04 9.85E-01 1.20E-05
20 8.91E-05 9.45 2.37E-04 1.07E+00 1.22E-05
21 9.00E-05 8.62 2.38E-04 1.07E+00 1.22E-05
22 8.88E-05 9.99 2.38E-04 1.07E+00 1.22E-05
23 9.03E-05 8.54 2.38E-04 1.07E+00 1.22E-05
24 7.10E-05 2.53 2.87E-04 1.02E+00 1.19E-05
25 6.30E-05 10.00 2.51E-04 1.05E+00 1.20E-05
26 6.48E-05 3.57 2.68E-04 1.03E+00 1.20E-05
27 6.77E-05 9.56 3.34E-04 9.78E-01 1.20E-05
28 8.16E-05 9.80 2.31E-04 1.08E+00 1.22E-05
29 7.23E-05 0.67 2.27E-04 1.09E+00 1.22E-05
30 9.68E-05 0.56 2.04E-04 1.12E+00 1.25E-05
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Parameter values of the integrative liver model for LPS induced signalling for all 30 parameter sets of the model
ensemble, continued.
k_TNF_mR_LSEC_ transc._e. k_TNF_LSEC_transl. k_TNF_mR_LSEC_degr. k_LPS_MC_degr. kA_TNF_mR_MC_transc._i.
1 1.00E-06 2.16E-05 0.59 1.20E-04 8.21E-01
2 1.00E-06 2.12E-05 0.61 1.35E-04 7.77E-01
3 1.00E-06 2.13E-05 0.59 1.24E-04 8.09E-01
4 1.00E-06 2.14E-05 0.61 1.45E-04 7.54E-01
5 1.00E-06 2.13E-05 0.60 1.29E-04 7.95E-01
6 1.00E-06 2.12E-05 0.61 1.35E-04 7.74E-01
7 1.00E-06 2.14E-05 0.61 1.45E-04 7.54E-01
8 1.00E-06 2.16E-05 0.60 1.20E-04 8.21E-01
9 1.00E-06 2.16E-05 0.59 1.20E-04 8.21E-01
10 1.00E-06 3.42E-05 0.37 8.52E-05 8.91E-01
11 1.00E-06 2.16E-05 0.60 1.20E-04 8.20E-01
12 1.00E-06 2.16E-05 0.59 1.20E-04 8.21E-01
13 1.00E-06 2.13E-05 0.59 1.24E-04 8.09E-01
14 1.00E-06 2.13E-05 0.61 1.42E-04 7.62E-01
15 1.00E-06 3.41E-05 0.37 8.52E-05 8.91E-01
16 1.00E-06 2.12E-05 0.61 1.34E-04 7.80E-01
17 1.00E-06 2.12E-05 0.60 1.34E-04 7.73E-01
18 1.00E-06 2.13E-05 0.59 1.24E-04 8.09E-01
19 1.00E-06 2.13E-05 0.61 1.42E-04 7.67E-01
20 1.00E-06 2.16E-05 0.59 1.20E-04 8.21E-01
21 1.00E-06 2.16E-05 0.60 1.20E-04 8.21E-01
22 1.00E-06 2.16E-05 0.59 1.20E-04 8.21E-01
23 1.00E-06 2.16E-05 0.59 1.20E-04 8.21E-01
24 1.00E-06 2.12E-05 0.61 1.34E-04 7.77E-01
25 1.00E-06 2.13E-05 0.59 1.24E-04 8.09E-01
26 1.00E-06 2.13E-05 0.60 1.29E-04 7.95E-01
27 1.00E-06 2.14E-05 0.61 1.45E-04 7.54E-01
28 1.00E-06 2.17E-05 0.59 1.18E-04 8.27E-01
29 1.00E-06 2.17E-05 0.59 1.17E-04 8.30E-01
30 1.00E-06 2.23E-05 0.56 1.09E-04 8.51E-01
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Parameter values of the integrative liver model for LPS induced signalling for all 30 parameter sets of the model
ensemble, continued.
vA_TNF_mR_MC_transc._i. k_TNF_mR_MC_transc._e.n k_TNF_MC_transl. k_TNF_mR_MC_degr.
1 5.86E-06 1.00E-06 2.15E-06 0.052
2 5.58E-06 1.00E-06 2.05E-06 0.054
3 5.76E-06 1.00E-06 2.11E-06 0.053
4 5.47E-06 1.00E-06 2.00E-06 0.056
5 5.67E-06 1.00E-06 2.08E-06 0.054
6 5.59E-06 1.00E-06 2.05E-06 0.054
7 5.47E-06 1.00E-06 2.00E-06 0.056
8 5.85E-06 1.00E-06 2.14E-06 0.052
9 5.85E-06 1.00E-06 2.15E-06 0.052
10 9.57E-06 1.00E-06 3.45E-06 0.028
11 5.85E-06 1.00E-06 2.14E-06 0.052
12 5.86E-06 1.00E-06 2.15E-06 0.052
13 5.76E-06 1.00E-06 2.11E-06 0.053
14 5.49E-06 1.00E-06 2.01E-06 0.055
15 9.48E-06 1.00E-06 3.46E-06 0.028
16 5.59E-06 1.00E-06 2.05E-06 0.054
17 5.59E-06 1.00E-06 2.05E-06 0.054
18 5.76E-06 1.00E-06 2.11E-06 0.053
19 5.49E-06 1.00E-06 2.01E-06 0.055
20 5.86E-06 1.00E-06 2.14E-06 0.052
21 5.85E-06 1.00E-06 2.14E-06 0.052
22 5.85E-06 1.00E-06 2.14E-06 0.052
23 5.85E-06 1.00E-06 2.14E-06 0.052
24 5.59E-06 1.00E-06 2.05E-06 0.054
25 5.76E-06 1.00E-06 2.11E-06 0.053
26 5.67E-06 1.00E-06 2.08E-06 0.053
27 5.47E-06 1.00E-06 2.00E-06 0.056
28 5.90E-06 1.00E-06 2.16E-06 0.051
29 5.93E-06 1.00E-06 2.17E-06 0.051
30 6.19E-06 1.00E-06 2.27E-06 0.049
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Table A.21: ODEs of the integrative liver model for LPS induced signalling.
d([p65_Pcyt] ·Vcyt)
dt = −
  
k_p65_nc_imp · [p65_Pcyt] − k_p65_nc_exp · [p65_Pnc]
− Vcyt ·  k_p65_degr · [p65_Pcyt]
+ Vcyt ·

vmx_kB:p65_phos · [”p65−kBcyt”]
Km_kB:p65_phos+ [”p65−kBcyt”]

− Vcyt · (k_p65_dephos · [p65_Pcyt])
d([ kB_P] ·Vcyt)
dt = + Vcyt ·

vmx_kB_phos · [ kBcyt]
Km_kB_phos+ [ kBcyt]

− Vcyt · (k_kB_P_degr · [ kB_P])
+ Vcyt ·

vmx_kB:p65_phos · [”p65−kBcyt”]
Km_kB:p65_phos+ [”p65−kBcyt”]

d([ KKb] ·Vcyt)
dt = − Vcyt ·

vmx_KKb_phos · [ KKb] · [TNF:TNFR1EL]
(Km_KKb_phos+ [ KKb]) · (K_KKb_phos+ [TNF:TNFR1EL])

− Vcyt · (k_bsl_KKb_phos · [ KKb])
+ Vcyt · (k_KKb_dephos · [ KKb_P])
d([ KKb_P] ·Vcyt)
dt = + Vcyt ·

vmx_KKb_phos · [ KKb] · [TNF:TNFR1EL]
(Km_KKb_phos+ [ KKb]) · (K_KKb_phos+ [TNF:TNFR1EL])

+ Vcyto · (k_bsl_KKb_phos · [ KKb])− Vcyt · (k_KKb_dephos · [ KKb_P])
d([”p65−kBcyt”] ·Vcyt)
dt = +
  
k_kB : p65_nc_exp · [”p65 − kBnc”] − k_kB : p65_nc_imp · [”p65 − kBcyt”]
+ Vcyt ·   k_kB : p65_ss · [ kBcyt] · [p65cyt] − k_kB : p65_diss · [”p65 − kBcyt”]− Vcyt · (k_p65_degrdtion · [”p65 − kBcytoplsm”])− Vcytoplsm · (k_kB_complex_cyt_degrdtion · [”p65 − kBcytoplsm”])
− Vcytoplsm ·

vmx_kB:p65_phosphoryltion · [”p65−kBcytoplsm”]
Km_kB:p65_phosphoryltion+ [”p65−kBcytoplsm”]

1
1
2
ODEs of the integrative liver model for LPS induced signalling.
d([ kB_mRNAcyt] ·Vcyt)
dt = − Vcyt ·
 
k_kB_mRNA_cyt_degr · [ kB_mRNAcyt]
+ (k_kB_mRNA_nc_exp · [ kB_mRNAnc])
d([ kBcyt] ·Vcytoplsm)
dt = − Vcyt ·
 
k_kB_cyt_degr · [ kBcyt]
− Vcyt ·

vmx_kB_phos · [ kBcyt]
Km_kB_phos+ [ kBcyt]

− Vcyt ·  k_kB : p65_ss · [ kBcyt] · [p65cyt] − k_kB : p65_diss · [”p65 − kBcyt”]
+ Vcyt ·  k_p65_degr · [”p65 − kBcyt”]
+ Vcyt ·

vmx_kB_trnsl · [ kB_mRNAcyt]
Km_kB_trnsl+ [ kB_mRNAcyt]

−   k_kB_nc_imp · [ kBcyt] − k_kB_nc_exp · [ kBnc]
d([p65cyt] ·Vcyt)
dt = + Vcyt · (k_p65_trnsl · [p65_mRNA])− Vcyt ·  k_kB : p65_ss · [ kBcyt] · [p65cyt] − k_kB : p65_diss · [”p65 − kBcyt”]
+ Vcyt ·  k_kB_com_cyt_degr · [”p65 − kBcyt”]
−  k_p65_nc_imp · [p65cyt] − k_p65_nc_exp · [p65nc]
+ Vcyt ·  k_p65_dephos · [p65_Pcyt]
− Vcyt ·  k_p65_degr · [p65cyt]
d([p38] ·Vcyt)
dt = − Vcytoplsm ·

vmx_p38_phosphorlytion · [p38]
Km_p38_phosphoryltion+ [p38]

− Vcytoplsm · (k_bsl_p38_phosphorlytion · [p38])
+ Vcyt · (k_p38_dephosphoryltion · [p38_P])
1
1
3
ODEs of the integrative liver model for LPS induced signalling.
d([p38_P] ·Vcyt)
dt = + Vcyt ·

vmx_p38_phos · [p38]
Km_p38_phos+ [p38]

+ Vcyt · (k_bsl_p38_phos · [p38])− Vcyt · (k_p38_dephos · [p38_P])
d([ JNK] ·Vcyt)
dt = − Vcyt ·

vmx_JNK_phos · [ JNK]
Km_JNK_phos+ [ JNK]

− Vcyt · (k_bsl_JNK_phos · [ JNK])
+ Vcyt · (k_JNK_dephos · [ JNK_P])
d([ JNK_P] ·Vcyt)
dt = + Vcyt ·

vmx_JNK_phos · [ JNK]
Km_JNK_phos+ [ JNK]

+ Vcyt · (k_bsl_JNK_phos · [ JNK])− Vcyt · (k_JNK_dephos · [ JNK_P])
d([TNFR1cyt] ·Vcyt)
dt = −
  
k_TNFR1_v2o_m_sh · [TNFR1cyt] − k_TNFR1_o_m2v_sh · [TNFR1EL]
+ Vcyt ·  k_TNF_int_degr · [TNF : TNFR1cyt]
d([TNF:TNFR1cyt] ·Vcyt)
dt = + (k_TNF : TNFR1_int · [TNF : TNFR1EL])− Vcyt ·  k_TNF_int_degr · [TNF : TNFR1cyt]
d([p65_Pnc] ·Vnc)
dt = +
  
k_p65_nc_imp · [p65_Pcyt] − k_p65_nc_exp · [p65_Pnc]− Vnc · (k_p65_degr · [p65_Pnc])− Vnc · (k_p65_dephos · [p65_Pnc])
− Vnc ·

vmx_p65_phos_MSK1 · [p65_Pnc]
Km_p65_phos_MSK1+ [p65_Pnc]

1
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ODEs of the integrative liver model for LPS induced signalling.
d([ kBnc] ·Vnc)
dt = + Vnc · (k_p65_degr · [”p65 − kBnc”])− Vnc · ((k_kB : p65_ss · [p65nc] · [ kBnc] − k_kB : p65_diss · [”p65 − kBnc”]))− Vnc · (k_kB_nc_degr · [ kBnc])
+
  
k_kB_nc_imp · [ kBcyt] − k_kB_nc_exp · [ kBnc]
d([”p65−kBnc”] ·Vnc)
dt = −
  
k_kB : p65_nc_exp · [”p65 − kBnc”] − k_kB : p65_nc_imp · [”p65 − kBcyt”]− Vnc · (k_p65_degr · [”p65 − kBnc”])− Vnc · (k_kB_complex_nc_degr · [”p65 − kBnc”])
+ Vnc · ((k_kB : p65_ss · [p65nc] · [ kBnc] − k_kB : p65_diss · [”p65 − kBnc”]))
d([ kB_mRNAnc] ·Vnc)
dt = − Vnc · (k_kB_mRNA_nc_degr · [ kB_mRNAnc])− (k_kB_mRNA_nc_exp · [ kB_mRNAnc])
+ Vnc · (k_kB_trnsc_e · [ kB_pre_mRNA_2])
d([ kB_pre_mRNA_1] ·Vnc)
dt = + Vnc · (k_bsl_kB_trnsc_i + K_p65_P_kB_trnsc_i · [p65_Pnc]
+ K_p65_kB_trnsc_i · [p65nc] + K_p65_P2_kB_trnsc_i · [p65_P2])− Vnc · (k_kB_trnsc_e · [ kB_pre_mRNA_1])
d([p65nc] ·Vnc)
dt = + Vnc · (k_kB_complex_nc_degr · [”p65 − kBnc”])
+ Vnc · (k_p65_dephos · [p65_Pnc])− Vnc · (k_p65_degr · [p65nc])
− Vnc ·

vmx_p65_phos_MSK1 · [p65nc]
Km_p65_phos_MSK1+ [p65nc]

+ Vnc · (k_p65_dephos · [p65_P2])
+
  
k_p65_nc_imp · [p65cyt] − k_p65_nc_exp · [p65nc]− Vnc · ((k_kB : p65_ss · [p65nc] · [ kBnc] − k_kB : p65_diss · [”p65 − kBnc”]))
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ODEs of the integrative liver model for LPS induced signalling.
d([p65_P2] ·Vnc)
dt = + Vnc ·

vmx_p65_phosp_MSK1 · [p65_Pnc]
Km_p65_phos_MSK1+ [p65_Pnc]

+ Vnc ·

vmx_p65_phos_MSK1 · [p65nc]
Km_p65_phos_MSK1+ [p65nc]

− Vnc · (k_p65_degr · [p65_P2])− Vnc · (k_p65_dephos · [p65_P2])
d([ kB_pre_mRNA_2] ·Vnc)
dt = + Vnc · (k_kB_trnsc_e · [ kB_pre_mRNA_1])− Vnc · (k_kB_trnsc_e · [ kB_pre_mRNA_2])
d([MSK1_P] ·Vnc)
dt = + Vnc ·

vmx_MSK1_phos · [MSK1]
Km_MSK1_phos+ [MSK1]

− Vnc · (k_MSK1_dephos · [MSK1_P])
d([MSK1] ·Vnc)
dt = − Vnc ·

vmx_MSK1_phos · [MSK1]
Km_MSK1_phos+ [MSK1]

+ Vnc · (k_MSK1_dephos · [MSK1_P])
d([TNF] ·VEL)
dt = − VEL · ((k_TNF : TNFR1_ss · [TNFR1EL] · [TNF] − k_TNF : TNFR1_diss · [TNF : TNFR1EL]))
+ (k_TNF_LSEC_trnsl · [TNF_mRNALSEC])
+ (k_TNF_MC_trnsl · [TNF_mRNAMC])− VEL · (k_TNF_degr · [TNF])
d([TNFR1EL] ·VEL)
dt = +
  
k_TNFR1_v2o_m_sh · [TNFR1cyt] − k_TNFR1_o_m2v_sh · [TNFR1EL]− VEL · ((k_TNF : TNFR1_ss · [TNFR1EL] · [TNF] − k_TNF : TNFR1_diss · [TNF : TNFR1EL]))
d([TNF:TNFR1EL] ·VEL)
dt = + VEL · ((k_TNF : TNFR1_ss · [TNFR1EL] · [TNF] − k_TNF : TNFR1_diss · [TNF : TNFR1EL]))− (k_TNF : TNFR1_int · [TNF : TNFR1EL])
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ODEs of the integrative liver model for LPS induced signalling.
d([LPS] ·VEL)
dt = − VEL · (k_LPS_LSEC_degr · [LPS])− VEL · (k_LPS_MC_degr · [LPS])
d([TNF_mRNALSEC] ·VLSEC)
dt = + VLSEC · (”k_TNF_mRNA_LSEC_trnsc_e” · [TNF_pre_mRNALSEC])− VLSEC · (k_TNF_mRNA_LSEC_degr · [TNF_mRNALSEC])
d([TNF_pre_mRNALSEC] ·VLSEC)
dt = + 2 · VLSEC ·

”vA_TNF_mRNA_LSEC_trnsc_i” · [LPS]
[LPS] + ”kA_TNF_mRNA_LSEC_trnsc_i”

− VLSEC · (”k_TNF_mRNA_LSEC_trnsc_e” · [TNF_pre_mRNALSEC])
d([TNF_mRNAMC] ·VMC)
dt = + VMC · (”k_TNF_mRNA_MC_trnscription_e” · [TNF_pre_mRNAMC])− VMC · (k_TNF_mRNA_MC_degr · [TNF_mRNAMC])
d([TNF_pre_mRNAMC] ·VMC)
dt = + 2 · VMC ·

”vA_TNF_mRNA_MC_ trnscription_initition” · [LPS]
[LPS] + ”kA_TNF_mRNA_MC_ trnscription_initition”

− VMC · (”k_TNF_mRNA_MC_trnsc_e” · [TNF_pre_mRNAMC])
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A.4 Fisher Information Results
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Table A.22: Table showing results for repeated parameter estimations with the Levenberg-Marquardt algorithm start-
ing from random start values. All parameters were fitted.
Target Function kcat_JNK_phos k_TNF_degr Km_JNK_phos k_basal_JNK_phos k_dephos
1.46883 0.0345847 0.0013199 0.001 2.21E-06 0.0013192
1.46883 0.4473 0.00131769 0.001 2.86E-05 0.00129496
1.46883 0.137783 0.00132213 0.001 8.79E-06 0.0013104
1.46883 0.0573401 0.0013194 0.001 3.67E-06 0.00131823
1.46883 0.176104 0.00132255 0.001 1.12E-05 0.00130754
1.46883 0.293112 0.00132303 0.001 1.87E-05 0.00129961
1.46883 0.045642 0.00131937 0.001 2.92E-06 0.00131901
1.46883 0.0050307 0.00132049 0.33558 2.41E-07 0.00132056
1.46883 0.312638 0.00131787 0.001 2.00E-05 0.00130341
1.46883 0.485551 0.00131743 0.001 3.11E-05 0.00129276
1.46883 0.00458472 0.00132036 0.001 2.93E-07 0.00132066
1.46883 0.00718942 0.00132032 0.001 4.59E-07 0.00132052
1.46883 0.45276 0.00131766 0.001 2.90E-05 0.00129464
1.46883 0.00922753 0.0013203 0.001 5.89E-07 0.00132042
1.46883 0.0904466 0.00131926 0.001 5.78E-06 0.00131626
1.46883 0.0024859 0.00132071 0.001 1.59E-07 0.00132044
1.46883 0.323356 0.001323 0.001 2.06E-05 0.00129771
1.46883 0.0203724 0.00131998 0.001 1.30E-06 0.00132002
1.46883 0.0119759 0.00132065 0.001 7.65E-07 0.00131989
1.46883 0.0433938 0.0013197 0.001 2.77E-06 0.00131882
1.46883 0.00628392 0.00132032 0.001 4.01E-07 0.00132058
1.46883 0.0585966 0.00132168 0.001 3.74E-06 0.00131589
1.46883 0.079687 0.00131927 0.001 5.09E-06 0.00131693
1.46883 0.00328182 0.00132073 0.001 2.10E-07 0.00132037
1.46883 0.00417854 0.00132035 0.543973 1.73E-07 0.00132077
1.46883 0.0017309 0.00132049 0.001 1.11E-07 0.0013207
1.46883 0.0569166 0.00131941 0.001 3.64E-06 0.00131825
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Table showing results for repeated parameter estimations with the Levenberg-Marquardt algorithm starting from
random start values. All parameters were fitted.
Target Function kcat_JNK_phos k_TNF_degr Km_JNK_phos k_basal_JNK_phos k_dephos
1.46883 0.322195 0.00132301 0.001 2.05E-05 0.00129778
1.46883 0.0102785 0.00132087 0.001 6.56E-07 0.00131979
1.46883 0.022664 0.00132114 0.001 1.45E-06 0.00131872
1.46883 0.344793 0.00132299 0.001 2.20E-05 0.00129636
1.46883 0.00532775 0.00132032 0.001 3.40E-07 0.00132064
1.46883 0.63723 0.00131639 0.001 4.08E-05 0.00128406
1.46883 0.0352835 0.00131988 0.001 2.25E-06 0.00131917
1.46883 0.0238077 0.00131998 0.001 1.52E-06 0.0013198
1.46883 0.0646185 0.00132178 0.001 4.12E-06 0.00131541
1.46883 0.453114 0.00132344 0.001 2.89E-05 0.00128902
1.46883 0.0343593 0.00132127 0.001 2.19E-06 0.00131785
1.46883 0.00515548 0.00132078 0.001 3.29E-07 0.0013202
1.46883 0.214213 0.00132295 0.001 1.37E-05 0.00130472
1.46883 0.102413 0.00132183 0.001 6.53E-06 0.00131296
1.46883 0.319128 0.00132301 0.001 2.03E-05 0.00129797
1.46883 0.0946245 0.00131925 0.001 6.05E-06 0.00131599
1.46883 0.0786372 0.00131927 0.001 5.03E-06 0.001317
1.46883 0.0191564 0.00131997 0.001 1.22E-06 0.0013201
1.46883 0.00832496 0.00132082 0.001 5.32E-07 0.00131995
1.46883 0.0383192 0.00131982 0.001 2.45E-06 0.00131904
1.46883 0.42192 0.00132324 0.001 2.69E-05 0.00129119
1.46883 0.665029 0.00132478 0.001 4.23E-05 0.00127423
1.46883 0.13603 0.00131899 0.001 8.70E-06 0.0013136
1.46883 0.151397 0.00131881 0.001 9.68E-06 0.0013128
1.46884 0.0124631 0.00132061 4.206 1.53E-07 0.00132051
1.46884 0.00792765 0.00132062 0.522783 3.33E-07 0.00132032
1
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Table showing results for repeated parameter estimations with the Levenberg-Marquardt algorithm starting from
random start values. All parameters were fitted.
Target Function kcat_JNK_phos k_TNF_degr Km_JNK_phos k_basal_JNK_phos k_dephos
1.46884 0.00590697 0.0013204 1.34311 1.61E-07 0.00132072
1.46884 0.0083292 0.00132062 1.63166 2.02E-07 0.00132044
1.46884 0.0156242 0.0013206 5.57139 1.52E-07 0.00132051
1.46884 0.0145744 0.00132055 5.12526 1.52E-07 0.00132056
1.46884 1.49553 0.00132021 0.001 9.55E-05 0.00122553
1.46884 0.022571 0.00132059 11.3221 1.17E-07 0.00132057
1.46884 0.00835475 0.00132053 1.99828 1.78E-07 0.00132063
1.46884 0.00534709 0.0013203 1.13915 1.60E-07 0.00132083
1.46884 1.38752 0.0013255 0.001 8.83E-05 0.00122756
1.46884 0.0131504 0.00132062 4.95502 1.41E-07 0.00132051
1.46884 0.00988306 0.00132061 2.27862 1.93E-07 0.00132046
1.46884 0.0457147 0.0013206 28.2206 1.00E-07 0.00132058
1.46884 1.50663 0.00132597 0.001 9.58E-05 0.00121955
1.46884 0.0130391 0.00132061 4.59373 1.49E-07 0.00132051
1.46884 0.00936844 0.0013206 2.49411 1.71E-07 0.0013205
1.46884 1.01711 0.00131512 0.001 6.52E-05 0.00126092
1.46884 0.0128232 0.00132028 4.35392 1.53E-07 0.00132083
1.46884 0.0089255 0.00132062 4.70513 1.00E-07 0.00132056
1.46884 0.00474953 0.00132066 0.752037 1.73E-07 0.00132045
1.46884 1.17172 0.00132515 0.001 7.46E-05 0.00124162
1.46884 0.0061153 0.00132063 1.44567 1.60E-07 0.00132048
1.46884 0.00928782 0.00132062 4.38123 1.10E-07 0.00132055
1.46884 1.15947 0.00132022 0.001 7.41E-05 0.00124695
1.46884 0.00598656 0.00132063 1.4421 1.57E-07 0.00132049
1.46884 0.0501746 0.00132061 31.0711 1.00E-07 0.00132057
1.46884 1.16499 0.00131506 0.001 7.47E-05 0.00125149
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Table showing results for repeated parameter estimations with the Levenberg-Marquardt algorithm starting from
random start values. All parameters were fitted.
Target Function kcat_JNK_phos k_TNF_degr Km_JNK_phos k_basal_JNK_phos k_dephos
1.46884 1.41947 0.00131495 0.001 9.10E-05 0.00123526
1.46884 0.0183075 0.00132041 6.69317 1.52E-07 0.0013207
1.46884 0.0107448 0.00132061 3.48365 1.53E-07 0.0013205
1.46884 0.00843744 0.00132066 0.701821 3.17E-07 0.00132028
1.46884 0.00761565 0.00132069 0.60267 3.04E-07 0.00132028
1.46884 0.0172039 0.00132037 6.27479 1.51E-07 0.00132075
1.46884 0.0103914 0.00132011 2.75074 1.77E-07 0.00132099
1.46884 0.0474251 0.00132029 21.9104 1.32E-07 0.00132084
1.46885 2.02529 0.00132806 0.001 0.000128596 0.00118471
1.46885 1.80642 0.00131377 0.001 0.000115954 0.00121151
1.46885 0.0115378 0.00132004 1.97022 2.48E-07 0.00132097
1.46885 1.61155 0.00132638 0.001 0.000102461 0.00121251
1.46885 2.03511 0.00131276 0.001 0.000130732 0.00119774
1.46887 2.78258 0.00133047 0.001 0.000176341 0.00113458
1.4689 3.78164 0.00133477 0.001 0.000238845 0.00106785
1.4689 0.991659 0.00132049 100 6.27E-07 0.00131999
1.4689 1.00608 0.00132048 100 6.36E-07 0.00131998
1.4689 3.8131 0.00133367 0.001 0.00024103 0.00106673
1.46891 4.07162 0.00133621 0.001 0.00025687 0.00104843
1.46892 0.171809 0.00131852 12.9867 7.86E-07 0.00132176
1.46892 0.0482643 0.00131678 1.5688 1.20E-06 0.00132315
1.46892 0.175285 0.00131888 13.3365 7.82E-07 0.00132129
1.46892 0.116316 0.00131854 8.06711 8.21E-07 0.0013217
1.46892 0.916758 0.00131553 78.233 7.42E-07 0.00132506
1.46892 0.227019 0.00131852 17.878 7.69E-07 0.00132178
1.46892 0.201057 0.00131398 15.513 7.81E-07 0.00132518
1.46892 0.0595629 0.00131668 2.85248 9.90E-07 0.00132347
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Table showing results for repeated parameter estimations with the Levenberg-Marquardt algorithm starting from
random start values. All parameters were fitted.
Target Function kcat_JNK_phos k_TNF_degr Km_JNK_phos k_basal_JNK_phos k_dephos
1.46892 0.2181 0.00131852 17.061 7.72E-07 0.00132178
1.46892 4.31627 0.00133796 0.001 0.000271934 0.00103166
1.46892 1.16497 0.00132153 100 7.36E-07 0.00131881
1.46892 0.0942623 0.00131577 6.06736 8.55E-07 0.00132501
1.46894 1.45097 0.00132042 100 9.17E-07 0.00131967
1.46894 4.80402 0.00134077 0.001 0.000301996 0.000998867
1.46895 4.9417 0.00134152 0.001 0.000310467 0.000989667
1.46896 5.11123 0.00134273 0.001 0.000320811 0.000978144
1.46897 0.806133 0.00132013 41.1852 1.22E-06 0.00131957
1.46897 0.669726 0.00132095 33.8743 1.23E-06 0.00131875
1.46897 1.09226 0.00131773 56.3539 1.22E-06 0.00132194
1.46897 0.136126 0.00132021 5.08857 1.43E-06 0.00131928
1.46897 0.224941 0.0013208 9.93709 1.31E-06 0.00131881
1.46897 0.370214 0.00132015 17.7954 1.26E-06 0.00131951
1.46897 0.41763 0.00132222 20.383 1.24E-06 0.00131747
1.46897 0.578398 0.00132335 29.0301 1.23E-06 0.00131634
1.46897 1.90546 0.00132037 100 1.20E-06 0.00131933
1.46897 0.217485 0.0013213 9.57082 1.31E-06 0.00131694
1.46897 0.659477 0.00132039 33.3308 1.23E-06 0.0013193
1.46897 0.0750276 0.00132373 1.06479 2.31E-06 0.00131486
1.46897 0.213073 0.00132076 9.30142 1.32E-06 0.00131883
1.46897 0.557286 0.00132012 27.7975 1.24E-06 0.00131955
1.46897 1.10782 0.00132012 57.3134 1.21E-06 0.00131958
1.46897 0.0926428 0.00132029 2.5498 1.67E-06 0.00131896
1.46897 0.111225 0.00132024 3.66751 1.52E-06 0.00131915
1.46897 0.285105 0.00131819 13.1471 1.29E-06 0.00132137
1.46897 0.0790253 0.00131907 1.57349 1.96E-06 0.00131987
1.46897 0.81766 0.00132013 41.7828 1.22E-06 0.00131957
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Table showing results for repeated parameter estimations with the Levenberg-Marquardt algorithm starting from
random start values. All parameters were fitted.
Target Function kcat_JNK_phos k_TNF_degr Km_JNK_phos k_basal_JNK_phos k_dephos
1.46897 1.60898 0.00132011 84.1024 1.21E-06 0.00131959
1.46897 0.354281 0.00131843 16.8871 1.27E-06 0.0013212
1.46897 0.251018 0.00132407 11.4203 1.29E-06 0.0013155
1.46897 0.509835 0.00132014 25.2728 1.24E-06 0.00131953
1.46897 0.0753669 0.00132081 0.9665 2.45E-06 0.00131765
1.46897 1.89494 0.00132009 99.5633 1.20E-06 0.00131962
1.46897 1.01078 0.0013199 52.1398 1.21E-06 0.00131978
1.46897 1.20283 0.00131849 62.3645 1.21E-06 0.0013212
1.46897 0.944487 0.00132012 48.5676 1.22E-06 0.00131958
1.46897 0.653019 0.0013201 32.9138 1.23E-06 0.00131959
1.46897 0.310955 0.00132014 14.5861 1.27E-06 0.0013195
1.46897 1.11063 0.00132396 57.7387 1.20E-06 0.00131563
1.46897 0.43664 0.00132231 21.3829 1.24E-06 0.0013174
1.46897 0.380302 0.00131843 18.2955 1.26E-06 0.0013212
1.46898 0.0777869 0.00132068 0.71172 2.90E-06 0.00131733
1.46898 0.0781506 0.00132109 0.689667 2.95E-06 0.00131687
1.46898 0.0779798 0.00132071 0.700988 2.93E-06 0.00131727
1.46898 1.98194 0.00132032 100 1.25E-06 0.00131932
1.46898 0.107637 0.0013212 0.302372 5.27E-06 0.00131404
1.46898 2.05471 0.00132031 100 1.30E-06 0.00131927
1.46901 2.37842 0.00132026 100 1.50E-06 0.00131906
1.46906 3.05851 0.00132014 100 1.93E-06 0.00131861
1.46906 3.032 0.00132014 100 1.91E-06 0.00131862
1.46908 6.38413 0.00135141 0.001 0.000397952 0.000892644
1.46911 3.64758 0.00131966 100 2.30E-06 0.00131879
1.46919 4.76565 0.00131985 100 3.01E-06 0.00131747
1.4692 4.93826 0.00131982 100 3.11E-06 0.00131736
1.46924 5.37603 0.00131972 100 3.39E-06 0.00131709
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Table showing results for repeated parameter estimations with the Levenberg-Marquardt algorithm starting from
random start values. All parameters were fitted.
Target Function kcat_JNK_phos k_TNF_degr Km_JNK_phos k_basal_JNK_phos k_dephos
1.46935 7.67487 0.00136552 0.001 0.000473044 0.000804205
1.46946 8.25794 0.00131922 100 5.19E-06 0.0013152
1.46975 12.0761 0.00131856 100 7.57E-06 0.00131271
1.46982 12.9489 0.00131847 100 8.12E-06 0.00131208
1.68199 11.0195 0.00332145 0.001 0.000160088 0.000150937
1.83661 10.7308 0.00380317 0.0010291 8.44E-05 6.99E-05
1.91406 100 0.00992343 0.001 8.81E-05 7.15E-05
1.93407 21.9137 0.018247 0.00100006 6.26E-05 0.000204818
1.93481 4.12923 0.0326082 0.898909 2.94E-06 0.000217684
1.93486 0.754208 0.0399491 1.49246 3.36E-07 0.000219747
1.93487 12.049 0.0686213 36.3242 2.08E-07 0.000219928
1.93487 0.0943579 0.0406187 0.016239 1.01E-07 0.00021995
1.93488 63.8689 0.0942029 0.257596 2.30E-05 0.000197169
1.93488 2.48546 0.0979295 1.87977 3.90E-07 0.000219807
1.93488 84.6172 0.099895 0.207902 2.97E-05 0.000189946
1.93488 87.5 0.0911549 0.126745 3.64E-05 0.000183856
1.93488 0.247605 0.0542249 0.00187139 2.02E-07 0.000220092
1.93488 73.7814 0.0999763 0.205435 2.61E-05 0.00019333
1.93488 89.6255 0.0596469 0.0993818 5.72E-05 0.000162914
1.93489 1.10033 0.000220401 0.158248 0.000190876 0.1
1.9349 79.8085 0.0894826 0.0424196 3.70E-05 0.00018006
1.93494 3.00583 0.000221083 3.53155 0.00013295 0.1
1.95464 10.6128 0.00412107 0.00116198 5.33E-05 4.01E-05
2.06752 10.6641 0.00442464 0.0016028 3.64E-05 2.54E-05
2.24667 10.5938 0.00474754 0.00196607 1.90E-05 1.19E-05
2.41683 10.1502 0.004819 0.00248415 6.62E-06 3.75E-06
2.41947 10.3326 0.00495557 0.00230054 6.44E-06 3.64E-06
1
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Table showing results for repeated parameter estimations with the Levenberg-Marquardt algorithm starting from
random start values. All parameters were fitted.
Target Function kcat_JNK_phos k_TNF_degr Km_JNK_phos k_basal_JNK_phos k_dephos
2.4442 10.124 0.00487221 0.00233531 4.81E-06 2.69E-06
2.45898 9.87908 0.00473212 0.00251236 3.86E-06 2.14E-06
2.46546 9.88066 0.00475408 0.00244604 3.44E-06 1.90E-06
2.4795 9.68655 0.00465075 0.00250576 2.54E-06 1.39E-06
2.47976 9.6833 0.00465007 0.0025488 2.52E-06 1.38E-06
2.48312 9.64554 0.00463351 0.00255259 2.31E-06 1.26E-06
3.60273 0.00293253 1.00E-06 0.001 2.63E-06 0.034096
3.9263 0.0059575 1.00E-06 0.001 6.70E-06 0.0361335
4.59804 0.0292215 1.00E-06 0.001 5.96E-05 0.0467708
5.327 30.244 0.0465899 0.828147 1.63E-07 0.0420533
5.327 17.7636 0.0444068 0.00692619 1.00E-07 0.0489692
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Table A.23: Table showing results for repeated parameter estimations with the Levenberg-Marquardt algorithm start-
ing from random start values. Only three parameters were fitted, after the Fisher information was employed to reduce
the number of fit parameters.
Target Function k_TNF_degr k_basal_JNK_phos k_dephos
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132103 1.41E-06 0.00131846
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132103 1.41E-06 0.00131847
1.46898 0.00132103 1.41E-06 0.00131846
1.46898 0.00132099 1.41E-06 0.0013185
1.46898 0.001321 1.41E-06 0.0013185
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132104 1.41E-06 0.00131845
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132103 1.41E-06 0.00131847
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132103 1.41E-06 0.00131847
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.001321 1.41E-06 0.0013185
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132105 1.41E-06 0.00131845
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Table showing results for repeated parameter estimations with the Levenberg-Marquardt algorithm starting from
random start values. Only three parameters were fitted, after the Fisher information was employed to reduce the
number of fit parameters.
Target Function k_TNF_degr k_basal_JNK_phos k_dephos
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132099 1.41E-06 0.0013185
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132101 1.41E-06 0.00131848
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132101 1.41E-06 0.00131849
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Table showing results for repeated parameter estimations with the Levenberg-Marquardt algorithm starting from
random start values. Only three parameters were fitted, after the Fisher information was employed to reduce the
number of fit parameters.
Target Function k_TNF_degr k_basal_JNK_phos k_dephos
1.46898 0.001321 1.41E-06 0.0013185
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.001321 1.41E-06 0.0013185
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132103 1.41E-06 0.00131847
1.46898 0.00132103 1.41E-06 0.00131846
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.001321 1.41E-06 0.00131849
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.001321 1.41E-06 0.0013185
1.46898 0.00132103 1.41E-06 0.00131846
1.46898 0.00132103 1.41E-06 0.00131846
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132101 1.41E-06 0.00131849
1
2
9
Table showing results for repeated parameter estimations with the Levenberg-Marquardt algorithm starting from
random start values. Only three parameters were fitted, after the Fisher information was employed to reduce the
number of fit parameters.
Target Function k_TNF_degr k_basal_JNK_phos k_dephos
1.93488 0.000220413 4.45E-06 0.1
1.46898 0.001321 1.41E-06 0.0013185
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132103 1.41E-06 0.00131847
1.46898 0.001321 1.41E-06 0.00131849
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.001321 1.41E-06 0.00131849
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.001321 1.41E-06 0.0013185
1.46898 0.00132101 1.41E-06 0.00131849
1.93488 0.00022041 4.45E-06 0.1
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132104 1.41E-06 0.00131845
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132104 1.41E-06 0.00131846
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Table showing results for repeated parameter estimations with the Levenberg-Marquardt algorithm starting from
random start values. Only three parameters were fitted, after the Fisher information was employed to reduce the
number of fit parameters.
Target Function k_TNF_degr k_basal_JNK_phos k_dephos
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132103 1.41E-06 0.00131847
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132103 1.41E-06 0.00131847
1.46898 0.00132103 1.41E-06 0.00131846
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132099 1.41E-06 0.0013185
1.46898 0.00132101 1.41E-06 0.00131848
1.46898 0.00132101 1.41E-06 0.00131848
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.001321 1.41E-06 0.0013185
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Table showing results for repeated parameter estimations with the Levenberg-Marquardt algorithm starting from
random start values. Only three parameters were fitted, after the Fisher information was employed to reduce the
number of fit parameters.
Target Function k_TNF_degr k_basal_JNK_phos k_dephos
1.46898 0.00132101 1.41E-06 0.00131849
1.93488 0.000220411 4.45E-06 0.1
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132103 1.41E-06 0.00131846
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.001321 1.41E-06 0.0013185
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132103 1.41E-06 0.00131847
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132105 1.41E-06 0.00131845
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Table showing results for repeated parameter estimations with the Levenberg-Marquardt algorithm starting from
random start values. Only three parameters were fitted, after the Fisher information was employed to reduce the
number of fit parameters.
Target Function k_TNF_degr k_basal_JNK_phos k_dephos
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.001321 1.41E-06 0.0013185
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.001321 1.41E-06 0.0013185
1.46898 0.001321 1.41E-06 0.0013185
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132103 1.41E-06 0.00131847
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.001321 1.41E-06 0.0013185
1.46898 0.00132103 1.41E-06 0.00131846
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132103 1.41E-06 0.00131846
1.46898 0.001321 1.41E-06 0.0013185
1.46898 0.00132103 1.41E-06 0.00131847
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132099 1.41E-06 0.0013185
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132101 1.41E-06 0.00131849
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Table showing results for repeated parameter estimations with the Levenberg-Marquardt algorithm starting from
random start values. Only three parameters were fitted, after the Fisher information was employed to reduce the
number of fit parameters.
Target Function k_TNF_degr k_basal_JNK_phos k_dephos
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132103 1.41E-06 0.00131846
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132103 1.41E-06 0.00131847
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.001321 1.41E-06 0.0013185
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132099 1.41E-06 0.0013185
1.46898 0.00132101 1.41E-06 0.00131848
1.46898 0.00132103 1.41E-06 0.00131847
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132101 1.41E-06 0.00131849
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132105 1.41E-06 0.00131845
1.46898 0.00132099 1.41E-06 0.00131851
1.46898 0.00132101 1.41E-06 0.00131848
1.46898 0.00132104 1.41E-06 0.00131846
1.46898 0.00132101 1.41E-06 0.00131849
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A.5 Supplementary DVD contents
1. PDF copy of this thesis
2. Supplementary Videos
(a) Single cell microscopy images form HLE cells with transiently trans-
fected RelA-RFP
(b) PDE simulations of the complete NκB model
3. Supplementary Scripts
(a) Cell-Profiler script to analyze microscopy images
(b) R script to analyze Cell-Profiler results
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